PLEDGE AND SECURITY AGREEMENT
Exhibit 10.2
Execution Version
PLEDGE AND SECURITY AGREEMENT, dated as of May 10, 2010, made by each of the Grantors listed on the signature pages hereto (together with each other person that executes a supplement hereto and becomes an “Additional Grantor” hereunder, each a “Grantor” and collectively, jointly and severally, the “Grantors”), in favor of Xxxxxx X.X., in its capacity as collateral agent for the Secured Parties referred to below (in such capacity, together with its successors and assigns in such capacity, if any, the “Collateral Agent”).
W I T N E S S E T H:
WHEREAS, Lantheus MI Intermediate, Inc., a Delaware corporation (the “Parent”), Lantheus Medical Imaging, Inc., a Delaware corporation (the “Borrower”), the “Guarantors” from time to time party thereto, the lenders from time to time party thereto (each a “Lender” and collectively, the “Lenders”), the Collateral Agent, Bank of Montreal, as administrative agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, if any, the “Administrative Agent” and together with the Collateral Agent, each an “Agent” and collectively, the “Agents”), Bank of Montreal and NATIXIS, as joint bookrunners, Bank of Montreal and NATIXIS, as joint lead arrangers, NATIXIS, as syndication agent, and Jefferies Finance, LLC, as documentation agent, dated as of May 10, 2010 (such agreement, as amended, restated, supplemented, modified or otherwise changed from time to time, including any replacement agreement therefor, being hereinafter referred to as the “Credit Agreement”);
WHEREAS, pursuant to the Credit Agreement, the Lenders have agreed to make revolving loans, which revolving loans will include a subfacility for the issuance of letters of credit (each a “Revolving Loan” and collectively, the “Revolving Loans”), to the Borrower;
WHEREAS, it is a condition precedent to the Lenders making any Revolving Loan and providing any other financial accommodation to the Borrower pursuant to the Credit Agreement that each Grantor shall have executed and delivered to the Collateral Agent a pledge and security agreement to the Collateral Agent, for the benefit of the Secured Parties, providing for, among other things, the grant to the Collateral Agent, for the benefit of the Secured Parties, of (a) a security interest in and Lien on the outstanding shares of Capital Stock (as defined in the Credit Agreement) and indebtedness from time to time owned by such Grantor of each Person now or hereafter existing and in which such Grantor has any interest at any time (subject to any express limitations set forth in Section 2), and (b) a security interest in all other personal property and fixtures of such Grantor (subject to any express limitations set forth in Section 2);
WHEREAS, the Grantors are mutually dependent on each other in the conduct of their respective businesses as an integrated operation, with credit needed from time to time by each Grantor often being provided through financing obtained by the other Grantors and
the ability to obtain such financing being dependent on the successful operations of all of the Grantors as a whole; and
WHEREAS, each Grantor has determined that the execution, delivery and performance of this Agreement directly benefit, and are in the best interest of, such Grantor;
NOW, THEREFORE, in consideration of the premises and the agreements herein and in order to induce the Collateral Agent and the Lenders to make and maintain the Revolving Loans and to assist in providing Letters of Credit and other financial accommodations to the Borrower pursuant to the Credit Agreement, the Grantors hereby jointly and severally agree with the Collateral Agent, for the benefit of the Secured Parties, as follows:
1. Definitions.
(a) Reference is hereby made to the Credit Agreement for a statement of the terms thereof. All capitalized terms used in this Agreement and the recitals hereto which are defined in the Credit Agreement or in Article 8 or 9 of the Uniform Commercial Code as in effect from time to time in the State of New York (the “Code”) and which are not otherwise defined herein shall have the same meanings herein as set forth therein; provided that terms used herein which are defined in the Code as in effect in the State of New York on the date hereof shall continue to have the same meaning notwithstanding any replacement or amendment of such statute except as the Collateral Agent may otherwise determine.
(b) The following terms shall have the respective meanings provided for in the Code: “Accounts”, “Account Debtor”, “Cash Proceeds”, “Certificate of Title”, “Chattel Paper”, “Commercial Tort Claim”, “Commodity Account”, “Commodity Contracts”, “Deposit Account”, “Documents”, “Electronic Chattel Paper”, “Equipment”, “Fixtures”, “General Intangibles”, “Goods”, “Instruments”, “Inventory”, “Investment Property”, “Letter-of-Credit Rights”, “Noncash Proceeds”, “Payment Intangibles”, “Proceeds”, “Promissory Notes”, “Record”, “Securities Account”, “Software”, “Supporting Obligations” and “Tangible Chattel Paper”.
(c) As used in this Agreement, the following terms shall have the respective meanings indicated below, such meanings to be applicable equally to both the singular and plural forms of such terms:
“Additional Collateral” has the meaning specified therefor in Section 4(a)(i) hereof.
“Certificated Entities” has the meaning specified therefor in Section 5(m) hereof.
“Copyright Licenses” means all licenses, contracts or other agreements, whether written or oral, naming any Grantor as licensee or licensor and providing for the grant of any right to use or sell any works covered by any Copyright.
“Existing Issuer” has the meaning specified therefor in the definition of the term “Pledged Shares”.
“Foreign Subsidiary” has the meaning specified therefor in Section 2 hereof.
“Intellectual Property” means all rights in all U.S and non-U.S. (i) published and unpublished works of authorship (including, without limitation, computer software), copyrights therein and thereto, and registrations and applications therefor, and all renewals, extensions, restorations and reversions thereof, including, without limitation, all copyright registrations and applications listed in Schedule II hereto (collectively, “Copyrights”); (ii) inventions, discoveries and all patents, registrations, and applications therefor, including, without limitation, divisions, continuations, continuations-in-part and renewal applications, and all renewals, extensions and reissues, including, without limitation, all patents and patent applications listed in Schedule II hereto (collectively, “Patents”); (iii) trademarks, service marks, brand names, certification marks, collective marks, d/b/a’s, Internet domain names, logos, symbols, trade dress, assumed names, fictitious names, trade names, and other indicia of origin, all applications and registrations for all of the foregoing, and all goodwill associated therewith and symbolized thereby, and all extensions, modifications and renewals of same, including, without limitation, all trademark registrations and applications listed in Schedule II hereto (collectively, “Trademarks”); (iv) confidential and proprietary information, trade secrets and know-how, including, without limitation, processes, schematics, databases, formulae, drawings, prototypes, models, designs and customer lists (collectively, “Trade Secrets”); and (v) all other intellectual property or proprietary rights and claims or causes of action arising out of or related to any infringement, misappropriation or other violation of any of the foregoing, including, without limitation, rights to recover for past, present and future violations thereof (collectively, “Other Proprietary Rights”).
“Licenses” means the Copyright Licenses, the Patent Licenses and the Trademark Licenses.
“Material Intellectual Property” means Intellectual Property owned by or licensed to a Grantor and material to the conduct of any Grantor’s business.
“Patent Licenses” means all licenses, contracts or other agreements, whether written or oral, naming any Grantor as licensee or licensor and providing for the grant of any right to manufacture, use or sell any invention covered by any Patent.
“Pledged Debt” means the indebtedness described in Schedule VI hereto and all indebtedness from time to time owned or acquired by a Grantor, the promissory notes and other Instruments evidencing any or all of such indebtedness, and all interest, cash, Instruments, Investment Property, financial assets, securities, Capital Stock, other equity interests, stock options and commodity contracts, notes, debentures, bonds, promissory notes or other evidences of indebtedness and all other property from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of such indebtedness.
“Pledged Interests” means, collectively, (a) the Pledged Debt, (b) the Pledged Shares and (c) all security entitlements in any and all of the foregoing.
“Pledged Issuer” has the meaning specified therefor in the definition of the term “Pledged Shares”.
“Pledged Shares” means (a) the shares of Capital Stock described in Schedule VII hereto, whether or not evidenced or represented by any stock certificate, certificated security or other Instrument, issued by the Persons described in such Schedule VII (the “Existing Issuers”), (b) the shares of Capital Stock at any time and from time to time acquired by a Grantor of any and all Persons now or hereafter existing (such Persons, together with the Existing Issuers, being hereinafter referred to collectively as the “Pledged Issuers” and each individually as a “Pledged Issuer”), whether or not evidenced or represented by any stock certificate, certificated security or other Instrument, subject, however, to the limitations set forth in Section 2 and (c) the certificates representing such shares of Capital Stock, all options and other rights, contractual or otherwise, in respect thereof and all dividends, distributions, cash, Instruments, Investment Property, financial assets, securities, Capital Stock, other equity interests, stock options and commodity contracts, notes, debentures, bonds, promissory notes or other evidences of indebtedness and all other property (including, without limitation, any stock dividend and any distribution in connection with a stock split) from time to time received, receivable or otherwise distributed in respect of or in exchange for any or all of such Capital Stock.
“Secured Parties” means, collectively, the Agents and the Lenders.
“Secured Obligations” has the meaning specified therefor in Section 3 hereof.
“Trademark Licenses” means all licenses, contracts or other agreements, whether written or oral, naming any Grantor as licensor or licensee and providing for the grant of any right concerning any Trademark, together with any goodwill connected with and symbolized by any such trademark licenses, contracts or agreements.
2. Grant of Security Interest. As collateral security for the payment, performance and observance of all of the Secured Obligations, each Grantor hereby pledges and assigns to the Collateral Agent (and its agents and designees), and grants to the Collateral Agent (and its agents and designees), for the benefit of the Secured Parties, a continuing security interest in, all personal property and Fixtures of such Grantor, wherever located and whether now or hereafter existing and whether now owned or hereafter acquired, of every kind and description, tangible or intangible, including, without limitation, the following (all being collectively referred to herein as the “Collateral”):
(a) all Accounts;
(b) all Chattel Paper (whether tangible or electronic);
(c) the Commercial Tort Claims specified on Schedule V;
(d) all Deposit Accounts, all cash, and all other property from time to time deposited therein or otherwise credited thereto and the monies and property in the possession or under the control of any Agent or any Lender or any affiliate, representative, agent or correspondent of any Agent or any Lender;
(e) all Documents;
(f) all General Intangibles (including, without limitation, all Payment Intangibles, Intellectual Property and Licenses);
(g) all Goods, including, without limitation, all Equipment, Fixtures and Inventory;
(h) all Instruments (including, without limitation, Promissory Notes);
(i) all Investment Property;
(j) all Letter-of-Credit Rights;
(k) all Pledged Interests;
(l) all Supporting Obligations;
(m) all other tangible and intangible personal property of such Grantor (whether or not subject to the Code), including, without limitation, all bank and other accounts and all cash and all investments therein, all proceeds, products, offspring, accessions, rents, profits, income, benefits, substitutions and replacements of and to any of the property of such Grantor described in the preceding clauses of this Section 2 (including, without limitation, any proceeds of insurance thereon and all causes of action, claims and warranties now or hereafter held by such Grantor in respect of any of the items listed above), and all books, correspondence, files and other Records, including, without limitation, all tapes, disks, cards, Software, data and computer programs in the possession or under the control of such Grantor or any other Person from time to time acting for such Grantor that at any time evidence or contain information relating to any of the property described in the preceding clauses of this Section 2 or are otherwise necessary or helpful in the collection or realization thereof; and
(n) all Proceeds, including all Cash Proceeds and Noncash Proceeds, and products of any and all of the foregoing Collateral;
in each case howsoever such Grantor’s interest therein may arise or appear (whether by ownership, security interest, claim or otherwise).
Notwithstanding anything herein to the contrary, the term “Collateral” shall not include, and no Grantor is pledging, nor granting a security interest hereunder in:
(i) any of such Grantor’s right, title or interest in any license, contract or agreement to which such Grantor is a party or any of its right, title or interest thereunder to the extent, but only to the extent, that such a grant would, under the express terms of such license, contract or agreement result in a breach of the terms of, or constitute a default under, such license, contract or agreement (other than to the extent that any such term (A) has been waived or (B) would be rendered ineffective pursuant to Sections 9-406, 9-408, 9-409 of the Code or other applicable provisions of the Uniform Commercial Code of any relevant jurisdiction or any other applicable law (including the Bankruptcy Code) or principles of equity); provided, that (x) immediately upon the ineffectiveness, lapse, termination or waiver of any such provision, the Collateral shall include, and such Grantor shall be deemed to have granted a security interest in, all such right, title and interest as if such provision had never been in effect, and (y) the foregoing exclusion shall in no way be construed so as to limit, impair or otherwise affect the Collateral Agent’s unconditional continuing security interest in and liens upon any rights or interests of a Grantor in or to the proceeds of, or any monies due or to become due under, any such license, contract or agreement,
(ii) any intent-to-use United States trademark applications (A) for which an amendment to allege use or statement of use has not been filed under 15 U.S.C. § 1051(c) or 15 U.S.C. § 1051(d), respectively, or if filed, has not been deemed in conformance with 15 U.S.C. § 1051(a) or examined and accepted, respectively, by the United States Patent and Trademark Office, provided that, upon such filing and acceptance, such intent-to-use applications shall be included in the definition of Collateral, or (B) to the extent that and for so long as such a grant would result in the abandonment, invalidation or unenforceability of such intent-to-use United States trademark applications under applicable law, provided, that (x) immediately upon such time that the grant of a security interest in such intent-to-use United States trademark applications would no longer result in the abandonment, invalidation or unenforceability of such intent-to-use United States trademark applications under applicable law, the Collateral shall include, and such Grantor shall be deemed to have granted a security interest in, all such intent-to-use United States trademark applications as if such applicable law had never been in effect and (y) the foregoing exclusion shall in no way be construed so as to limit, impair or otherwise affect the Collateral Agent’s unconditional continuing security interest in and liens upon any rights or interests of a Grantor in or to the proceeds of, or any monies due or to become due under, any such intent-to-use United States trademark applications,
(iii) any Excluded Account, or
(iv) in the case of a Subsidiary of such Grantor organized under the laws of a jurisdiction other than the United States, any of the states thereof or the District of Columbia and which is a “controlled foreign corporation” as such term is defined in Section 957 of the Internal Revenue Code (a “Foreign Subsidiary”) and which is a “controlled foreign corporation” (as such term is defined in Section 957 of
the Internal Revenue Code of 1986 (a “CFC”), more than 65% of the issued and outstanding shares of Capital Stock entitled to vote (within the meaning of Treas. Reg. Section 1.956 2(c)(2)) (it being understood and agreed that the Collateral shall include 100% of the issued and outstanding shares of Capital Stock not entitled to vote within the meaning of Treas. Reg. Section 1.956 2(c)(2)) or other equity interest of such CFC (and for the avoidance of doubt, each Loan Party will refrain from pledging the Capital Stock of any CFC to any Person other than a pledge of 65% of its voting Capital Stock and 100% of its non-voting Capital Stock to the Collateral Agent, for the benefit of the Secured Parties.
3. Security for Secured Obligations. The security interest created hereby in the Collateral constitutes continuing collateral security for all of the following obligations, whether now existing or hereafter incurred (the “Secured Obligations”):
(a) the prompt payment by each Grantor, as and when due and payable (whether by scheduled maturity, required prepayment, acceleration, demand or otherwise), of all amounts from time to time owing by it in respect of the Credit Agreement and/or the other Loan Documents, including, without limitation, (i) all Obligations, (ii) all Letter of Credit Obligations, (iii) in the case of a Guarantor, all amounts from time to time owing by such Grantor in respect of its guaranty made pursuant to Article XI of the Credit Agreement or under any other Guaranty to which it is a party, including, without limitation, all obligations guaranteed by such Grantor and (iv) all interest, fees, commissions, charges, expense reimbursements, indemnifications and all other amounts due or to become due under any Loan Document (including, without limitation, all interest, fees, commissions, charges, expense reimbursements, indemnifications and other amounts that accrue after the commencement of any Insolvency Proceeding of any Loan Party, whether or not the payment of such interest, fees, commissions, charges, expense reimbursements, indemnifications and other amounts are unenforceable or are not allowable, in whole or in part, due to the existence of such Insolvency Proceeding); and
(b) the due performance and observance by each Grantor of all of its other obligations from time to time existing in respect of the Loan Documents.
4. Delivery of the Pledged Interests.
(a) (i) All promissory notes evidencing the Pledged Debt on the Effective Date and all certificates representing the Pledged Shares on the Effective Date shall be delivered to the Collateral Agent (or its custodian, designee or other nominee) on or prior to the Effective Date. All other promissory notes, certificates and Instruments constituting Pledged Interests from time to time required to be pledged to the Collateral Agent pursuant to the terms of this Agreement or the Credit Agreement (the “Additional Collateral”) shall be delivered to the Collateral Agent (or its custodian, designee or other nominee) promptly upon, but in any event within fourteen (14) days (or such later date acceptable to the Collateral Agent) of, receipt thereof by or on behalf of any of the Grantors, provided that such delivery requirement shall not apply to any Pledged Debt having a face amount of less
than $500,000 individually but only to the extent the aggregate face amount of such Pledged Debt does not exceed $1,000,000 collectively. All such promissory notes, certificates and Instruments shall be held by or on behalf of the Collateral Agent (or its custodian, designee or other nominee) pursuant hereto and shall be delivered in suitable form for transfer by delivery or shall be accompanied by duly executed instruments of transfer or assignment or undated stock powers executed in blank, all in form and substance reasonably satisfactory to the Collateral Agent. If any Pledged Interests consists of uncertificated securities, unless the immediately following sentence is applicable thereto, such Grantor shall cause the Collateral Agent (or its designated custodian or nominee) to become the registered holder thereof, or cause each issuer of such securities to agree that it will comply with instructions originated by the Collateral Agent with respect to such securities without further consent by such Grantor. If any Pledged Interests consists of security entitlements, such Grantor shall transfer such security entitlements to the Collateral Agent (or its custodian, nominee or other designee), or cause the applicable securities intermediary to agree that it will comply with entitlement orders by the Collateral Agent without further consent by such Grantor.
(ii) Within twenty (20) days (or such later date acceptable to the Collateral Agent) of the receipt by a Grantor of any Additional Collateral, a Pledge Amendment, duly executed by such Grantor, in substantially the form of Exhibit A hereto (a “Pledge Amendment”), shall be delivered to the Collateral Agent, in respect of the Additional Collateral that must be pledged pursuant to this Agreement and the Credit Agreement. The Pledge Amendment shall from and after delivery thereof constitute part of Schedules VI and VII hereto. Each Grantor hereby authorizes the Collateral Agent to attach each Pledge Amendment to this Agreement and agrees that all promissory notes, certificates or Instruments listed on any Pledge Amendment delivered to the Collateral Agent (or its custodian, designee or other nominee) shall for all purposes hereunder constitute Pledged Interests and such Grantor shall be deemed upon delivery thereof to have made the representations and warranties set forth in Section 5 hereof with respect to such Additional Collateral.
(b) If any Grantor shall receive, by virtue of such Grantor’s being or having been an owner of any Pledged Interests, any (i) stock certificate (including, without limitation, any certificate representing a stock dividend or distribution in connection with any increase or reduction of capital, reclassification, merger, consolidation, sale of assets, combination of shares, stock split, spin-off or split-off), promissory note or other Instrument, (ii) option or right, whether as an addition to, substitution for, or in exchange for, any Pledged Interests, or otherwise, (iii) dividends payable in cash (except such dividends permitted to be retained by any such Grantor pursuant to Section 7 hereof) or in securities or other property or (iv) dividends, distributions, cash, Instruments, Investment Property and other property in connection with a partial or total liquidation or dissolution or in connection with a reduction of capital, capital surplus or paid-in surplus, such Grantor shall receive such stock certificate, promissory note, Instrument, option, right, payment or distribution in trust for the benefit of the Collateral Agent, shall segregate it from such Grantor’s other property and shall promptly deliver it forthwith to the Collateral Agent, in the exact form received, with any necessary indorsement and/or appropriate stock powers duly executed in blank, to
be held by the Collateral Agent as Pledged Interests and as further collateral security for the Secured Obligations.
5. Representations and Warranties. Each Grantor jointly and severally represents and warrants as follows:
(a) Schedule I hereto sets forth as of the Effective Date (i) the exact legal name of each Grantor, (ii) the state or jurisdiction of organization of each Grantor, (iii) the type of organization of each Grantor, (iv) the organizational identification number of each Grantor or states that no such organizational identification number exists and (v) the federal employer identification number of each Grantor.
(b) This Agreement is a legal, valid and binding obligation of such Grantor, enforceable against such Grantor in accordance with its terms, except as may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws.
(c) All Equipment, Fixtures, Inventory and other Goods (other than Inventory in transit to customers) located in the continental United States now existing are, and all Equipment, Fixtures, Inventory and other Goods (other than Inventory in transit to customers) located in the continental United States hereafter existing will be, located at the addresses specified therefor in Schedule III hereto (as amended, supplemented or otherwise modified from time to time in accordance with Section 6(b)), except for any location where the fair market value of the Equipment, Fixtures, Inventory and other Goods at such location is less than $1,000,000 in the aggregate. Each Grantor’s chief place of business and chief executive office, the place where such Grantor keeps its Records concerning Accounts and all originals of all Chattel Paper are located at the addresses specified therefor in Schedule III hereto (as amended, supplemented or otherwise modified from time to time in accordance with the terms hereof). None of the Accounts is evidenced by Promissory Notes or other Instruments (except for Promissory Notes evidencing indebtedness of not more than $500,000 individually and $1,000,000 in the aggregate) that have not been delivered to the Collateral Agent in accordance with this Agreement. Set forth in Schedule II hereto is a complete and correct list of each formal legal name used by any Grantor during the past five years. Schedule VIII hereto sets forth for each Grantor a true and complete list of all Investment Property, including all securities, securities entitlements, Instruments, Chattel Paper, Letters of Credit and any certificates or instruments evidencing the foregoing held by or on behalf of or issued in favor of each Grantor (excluding the assets already identified on Schedules VI and VII), whether or not evidenced by certificates or Instruments.
(d) [Reserved.]
(e) (i) The Grantors own and control, or otherwise possess adequate rights to use, all Intellectual Property necessary to conduct their business except as could not reasonably be expected to have a Material Adverse Effect. Schedule II hereto sets forth a true and complete list of all Intellectual Property that is the subject of U.S. registrations or applications for registration in the U.S. owned by each Grantor as of the date hereof. To the
applicable Grantor’s knowledge, all such Intellectual Property is valid, subsisting and enforceable, has not been abandoned in whole or in part and is not subject to any outstanding order, judgment or decree restricting its use or adversely affecting the Grantor’s rights thereto, except to the extent the loss of any such Intellectual Property (either individually or in the aggregate) could not reasonably be expected to have a Material Adverse Effect.
(ii) Such Grantor is not violating and has not violated any Intellectual Property rights or any third party except as could not reasonably be expected to have a Material Adverse Effect. There are no suits, actions, reissues, reexaminations, public protests, interferences, arbitrations, mediations, oppositions, cancellations, Internet domain name dispute resolutions or other proceedings (collectively, “Suits”) pending, decided, asserted by or against such Grantor or, to such Grantor’s knowledge, threatened concerning the violation of any Intellectual Property rights or concerning the Material Intellectual Property owned or controlled by a Grantor, and, to any Grantor’s knowledge, no valid basis for any such Suits or claims exists, except as could not reasonably be expected to have a Material Adverse Effect. To the Grantors’ knowledge, there are no Suits or claims pending, decided, threatened or asserted against the Grantors concerning the Licenses or the right of the Grantor to use the Licenses, and no valid basis for any such Suits or claims exists, except as could not reasonably be expected to have a Material Adverse Effect.
(f) (i) None of the Other Proprietary Rights or Trade Secrets of any Grantor have been used, divulged, disclosed or appropriated to the detriment of such Grantor for the benefit of any other Person other than such Grantor; (ii) no employee, independent contractor or agent of any Grantor has misappropriated any Other Proprietary Rights or Trade Secrets of any other Person in the course of the performance of his or her duties as an employee, independent contractor or agent of such Grantor; and (iii) no employee, independent contractor or agent of any Grantor is in default or breach of any term of any employment agreement, non-disclosure agreement, assignment of inventions agreement or similar agreement, or contract relating an any way to the protection, ownership, development, use or transfer of such Grantor’s Intellectual Property Collateral, except to the extent any of the foregoing could not reasonably be expected (either individually or in the aggregate) to have a Material Adverse Effect.
(g) The Existing Issuers set forth in Schedule VII identified as a Subsidiary of a Grantor are each such Grantor’s only Subsidiaries existing on the date hereof. The Pledged Shares have been duly authorized and validly issued and are fully paid and nonassessable and the holders thereof are not entitled to any preemptive, first refusal or other similar rights. Except as noted in Schedule VII hereto, the Pledged Shares constitute 100% of the issued shares of Capital Stock of the Pledged Issuers as of the date hereof. All other shares of Capital Stock constituting Pledged Interests will be duly authorized and validly issued, fully paid and nonassessable.
(h) The promissory notes currently evidencing the Pledged Debt have been, and all other promissory notes from time to time evidencing Pledged Debt, when
executed and delivered, will have been, duly authorized, executed and delivered by the respective makers thereof, and all such promissory notes are or will be, as the case may be, legal, valid and binding obligations of such makers, enforceable against such makers in accordance with their respective terms, except as may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws.
(i) The Grantors are and will be at all times the sole and exclusive owners of, or otherwise have and will have adequate rights in, the Collateral free and clear of any Lien except for the Permitted Liens. No effective financing statement or other instrument similar in effect covering all or any part of the Collateral is on file in any recording or filing office except (i) such as may have been filed to perfect or protect any Permitted Lien, and (ii) in connection with the Existing Credit Agreement; provided, that the liens in connection with the Existing Credit Agreement shall be terminated concurrently with the Effective Date.
(j) The exercise by the Collateral Agent of any of its rights and remedies hereunder will not contravene any law or any Contractual Obligation binding on or otherwise affecting any Grantor or any of its properties and will not result in, or require the creation of, any Lien upon or with respect to any of its properties other than Liens created pursuant to the Loan Documents.
(k) No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority or any other Person, is required for (i) the due execution, delivery and performance by any Grantor of this Agreement, (ii) the grant by any Grantor of the security interest purported to be created hereby in the Collateral or (iii) the exercise by the Collateral Agent of any of its rights and remedies hereunder, except, in the case of this clause (iii), as may be required in connection with any sale of any Pledged Interests by laws affecting the offering and sale of securities generally. No authorization or approval or other action by, and no notice to or filing with, any Governmental Authority or any other Person, is required for the perfection of the security interest purported to be created hereby in the Collateral, except (A) for the filing under the Uniform Commercial Code as in effect in the applicable jurisdiction of the financing statements described in Schedule IV hereto, all of which financing statements shall be duly filed on or around the Effective Date and from such date shall be in full force and effect, (B) with respect to the perfection of the security interest created hereby in the United States Intellectual Property, for the recording of the appropriate Assignment for Security, substantially in the form of Exhibit B hereto in the United States Patent and Trademark Office or the United States Copyright Office, as applicable, (C) with respect to any action that may be necessary to obtain control of Collateral constituting Deposit Accounts, Electronic Chattel Paper, Investment Property or Letter-of-Credit Rights, the taking of such actions, and (D) the Collateral Agent’s having possession of all Documents, Chattel Paper, Instruments and cash constituting Collateral (subclauses (A), (B), (C) and (D), each a “Perfection Requirement” and collectively, the “Perfection Requirements”).
(l) This Agreement creates a legal, valid and enforceable security interest in favor of the Collateral Agent, for the benefit of the Secured Parties, in the Collateral, as
security for the Secured Obligations. The satisfaction of the Perfection Requirements will result in the perfection of such security interests. After satisfaction of the Perfection Requirements, such security interests are, or in the case of Collateral in which any Grantor obtains rights after the date hereof, will be, perfected, first priority security interests, subject in priority only to the Permitted Liens that, pursuant to the definition of the term “Permitted Liens”, are not prohibited from being prior to the Liens in favor of the Collateral Agent, for the benefit of the Secured Parties, and the recording of such instruments of assignment described above. Such Perfection Requirements and all other action necessary or desirable to perfect and protect such security interest have been duly made or taken, except for (i) the Collateral Agent’s having possession of all Instruments, Documents, Chattel Paper and cash constituting Collateral after the date hereof, (ii) the Collateral Agent’s having control of all Deposit Accounts, Electronic Chattel Paper, Investment Property or Letter-of-Credit Rights constituting Collateral after the date hereof, and (iii) the other filings and recordations and actions described in Section 5(l) hereof.
(m) As of the date hereof, no Grantor holds any Commercial Tort Claims, except for such claims described in Schedule V.
(n) With respect to each Grantor and its Subsidiaries that is a partnership or a limited liability company, none of the partnership interests or membership interests of such Person are (i) dealt in or traded on securities exchanges or in securities markets, (ii) securities for purposes of Article 8 of any relevant Uniform Commercial Code, (iii) investment company securities within the meaning of Section 8-103 of any relevant Uniform Commercial Code or (iv) evidenced by a certificate. The partnership interests or membership interests of any Grantor and its Subsidiaries constitute General Intangibles.
6. Covenants as to the Collateral. So long as any of the Secured Obligations (whether or not due) shall remain unpaid or any Lender shall have any Revolving Credit Commitment under the Credit Agreement, unless the Collateral Agent shall otherwise consent in writing:
(a) Further Assurances. Each Grantor will at its expense, at any time and from time to time, promptly execute and deliver all further instruments and documents and take all further action that may be necessary or desirable or that the Collateral Agent may reasonably request in order (i) to perfect and protect, or maintain the perfection of, the security interest and Lien purported to be created hereby; (ii) to enable the Collateral Agent to exercise and enforce its rights and remedies hereunder in respect of the Collateral; or (iii) otherwise to effect the purposes of this Agreement, including, without limitation: (A) if a Default or an Event of Default has occurred and is continuing, marking conspicuously all Chattel Paper, Instruments and Licenses and, at the request of the Collateral Agent, all of its Records pertaining to the Collateral with a legend, in form and substance reasonably satisfactory to the Collateral Agent, indicating that such Chattel Paper, Instrument, License or Collateral is subject to the security interest created hereby, (B) if any Account shall be evidenced by a Promissory Note or other Instrument or Chattel Paper, delivering and pledging to the Collateral Agent such Promissory Note, other Instrument or Chattel Paper,
duly endorsed and accompanied by executed instruments of transfer or assignment, all in form and substance satisfactory to the Collateral Agent, provided that such delivery requirement shall not apply to any Pledged Debt having a face amount of less than $500,000 individually but only to the extent the aggregate face amount of such Pledged Debt does not exceed $1,000,000 collectively, (C) executing and filing (to the extent, if any, that such Grantor’s signature is required thereon) or authenticating the filing of, such financing or continuation statements, or amendments thereto, (D) with respect to Intellectual Property hereafter existing and not covered by an appropriate security interest grant, the executing and recording in the United States Patent and Trademark Office or the United States Copyright Office, as applicable, appropriate instruments granting a security interest, as may be necessary or desirable or that the Collateral Agent may reasonably request in order to perfect and preserve the security interest purported to be created hereby, (E) delivering to the Collateral Agent irrevocable proxies in respect of the Pledged Interests, (F) furnishing to the Collateral Agent from time to time statements and schedules further identifying and describing the Collateral and such other reports in connection with the Collateral as the Collateral Agent may reasonably request, all in reasonable detail, (G) if at any time after the date hereof, any Grantor acquires or holds any Commercial Tort Claim (other than any Commercial Tort Claims having a value of less than $500,000 individually and $1,000,000 in the aggregate,) immediately notifying the Collateral Agent in a writing signed by such Grantor setting forth a brief description of such Commercial Tort Claim and granting to the Collateral Agent a security interest therein and in the proceeds thereof, which writing shall incorporate the provisions hereof and shall be in form and substance reasonably satisfactory to the Collateral Agent, and (H) taking all actions required by law in any relevant Uniform Commercial Code jurisdiction, or by other law as applicable in any foreign jurisdiction.
(b) Location of Equipment and Inventory. Each Grantor will keep the Equipment and Inventory (other than Equipment and Inventory sold in the ordinary course of business in accordance with Section 6(g) hereof or located outside of the continental United States) at the locations specified in Schedule III hereto or, upon prompt written notice thereafter to the Collateral Agent accompanied by a new Schedule III hereto indicating each new location containing Records concerning Accounts or Equipment and Inventory with an aggregate fair market value in excess of $1,000,000, at such other locations as the Grantors may elect. If any Grantor moves the location of its primary Records concerning Accounts to a new leased location after the date hereof, upon the reasonable request of Collateral Agent, each Grantor shall use commercially reasonable efforts to (A) obtain written subordinations or waivers, in form and substance satisfactory to the Collateral Agent, of all present and future Liens to which the owner or lessor of such premises may be entitled to assert against the Collateral located at such premises, and (B) obtain written access agreements, in form and substance reasonably satisfactory to the Collateral Agent, providing access to the Collateral located on such premises in order to remove such Collateral from such premises during an Event of Default.
(c) Equipment. Each Grantor will promptly furnish to the Collateral Agent a statement describing in reasonable detail any loss or damage to any Equipment in excess of $1,000,000.
(d) Insurance. Each Grantor will, at its own expense, maintain insurance with respect to the Collateral in accordance with the terms of the Credit Agreement. Each Grantor will, if so requested by the Collateral Agent, deliver to the Collateral Agent original or duplicate insurance policies and, as often as the Collateral Agent may reasonably request, a report of a reputable insurance broker with respect to such insurance. Each Grantor will also, at the reasonable request of the Collateral Agent, execute and deliver instruments of assignment of such insurance policies and cause the respective insurers to acknowledge notice of such assignment.
(e) Provisions Concerning the Accounts. Each Grantor will, except as otherwise provided in this subsection (e), continue to collect, at its own expense, all amounts due or to become due under the Accounts. In connection with such collections, each Grantor may (and, if an Event of Default has occurred and is continuing, at the Collateral Agent’s direction, will) take such action as such Grantor (or, if an Event of Default has occurred and is continuing, the Collateral Agent) may reasonably deem necessary or advisable to enforce collection or performance of the Accounts; provided, however, that the Collateral Agent shall have the right at any time, upon the occurrence and during the continuance of an Event of Default, to notify the Account Debtors or obligors under any Accounts of the assignment of such Accounts to the Collateral Agent and to direct such Account Debtors or obligors to make payment of all amounts due or to become due to such Grantor thereunder directly to the Collateral Agent or its designated agent and, upon such notification and at the expense of such Grantor and to the extent permitted by law, to enforce collection of any such Accounts and to adjust, settle or compromise the amount or payment thereof, in the same manner and to the same extent as such Grantor might have done. After the occurrence and during the continuance of an Event of Default and after receipt by any Grantor of a notice from the Collateral Agent that the Collateral Agent has notified, intends to notify, or has enforced or intends to enforce a Grantor’s rights against the Account Debtors or obligors under any Accounts as referred to in the proviso to the immediately preceding sentence, (A) all amounts and proceeds (including Instruments) received by such Grantor in respect of the Accounts shall be received in trust for the benefit of the Collateral Agent hereunder, shall be segregated from other funds of such Grantor and shall be forthwith paid over to the Collateral Agent or its designated agent in the same form as so received (with any necessary endorsement) to be held as cash collateral and either (x) credited to the Loan Account so long as no Event of Default shall have occurred and be continuing or (y) if any Event of Default shall have occurred and be continuing, applied as specified in Section 9(d) hereof, and (B) such Grantor will not adjust, settle or compromise the amount or payment of any Account or release wholly or partly any Account Debtor or obligor thereof or allow any credit or discount thereon.
(f) Provisions Concerning the Pledged Interests. Each Grantor will
(i) at the Grantors’ joint and several expense, promptly deliver to the Collateral Agent a copy of each material notice or other communication received by it in respect of the Pledged Interests;
(ii) at the Grantors’ joint and several expense, defend the Collateral Agent’s right, title and security interest in and to the Pledged Interests against the claims of any Person; and
(iii) with respect to any Subsidiary of the Parent, not permit the issuance of (A) any additional shares of any class of Capital Stock of any Pledged Issuer, (B) any securities convertible voluntarily by the holder thereof or automatically upon the occurrence or non-occurrence of any event or condition into, or exchangeable for, any such shares of Capital Stock or (C) any warrants, options, contracts or other commitments entitling any Person to purchase or otherwise acquire any such shares of Capital Stock, unless in each case the applicable Grantor makes the deliveries and takes the other actions required by Section 4.
(g) Transfers and Other Liens.
(i) Except to the extent expressly permitted by Section 7.02(c) of the Credit Agreement, no Grantor will sell, assign (by operation of law or otherwise), lease, license, exchange or otherwise transfer or dispose of any of the Collateral.
(ii) Except to the extent expressly permitted by Section 7.02(a) of the Credit Agreement, no Grantor will create, suffer to exist or grant any Lien upon or with respect to any Collateral.
(h) Intellectual Property.
(i) Each Grantor has duly executed and delivered the applicable Grant of a Security Interest in the form attached hereto as Exhibit B.
(ii) Each Grantor (either itself or through its licensees or its sublicensees) agrees that it will not do any act or omit to do any act whereby any Material Intellectual Property may become invalidated or dedicated to the public, and agrees that it shall continue to xxxx any products covered by a Patent with the relevant patent number as necessary to establish and preserve its rights under applicable patent laws, except where the failure to do so could not reasonably be expected to result in a Material Adverse Effect.
(iii) Each Grantor (either itself or through its licensees or its sublicensees) will, for each Trademark that constitutes Material Intellectual Property, take such actions that in its commercially reasonable business judgment are necessary to: (A) maintain such Trademark in full force free from any claim of abandonment or invalidity for non use, (B) maintain the quality of products and services offered under such Trademark, (C) display such Trademark with notice of U.S. or non-U.S. registration to the extent necessary to establish and preserve its rights under applicable law, except where the failure to do so could not reasonably be expected to result in a Material Adverse Effect and (D) not knowingly use or knowingly permit the use of such Trademark in violation of any third party rights.
(iv) Each Grantor (either itself or through its licensees or sublicensees) will, for each work covered by a Copyright that constitutes Material Intellectual Property, continue to publish, reproduce, display, adopt and distribute the work with appropriate copyright notice as necessary to establish and preserve its rights under applicable copyright laws, except where the failure to do so could not reasonably be expected to result in a Material Adverse Effect.
(v) Each Grantor shall notify the Collateral Agent promptly if it knows that any Material Intellectual Property may become abandoned, lost or dedicated to the public in violation of the foregoing clauses (ii) and (iii), or of any final determination (including the institution of, or any such determination in, any proceeding in the United States Patent and Trademark Office, United States Copyright Office or any court or similar office of any country) that could reasonably be expected to result in a Material Adverse Effect regarding such Grantor’s ownership of any Material Intellectual Property, its right to register the same, or its right to keep and maintain the same. Notwithstanding anything to the contrary contained herein, the Grantors may abandon or otherwise dispose of immaterial Intellectual Property if, in such Grantor’s commercially reasonable business judgment, such Intellectual Property is no longer of any useful economic value.
(vi) If any Grantor (A) files an application or registration for any Intellectual Property with the United States Patent and Trademark Office or United States Copyright Office, either itself or through any agent, employee, licensee or designee or (B) obtains rights to or develops any new Intellectual Property or any reissue, division, continuation, renewal, extension or continuation-in-part of any existing Intellectual Property, whether pursuant to any license or otherwise, the provisions of Section 2 hereof shall automatically apply thereto and such Grantor shall give to the Collateral Agent notice of any applications or registrations on a quarterly basis and, upon request of the Collateral Agent, execute and deliver any and all agreements, instruments, documents and papers as the Collateral Agent may reasonably request to evidence the Collateral Agent’s security interest in such Intellectual Property.
(vii) Each Grantor will take all necessary steps in its commercially reasonable business judgment, in any proceeding before the United States Patent and Trademark Office, United States Copyright Office, to maintain and pursue each application relating to the Material Intellectual Property of such Grantor (and to obtain the relevant grant or registration) and to maintain each issued Patent and each registration of the Trademarks and Copyrights that constitutes Material Intellectual Property.
(viii) If any Grantor has reason to believe that any Collateral consisting of any Grantor’s Material Intellectual Property has been infringed, misappropriated or diluted by a third party, such Grantor shall, consistent with its commercially reasonable business judgment, xxx for infringement, misappropriation
or dilution and to recover any and all damages for such infringement, misappropriation or dilution, and take such other actions as are appropriate under the circumstances to protect such Collateral and promptly shall notify the Collateral Agent of the initiation of any such suit.
(ix) Upon and during the continuance of an Event of Default, (i) no Grantor shall abandon or otherwise permit any Intellectual Property to become invalid and (ii) upon the reasonable request of the Collateral Agent, each Grantor shall use its commercially reasonable efforts to obtain all requisite consents or approvals by the licensor of each License that constitutes Collateral owned by such Grantor to effect the assignment of all such Grantor’s right, title and interest thereunder to the Collateral Agent or its designee.
(x) Each Grantor shall execute, authenticate and deliver any and all assignments, agreements, instruments, documents and papers as the Collateral Agent may reasonably request to evidence the Collateral Agent’s security interest hereunder in such Intellectual Property and the General Intangibles of such Grantor relating thereto or represented thereby, each Grantor hereby appoints the Collateral Agent as its attorney in fact to execute and file such writings for the foregoing purposes, all acts of such attorney being hereby ratified and confirmed; such power, being coupled with an interest, is irrevocable.
(i) [Reserved.]
(j) [Reserved.]
(k) Control. Each Grantor hereby agrees to take any or all action that may be necessary or desirable or that the Collateral Agent may reasonably request in order for the Collateral Agent to obtain control in accordance with Sections 9-104, 9-105, 9-106, and 9-107 of the Code with respect to the following Collateral: (i) Electronic Chattel Paper, other than Electronic Chattel Paper having a face amount of less than $500,000 individually but only to the extent the aggregate face amount of such Electronic Chattel Paper does not exceed $500,000 collectively, (ii) Investment Property and (iii) Letter-of-Credit Rights, other than any Letter-of-Credit Rights having a face amount of less than $1,000,000 individually but only to the extent the aggregate face amount of such Letter-of-Credit Rights does not exceed $1,000,000 collectively or any Letter-of-Credit Right that constitutes a Supporting Obligation. Each Grantor hereby acknowledges and agrees that any agent or designee of the Collateral Agent shall be deemed to be a “secured party” with respect to the Collateral under the control of such agent or designee for all purposes.
(l) Records; Inspection and Reporting.
(i) Each Grantor shall keep adequate records concerning the Accounts, Chattel Paper and Pledged Interests. Without limiting any rights, powers and privileges of the Agents under the Credit Agreement, if any Event of Default shall have occurred and be continuing, each Grantor shall permit the Agents, or any
agents or representatives thereof or such professionals or other Persons as the Agents may designate (A) to examine and make copies of and abstracts from such Grantor’s books and records, (B) to visit and inspect its properties, (C) to verify materials, leases, notes, Accounts, Inventory and other assets of such Grantor from time to time, (D) to conduct audits, physical counts, appraisals and/or valuations, environmental site assessments or examinations at the locations of such Grantor and (E) to discuss such Grantor’s affairs, finances and accounts with any of its directors, officers, managerial employees, independent accountants or any of its other representatives, in each case as provided in the Credit Agreement.
(ii) Except as otherwise expressly permitted by Section 7.02(l) of the Credit Agreement, no Grantor shall, without giving the Collateral Agent at least ten Business Days’ prior written notice, change (A) its name, identity or organizational structure, (B) its jurisdiction of incorporation or organization as set forth in Schedule I hereto or (C) its chief executive office as set forth in Schedule III hereto. In connection with the foregoing, each Grantor shall take all actions necessary or reasonably requested by the Collateral Agent to maintain the continuous validity, perfection and the same or better priority of the Collateral Agent’s security interest in the Collateral granted or intended to be granted pursuant to this Agreement. Each Grantor shall immediately notify the Collateral Agent upon obtaining an organizational identification number, if on the date hereof such Grantor did not have such identification number.
(m) Partnership and Limited Liability Company Interest. Except with respect to partnership interests and membership interests evidenced by a certificate, which certificate has been pledged and delivered to the Collateral Agent pursuant to Section 4 hereof, no Grantor that is a partnership or a limited liability company shall, nor shall any Grantor with any Subsidiary that is a partnership or a limited liability company, permit such partnership interests or membership interests to (i) be dealt in or traded on securities exchanges or in securities markets, (ii) become a security for purposes of Article 8 of any relevant Uniform Commercial Code, (iii) become an investment company security within the meaning of Section 8-103 of any relevant Uniform Commercial Code or (iv) be evidenced by a certificate unless such certificate is delivered to the Collateral Agent. Each Grantor agrees that such partnership interests or membership interests shall constitute General Intangibles.
7. Voting Rights, Dividends, Etc. in Respect of the Pledged Interests.
(a) So long as no Event of Default shall have occurred and be continuing:
(i) each Grantor may exercise any and all voting and other consensual rights pertaining to any Pledged Interests for any purpose not inconsistent with the terms of this Agreement, the Credit Agreement or the other Loan Documents; and
(ii) each of the Grantors may receive and retain any and all dividends, interest or other distributions paid in respect of the Pledged Interests to the
extent permitted by the Financing Agreement; provided, however, that any and all (A) dividends and interest paid or payable other than in cash in respect of, and Instruments and other property received, receivable or otherwise distributed in respect of or in exchange for, any Pledged Interests which at the time of such distribution was not permitted by the Financing Agreement (B) dividends and other distributions paid or payable in cash in respect of any Pledged Interests in connection with a partial or total liquidation or dissolution or in connection with a reduction of capital, capital surplus or paid-in surplus which at the time of such distribution was not permitted by the Financing Agreement, and (C) cash paid, payable or otherwise distributed in redemption of, or in exchange for, any Pledged Interests, together with any dividend, interest or other distribution or payment which at the time of such payment was not permitted by the Financing Agreement, shall be, and shall forthwith be delivered to the Collateral Agent, to hold as, Pledged Interests and shall, if received by any of the Grantors, be received in trust for the benefit of the Collateral Agent, shall be segregated from the other property or funds of the Grantors, and shall be forthwith delivered to the Collateral Agent in the exact form received with any necessary indorsement and/or appropriate stock powers duly executed in blank, to be held by the Collateral Agent as Pledged Interests and as further collateral security for the Secured Obligations; and
(iii) the Collateral Agent will execute and deliver (or cause to be executed and delivered) to a Grantor all such proxies and other instruments as such Grantor may reasonably request for the purpose of enabling such Grantor to exercise the voting and other rights which it is entitled to exercise pursuant to Section 7(a)(i) hereof and to receive the dividends, interest and/or other distributions which it is authorized to receive and retain pursuant to Section 7(a)(ii) hereof.
(b) Upon the occurrence and during the continuance of an Event of Default:
(i) upon notice from the Collateral Agent to such Grantor, all rights of each Grantor to exercise the voting and other consensual rights which it would otherwise be entitled to exercise pursuant to Section 7(a)(i) hereof, and to receive the dividends, distributions, interest and other payments that it would otherwise be authorized to receive and retain pursuant to Section 7(a)(ii) hereof, shall cease, and all such rights shall thereupon become vested in the Collateral Agent, which shall thereupon have the sole right to exercise such voting and other consensual rights and to receive and hold as Pledged Interests such dividends, distributions and interest payments;
(ii) the Collateral Agent is authorized to notify each debtor with respect to the Pledged Debt to make payment directly to the Collateral Agent (or its designee) and may collect any and all moneys due or to become due to any Grantor in respect of the Pledged Debt, and each of the Grantors hereby authorizes each such
debtor to make such payment directly to the Collateral Agent (or its designee) without any duty of inquiry;
(iii) without limiting the generality of the foregoing, the Collateral Agent may at its option exercise any and all rights of conversion, exchange, subscription or any other rights, privileges or options pertaining to any of the Pledged Interests as if it were the absolute owner thereof, including, without limitation, the right to exchange, in its discretion, any and all of the Pledged Interests upon the merger, consolidation, reorganization, recapitalization or other adjustment of any Pledged Issuer, or upon the exercise by any Pledged Issuer of any right, privilege or option pertaining to any Pledged Interests, and, in connection therewith, to deposit and deliver any and all of the Pledged Interests with any committee, depository, transfer agent, registrar or other designated agent upon such terms and conditions as it may reasonably determine; and
(iv) all dividends, distributions, interest and other payments that are received by any of the Grantors contrary to the provisions of Section 7(b)(i) hereof shall be received in trust for the benefit of the Collateral Agent, shall be segregated from other funds of the Grantors, and shall be forthwith paid over to the Collateral Agent as Pledged Interests in the exact form received with any necessary indorsement and/or appropriate stock powers duly executed in blank, to be held by the Collateral Agent as Pledged Interests and as further collateral security for the Secured Obligations.
8. Additional Provisions Concerning the Collateral.
(a) To the maximum extent permitted by applicable law, and for the purpose of taking any action that the Collateral Agent may deem necessary or advisable to accomplish the purposes of this Agreement, each Grantor hereby (i) authorizes the Collateral Agent to execute any such agreements, instruments or other documents in such Grantor’s name and to file such agreements, instruments or other documents in such Grantor’s name and in any appropriate filing office, (ii) authorizes the Collateral Agent at any time and from time to time to file, one or more financing or continuation statements and amendments thereto, relating to the Collateral (including, without limitation, any such financing statements that (A) describe the Collateral as “all assets” or “all personal property” (or words of similar effect) or that describe or identify the Collateral by type or in any other manner as the Collateral Agent may determine, regardless of whether any particular asset of such Grantor falls within the scope of Article 9 of the Uniform Commercial Code or whether any particular asset of such Grantor constitutes part of the Collateral, and (B) contain any other information required by Part 5 of Article 9 of the Code for the sufficiency or filing office acceptance of any financing statement, continuation statement or amendment, including, without limitation, whether such Grantor is an organization, the type of organization and any organizational identification number issued to such Grantor) and (iii) ratifies such authorization to the extent that the Collateral Agent has filed any such financing statements, continuation statements, or amendments thereto, prior to the date hereof. A photocopy or
other reproduction of this Agreement or any financing statement covering the Collateral or any part thereof shall be sufficient as a financing statement where permitted by law.
(b) Each Grantor hereby irrevocably appoints the Collateral Agent as its attorney-in-fact and proxy, with full authority in the place and stead of such Grantor and in the name of such Grantor or otherwise, from time to time in the Collateral Agent’s reasonable discretion, to take any action and to execute any instrument that the Collateral Agent may deem necessary or advisable to accomplish the purposes of this Agreement (subject to the rights of a Grantor under Section 6 hereof and Section 7(a) hereof), including, without limitation, (i) to obtain and adjust insurance required to be paid to the Collateral Agent pursuant to the Credit Agreement, (ii) to ask, demand, collect, xxx for, recover, compound, receive and give acquittance and receipts for moneys due and to become due under or in respect of any Collateral, (iii) to receive, endorse, and collect any drafts or other Instruments, Documents and Chattel Paper in connection with clause (i) or (ii) above, (iv) to receive, indorse and collect all Instruments made payable to such Grantor representing any dividend, interest payment or other distribution in respect of any Pledged Interests and to give full discharge for the same, (v) upon the occurrence and during the continuance of an Event of Default, to file any claims or take any action or institute any proceedings which the Collateral Agent may deem necessary or desirable for the collection of any Collateral or otherwise to enforce the rights of the Collateral Agent and the Lenders with respect to any Collateral, (vi) upon the occurrence and during the continuance of an Event of Default, to execute assignments, licenses and other documents to enforce the rights of the Collateral Agent and the Lenders with respect to any Collateral, (vii) upon the occurrence and during the continuance of an Event of Default, to pay or discharge taxes or Liens levied or placed upon or threatened against the Collateral, the legality or validity thereof and the amounts necessary to discharge the same to be determined by the Collateral Agent in its sole discretion, and such payments made by the Collateral Agent to become Obligations of such Grantor to the Collateral Agent, due and payable immediately without demand, and (viii) upon the occurrence and during the continuance of an Event of Default, to sign and endorse any invoices, freight or express bills, bills of lading, storage or warehouse receipts, assignments, verifications and notices in connection with Accounts, Chattel Paper and other documents relating to the Collateral. This power is coupled with an interest and is irrevocable until the date on which all of the Secured Obligations have been indefeasibly paid in full in cash after the termination of each Lender’s Revolving Credit Commitment and each of the Loan Documents.
(c) For the purpose of enabling the Collateral Agent to exercise rights and remedies hereunder, at such time as the Collateral Agent shall be lawfully entitled to exercise such rights and remedies, and for no other purpose, effective upon the occurrence and during the continuance of an Event of Default each Grantor hereby grants to the Collateral Agent an irrevocable, non-exclusive license (exercisable without payment of royalty or other compensation to any Grantor) to use, assign, license or sublicense any Intellectual Property now or hereafter owned by any Grantor, wherever the same may be located, including in such license reasonable access to all media in which any of the licensed items may be recorded or stored and to all computer programs used for the compilation or printout thereof;
provided that the Collateral Agent shall exercise reasonable standards of quality control over any goods bearing Grantor’s Trademarks. Notwithstanding anything contained herein to the contrary, but subject to the provisions of the Credit Agreement that limit the right of a Grantor to dispose of its property and Section 6(i) hereof, so long as no Event of Default shall have occurred and be continuing, each Grantor may exploit, use, enjoy, protect, license, sublicense, assign, sell, dispose of or take other actions with respect to the Intellectual Property in the ordinary course of its business. In furtherance of the foregoing, unless an Event of Default shall have occurred and be continuing, the Collateral Agent shall from time to time, upon the request of a Grantor, execute and deliver any instruments, certificates or other documents, in the form so requested, which such Grantor shall have certified are appropriate (in such Grantor’s judgment) to allow it to take any action permitted above (including relinquishment of the license provided pursuant to this clause (c) as to any Intellectual Property). Further, upon the date on which all of the Secured Obligations have been indefeasibly paid in full in cash after the termination of each Lender’s Revolving Credit Commitment and each of the Loan Documents, the Collateral Agent (subject to Section 13(e) hereof) shall release and reassign to the Grantors all of the Collateral Agent’s right, title and interest in and to the Intellectual Property, and the Licenses, all without recourse, representation or warranty whatsoever and at the Grantors’ sole expense. The exercise of rights and remedies hereunder by the Collateral Agent shall not terminate the rights of the holders of any licenses or sublicenses theretofore granted by any Grantor in accordance with the second sentence of this clause (c). Each Grantor hereby releases the Collateral Agent from any claims, causes of action and demands at any time arising out of or with respect to any actions taken or omitted to be taken by the Collateral Agent under the powers of attorney granted herein other than actions taken or omitted to be taken through the Collateral Agent’s gross negligence or willful misconduct, as determined by a final determination of a court of competent jurisdiction.
(d) Upon the occurrence and during the continuance of any Event of Default, if any Grantor fails to perform any agreement or obligation contained herein, the Collateral Agent may itself perform, or cause performance of, such agreement or obligation, in the name of such Grantor or the Collateral Agent, and the expenses of the Collateral Agent incurred in connection therewith shall be jointly and severally payable by the Grantors pursuant to Section 10 hereof and shall be secured by the Collateral.
(e) The powers conferred on the Collateral Agent hereunder are solely to protect its interest in the Collateral and shall not impose any duty upon it to exercise any such powers. Other than the exercise of reasonable care to assure the safe custody of any Collateral in its possession and the accounting for moneys actually received by it hereunder, the Collateral Agent shall have no duty as to any Collateral or as to the taking of any necessary steps to preserve rights against prior parties or any other rights pertaining to any Collateral and shall be relieved of all responsibility for any Collateral in its possession upon surrendering it or tendering surrender of it to any of the Grantors (or whomsoever shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct). The Collateral Agent shall be deemed to have exercised reasonable care in the custody and preservation of any Collateral in its possession if such Collateral is accorded treatment
substantially equal to that which the Collateral Agent accords its own property, it being understood that the Collateral Agent shall not have responsibility for ascertaining or taking action with respect to calls, conversions, exchanges, maturities, tenders or other matters relating to any Collateral, whether or not the Collateral Agent has or is deemed to have knowledge of such matters. The Collateral Agent shall not be liable or responsible for any loss or damage to any of the Collateral, or for any diminution in the value thereof, by reason of the act or omission of any warehouseman, carrier, forwarding agency, consignee or other agent or bailee selected by the Collateral Agent in good faith.
(f) Anything herein to the contrary notwithstanding (i) each Grantor shall remain liable under the Licenses and otherwise in respect of the Collateral to the extent set forth therein to perform all of its obligations thereunder to the same extent as if this Agreement had not been executed, (ii) the exercise by the Collateral Agent of any of its rights hereunder shall not release any Grantor from any of its obligations under the Licenses or otherwise in respect of the Collateral, and (iii) the Collateral Agent shall not have any obligation or liability by reason of this Agreement under the Licenses or otherwise in respect of the Collateral, nor shall the Collateral Agent be obligated to perform any of the obligations or duties of any Grantor thereunder or to take any action to collect or enforce any claim for payment assigned hereunder.
(g) The Collateral Agent may at any time in its discretion (i) without notice to any Grantor, transfer or register in the name of the Collateral Agent or any of its nominees any or all of the Pledged Interests, subject only to the revocable rights of such Grantor under Section 7(a) hereof, and (ii) exchange certificates or Instruments constituting Pledged Interests for certificates or Instruments of smaller or larger denominations.
9. Remedies Upon Default. If any Event of Default shall have occurred and be continuing:
(a) The Collateral Agent may exercise in respect of the Collateral, in addition to any other rights and remedies provided for herein or otherwise available to it, all of the rights and remedies of a secured party upon default under the Code (whether or not the Code applies to the affected Collateral), and also may (i) take absolute control of the Collateral, including, without limitation, transfer into the Collateral Agent’s name or into the name of its nominee or nominees (to the extent the Collateral Agent has not theretofore done so) and thereafter receive, for the benefit of the Collateral Agent and the Lenders, all payments made thereon, give all consents, waivers and ratifications in respect thereof and otherwise act with respect thereto as though it were the outright owner thereof, (ii) require each Grantor to, and each Grantor hereby agrees that it will at its expense and upon request of the Collateral Agent forthwith, assemble all or part of the Collateral as directed by the Collateral Agent and make it available to the Collateral Agent at a place or places to be designated by the Collateral Agent that is reasonably convenient to both parties, and the Collateral Agent may enter into and occupy any premises owned or leased by any Grantor where the Collateral or any part thereof is located or assembled for a reasonable period in order to effectuate the Collateral Agent’s rights and remedies hereunder or under law,
without obligation to any Grantor in respect of such occupation, and (iii) without notice except as specified below and without any obligation to prepare or process the Collateral for sale, (A) sell the Collateral or any part thereof in one or more parcels at public or private sale, at any of the Collateral Agent’s offices, at any exchange or broker’s board or elsewhere, for cash, on credit or for future delivery, and at such price or prices and upon such other terms as the Collateral Agent may deem commercially reasonable and/or (B) lease, license or otherwise dispose of the Collateral or any part thereof upon such terms as the Collateral Agent may deem commercially reasonable. Each Grantor agrees that, to the extent notice of sale or any other disposition of the Collateral shall be required by law, at least five (5) Business Days’ prior notice to the applicable Grantor of the time and place of any public sale or the time after which any private sale or other disposition of the Collateral is to be made shall constitute reasonable notification. The Collateral Agent shall not be obligated to make any sale or other disposition of Collateral regardless of notice of sale having been given. The Collateral Agent may adjourn any public or private sale from time to time by announcement at the time and place fixed therefor, and such sale may, without further notice, be made at the time and place to which it was so adjourned. To the extent permitted by law, each Grantor hereby waives any claims against the Collateral Agent and the Lenders arising by reason of the fact that the price at which the Collateral may have been sold at a private sale was less than the price which might have been obtained at a public sale or was less than the aggregate amount of the Secured Obligations, even if the Collateral Agent accepts the first offer received and does not offer the Collateral to more than one offeree, and waives all rights that such Grantor may have to require that all or any part of the Collateral be marshaled upon any sale (public or private) thereof. Each Grantor hereby acknowledges that (i) any such sale of the Collateral by the Collateral Agent shall be made without warranty, (ii) the Collateral Agent may specifically disclaim any warranties of title, possession, quiet enjoyment or the like, (iii) the Collateral Agent may bid (which bid may be, in whole or in part, in the form of cancellation of indebtedness), if permitted by law, for the purchase, lease, license or other disposition of the Collateral or any portion thereof for the account of the Collateral Agent (on behalf of itself and the Lenders) and (iv) such actions set forth in clauses (i), (ii) and (iii) above shall not adversely affect the commercial reasonableness of any such sale of the Collateral. In addition to the foregoing, (i) upon written notice to any Grantor from the Collateral Agent, each Grantor shall cease any use of the Intellectual Property for any purpose described in such notice; (ii) the Collateral Agent may, at any time and from time to time, upon five (5) Business Days’ prior notice to any Grantor, license, whether general, special or otherwise, and whether on an exclusive or non-exclusive basis, any of the Intellectual Property, throughout the universe for such term or terms, on such conditions, and in such manner, as the Collateral Agent shall in its sole discretion determine; and (iii) the Collateral Agent may, at any time, pursuant to the authority granted in Section 8 hereof (such authority being effective upon the occurrence and during the continuance of an Event of Default), execute and deliver on behalf of a Grantor, one or more instruments of assignment of the Intellectual Property (or any application or registration thereof), in form suitable for filing, recording or registration in any country.
(b) In the event that the Collateral Agent determines to exercise its right to sell all or any part of the Pledged Interests pursuant to Section 9(a) hereof, each Grantor will,
at such Grantor’s expense and upon request by the Collateral Agent: (i) execute and deliver, and cause each issuer of such Pledged Interests and the directors and officers thereof to execute and deliver, all such instruments and documents, and do or cause to be done all such other acts and things, as may be necessary or, in the opinion of the Collateral Agent, advisable to register such Pledged Interests under the provisions of the Securities Act, and to cause the registration statement relating thereto to become effective and to remain effective for such period as prospectuses are required by law to be furnished, and to make all amendments and supplements thereto and to the related prospectus which, in the opinion of the Collateral Agent, are necessary or advisable, all in conformity with the requirements of the Securities Act and the rules and regulations of the SEC applicable thereto, (ii) cause each issuer of such Pledged Interests to qualify such Pledged Interests under the state securities or “Blue Sky” laws of each jurisdiction, and to obtain all necessary governmental approvals for the sale of the Pledged Interests, as requested by the Collateral Agent, (iii) cause each Pledged Issuer to make available to its securityholders, as soon as practicable, an earnings statement which will satisfy the provisions of Section 11(a) of the Securities Act, and (iv) do or cause to be done all such other acts and things as may be necessary to make such sale of such Pledged Interests valid and binding and in compliance with applicable law.
(c) Notwithstanding the provisions of Section 9(b) hereof, each Grantor recognizes that the Collateral Agent may deem it impracticable to effect a public sale of all or any part of the Pledged Shares or any other securities constituting Pledged Interests and that the Collateral Agent may, therefore, determine to make one or more private sales of any such securities to a restricted group of purchasers who will be obligated to agree, among other things, to acquire such securities for their own account, for investment and not with a view to the distribution or resale thereof. Each Grantor acknowledges that any such private sale may be at prices and on terms less favorable to the seller than the prices and other terms which might have been obtained at a public sale and, notwithstanding the foregoing, agrees that such private sales shall be deemed to have been made in a commercially reasonable manner and that the Collateral Agent shall have no obligation to delay the sale of any such securities for the period of time necessary to permit the issuer of such securities to register such securities for public sale under the Securities Act. Each Grantor further acknowledges and agrees that any offer to sell such securities which has been (i) publicly advertised on a bona fide basis in a newspaper or other publication of general circulation in the financial community of New York, New York (to the extent that such an offer may be so advertised without prior registration under the Securities Act) or (ii) made privately in the manner described above to not less than fifteen bona fide offerees shall be deemed to involve a “public disposition” for the purposes of Section 9-610(c) of the Code (or any successor or similar, applicable statutory provision) as then in effect in the State of New York, notwithstanding that such sale may not constitute a “public offering” under the Securities Act, and that the Collateral Agent may, in such event, bid for the purchase of such securities.
(d) Any cash held by the Collateral Agent (or its agent or designee) as Collateral and all Cash Proceeds received by the Collateral Agent (or its agent or designee) in respect of any sale of or collection from, or other realization upon, all or any part of the Collateral may, in the discretion of the Collateral Agent, be held by the Collateral Agent (or
its agent or designee) as collateral for, and/or then or at any time thereafter applied (after payment of any amounts payable to the Collateral Agent pursuant to Section 10 hereof) in whole or in part by the Collateral Agent against, all or any part of the Secured Obligations in such order as the Collateral Agent shall elect, consistent with the provisions of the Credit Agreement. Any surplus of such cash or Cash Proceeds held by the Collateral Agent (or its agent or designee) and remaining after the date on which all of the Secured Obligations have been indefeasibly paid in full in cash after the termination of each Lender’s Revolving Credit Commitment and each of the Loan Documents, shall be paid over to whomsoever shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct.
(e) In the event that the proceeds of any such sale, collection or realization are insufficient to pay all amounts to which the Collateral Agent and the Lenders are legally entitled, the Grantors shall be jointly and severally liable for the deficiency, together with interest thereon at the highest rate specified in any applicable Loan Document for interest on overdue principal thereof or such other rate as shall be fixed by applicable law, together with the costs of collection and the reasonable fees, costs, expenses and other client charges of any attorneys employed by the Collateral Agent to collect such deficiency.
(f) Each Grantor hereby acknowledges that if the Collateral Agent complies with any applicable requirements of law in connection with a disposition of the Collateral, such compliance will not adversely affect the commercial reasonableness of any sale or other disposition of the Collateral.
(g) The Collateral Agent shall not be required to marshal any present or future collateral security (including, but not limited to, this Agreement and the Collateral) for, or other assurances of payment of, the Secured Obligations or any of them or to resort to such collateral security or other assurances of payment in any particular order, and all of the Collateral Agent’s rights hereunder and in respect of such collateral security and other assurances of payment shall be cumulative and in addition to all other rights, however existing or arising. To the extent that any Grantor lawfully may, such Grantor hereby agrees that it will not invoke any law relating to the marshalling of collateral which might cause delay in or impede the enforcement of the Collateral Agent’s rights under this Agreement or under any other instrument creating or evidencing any of the Secured Obligations or under which any of the Secured Obligations is outstanding or by which any of the Secured Obligations is secured or payment thereof is otherwise assured, and, to the extent that it lawfully may, each Grantor hereby irrevocably waives the benefits of all such laws.
10. Indemnity and Expenses.
(a) Each Grantor jointly and severally agrees to defend, protect, indemnify and hold harmless each Agent and each other Indemnitee from and against any and all claims, losses, damages, liabilities, obligations, penalties, fees, reasonable out-of-pocket costs and expenses (including, without limitation, reasonable out-of-pocket attorneys’ fees, costs, expenses and disbursements, which will be limited to one primary counsel and, if necessary, one local counsel per jurisdiction for the indemnified parties, unless a conflict of
interest exists) incurred by such Agent or such Indemnitee to the extent that they arise out of or otherwise result from or relate to or are in connection with this Agreement (including, without limitation, enforcement of this Agreement), except claims, losses or liabilities resulting from such Agent’s or such Indemnitee’s gross negligence, willful misconduct or bad faith, or material breach of the Loan Documents by such Agent or Indemnitee, in each case as determined by a final judgment of a court of competent jurisdiction.
(b) Each Grantor jointly and severally agrees to pay to the Agents upon demand the amount of any and all reasonable costs and expenses, including the reasonable fees, costs, expenses and disbursements of one primary counsel and if necessary one local counsel per jurisdiction for the Agents and of any experts and agents (including, without limitation, any collateral trustee which may act as agent of the Agents), which the Agents may incur in connection with (i) the preparation, negotiation, execution, delivery, recordation, administration, amendment, waiver or other modification or termination of this Agreement, (ii) the custody, preservation, use or operation of, or the sale of, collection from, or other realization upon, any Collateral, (iii) the exercise or enforcement of any of the rights of the Agents hereunder, or (iv) the failure by any Grantor to perform or observe any of the provisions hereof.
11. Notices, Etc. All notices and other communications provided for hereunder shall be given in accordance with the notice provision of the Credit Agreement.
12. Security Interest Absolute; Joint and Several Obligations.
(a) All rights of the Secured Parties and the L/C Issuer, all Liens and all obligations of each of the Grantors hereunder shall be absolute and unconditional irrespective of (i) any lack of validity or enforceability of the Credit Agreement or any other Loan Document, (ii) any change in the time, manner or place of payment of, or in any other term in respect of, all or any of the Secured Obligations, or any other amendment or waiver of or consent to any departure from the Credit Agreement or any other Loan Document, (iii) any exchange or release of, or non-perfection of any Lien on any Collateral, or any release or amendment or waiver of or consent to departure from any guaranty, for all or any of the Secured Obligations, or (iv) any other circumstance that might otherwise constitute a defense available to, or a discharge of, any of the Grantors in respect of the Secured Obligations. All authorizations and agencies contained herein with respect to any of the Collateral are irrevocable and powers coupled with an interest.
(b) Each Grantor hereby waives, to the extent permitted by law, (i) promptness and diligence, (ii) notice of acceptance and notice of the incurrence of any Obligation by the Borrower, (iii) notice of any actions taken by any Agent, any Lender, any Guarantor or any other Person under any Loan Document or any other agreement, document or instrument relating thereto, (iv) all other notices, demands and protests, and all other formalities of every kind in connection with the enforcement of the Obligations, the omission of or delay in which, but for the provisions of this subsection (b), might constitute grounds for relieving such Grantor of any such Grantor’s obligations hereunder and (v) any
requirement that any Agent or any Lender protect, secure, perfect or insure any security interest or other lien on any property subject thereto or exhaust any right or take any action against any Grantor or any other Person or any collateral.
(c) All of the obligations of the Grantors hereunder are joint and several. The Collateral Agent may, in its sole and absolute discretion, enforce the provisions hereof against any of the Grantors and shall not be required to proceed against all Grantors jointly or seek payment from the Grantors ratably. In addition, the Collateral Agent may, in its sole and absolute discretion, select the Collateral of any one or more of the Grantors for sale or application to the Secured Obligations, without regard to the ownership of such Collateral, and shall not be required to make such selection ratably from the Collateral owned by all of the Grantors. The release or discharge of any Grantor by the Collateral Agent shall not release or discharge any other Grantor from the obligations of such Person hereunder.
13. Miscellaneous.
(a) No amendment of any provision of this Agreement (including any Schedule attached hereto) shall be effective unless it is in writing and signed by each Grantor affected thereby and the Collateral Agent, and no waiver of any provision of this Agreement, and no consent to any departure by any Grantor therefrom, shall be effective unless it is in writing and signed by the Collateral Agent, and then such waiver or consent shall be effective only in the specific instance and for the specific purpose for which given.
(b) No failure on the part of the Secured Parties or the L/C Issuer to exercise, and no delay in exercising, any right hereunder or under any other Loan Document shall operate as a waiver thereof; nor shall any single or partial exercise of any such right preclude any other or further exercise thereof or the exercise of any other right. The rights and remedies of the Secured Parties and the L/C Issuer provided herein and in the other Loan Documents are cumulative and are in addition to, and not exclusive of, any rights or remedies provided by law. The rights of the Secured Parties and the L/C Issuer under any Loan Document against any party thereto are not conditional or contingent on any attempt by such Person to exercise any of its rights under any other Loan Document against such party or against any other Person, including but not limited to, any Grantor.
(c) This Agreement shall create a continuing security interest in the Collateral and shall (i) remain in full force and effect, subject to paragraph (e) below, until the date on which all of the Secured Obligations have been indefeasibly paid in full (other than Contingent Indemnification Obligations) in cash after the termination of each Lender’s Revolving Credit Commitment and each of the Loan Documents and (ii) be binding on each Grantor all other Persons who become bound as debtor to this Agreement in accordance with Section 9-203(d) of the Code, and shall inure, together with all rights and remedies of the Secured Parties and the L/C Issuer hereunder, to the benefit of the Secured Parties and the L/C Issuer and their respective successors, transferees and assigns. Without limiting the generality of clause (ii) of the immediately preceding sentence, the Secured Parties and the L/C Issuer may assign or otherwise transfer their respective rights and obligations under this
Agreement and any other Loan Document to any other Person pursuant to the terms of the Credit Agreement, and such other Person shall thereupon become vested with all of the benefits in respect thereof granted to the Secured Parties and the L/C Issuer herein or otherwise. Upon any such assignment or transfer, all references in this Agreement to any Secured Party or the L/C Issuer shall mean the assignee of any such Secured Party or such L/C Issuer. Except to the extent expressly permitted by the Credit Agreement, none of the rights or obligations of any Grantor hereunder may be assigned or otherwise transferred without the prior written consent of the Collateral Agent, and any such assignment or transfer shall be null and void.
(d) Upon the date on which all of the Secured Obligations have been indefeasibly paid in full in cash (other than Contingent Indemnification Obligations) after the termination of each Lender’s Revolving Credit Commitment and each of the Loan Documents, (i) subject to paragraph (e) below, this Agreement and the security interests and licenses created hereby shall terminate and all rights to the Collateral shall revert to the Grantors and (ii) the Collateral Agent will, upon the Grantors’ request and at the Grantors’ expense, without any representation, warranty or recourse whatsoever, (A) return to the Grantors (or whomsoever shall be lawfully entitled to receive the same or as a court of competent jurisdiction shall direct) such of the Collateral as shall not have been sold or otherwise disposed of or applied pursuant to the terms hereof and (B) execute and deliver to the Grantors such documents as the Grantors shall reasonably request to evidence such termination. In addition, upon the incurrence or assumption of Indebtedness by a Grantor in a transaction permitted by clause (e) of the definition of Permitted Liens and Section 7.02(b), upon the Grantors’ request and at the Grantors’ expense, without any representation, warranty or recourse whatsoever, the Collateral Agent agrees to execute and deliver to the Grantors such documents as the Grantors shall reasonably request to evidence the release of the Collateral Agent’s security interest in the items of property that are the subject of such transaction.
(e) This Agreement shall remain in full force and effect and continue to be effective should any petition be filed by or against any Grantor for liquidation or reorganization, should any Grantor become insolvent or make an assignment for the benefit of any creditor or creditors or should a receiver or trustee be appointed for all or any significant part of any Grantor’s assets, and shall continue to be effective or be reinstated, as the case may be, if at any time payment or performance of the Secured Obligations, or any part thereof, is, pursuant to applicable law, rescinded or reduced in amount, or must otherwise be restored or returned by any obligee of the Secured Obligations, whether as a “voidable preference,” “fraudulent conveyance,” or otherwise, all as though such payment or performance had not been made. In the event that any payment, or any part thereof, is rescinded, reduced, restored or returned, the Secured Obligations shall be reinstated and deemed reduced only by such amount paid and not so rescinded, reduced, restored or returned.
(f) Upon the execution and delivery, or authentication, by any Person of a security agreement supplement in substantially the form of Exhibit C hereto (each a
“Security Agreement Supplement”), (i) such Person shall be referred to as an “Additional Grantor” and shall be and become a Grantor, and each reference in this Agreement to “Grantor” shall also mean and be a reference to such Additional Grantor, and each reference in this Agreement and the other Loan Documents to “Collateral” shall also mean and be a reference to the Collateral of such Additional Grantor, and (ii) the supplemental Schedules I-VIII attached to each Security Agreement Supplement shall be incorporated into and become a part of and supplement Schedules I-VIII, respectively, hereto, and the Collateral Agent may attach such Schedules as supplements to such Schedules, and each reference to such Schedules shall mean and be a reference to such Schedules, as supplemented pursuant hereto.
(g) THIS AGREEMENT SHALL BE GOVERNED BY, CONSTRUED AND INTERPRETED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW YORK, EXCEPT AS REQUIRED BY MANDATORY PROVISIONS OF LAW AND EXCEPT TO THE EXTENT THAT THE VALIDITY AND PERFECTION OR THE PERFECTION AND THE EFFECT OF PERFECTION OR NON-PERFECTION OF THE SECURITY INTEREST CREATED HEREBY, OR REMEDIES HEREUNDER, IN RESPECT OF ANY PARTICULAR COLLATERAL ARE GOVERNED BY THE LAW OF A JURISDICTION OTHER THAN THE STATE OF NEW YORK.
(h) In addition to and without limitation of any of the foregoing, this Agreement shall be deemed to be a Loan Document and shall otherwise be subject to all of terms and conditions contained in Sections 12.10 and 12.11 of the Credit Agreement, mutatis mutandi.
(i) Each Grantor irrevocably and unconditionally waives any right it may have to claim or recover in any legal action, suit or proceeding with respect to this Agreement any special, exemplary, punitive or consequential damages.
(j) Any provision of this Agreement which is prohibited or unenforceable in any jurisdiction shall, as to such jurisdiction, be ineffective to the extent of such prohibition or unenforceability without invalidating the remaining portions hereof or thereof or affecting the validity or enforceability of such provision in any other jurisdiction.
(k) Section headings herein are included for convenience of reference only and shall not constitute a part of this Agreement for any other purpose.
(l) This Agreement may be executed in any number of counterparts and by the different parties hereto on separate counterparts, each of which shall be deemed an original, but all of such counterparts taken together shall constitute one and the same agreement. Delivery of an executed counterpart of this Agreement by facsimile or electronic mail shall be equally effective as delivery of an original executed counterpart.
[REMAINDER OF THIS PAGE INTENTIONALLY LEFT BLANK]
IN WITNESS WHEREOF, each Grantor has caused this Agreement to be executed and delivered by its officer thereunto duly authorized, as of the date first above written.
|
|
GRANTORS: |
||
|
|
|
||
|
|
LANTHEUS MEDICAL IMAGING, INC. |
||
|
|
|
|
|
|
|
By: |
/s/ Xxxxxx Xxxxxxx |
|
|
|
Name: Xxxxxx Xxxxxxx |
||
|
|
Title: President and Chief Executive Officer |
||
|
|
|
|
|
|
|
|
|
|
|
|
|||
|
|
|
|
|
|
|
By: |
/s/ Xxxxxx Xxxxxxx |
|
|
|
Name: Xxxxxx Xxxxxxx |
||
|
|
Title: President and Chief Executive Officer |
||
|
|
|
|
|
|
|
|
|
|
|
|
LANTHEUS MI REAL ESTATE, LLC |
||
|
|
|
|
|
|
|
By: |
Lantheus Medical Imaging, Inc., its sole member |
|
|
|
|
|
|
|
|
|
By: |
/s/ Xxxxxx Xxxxxxx |
|
|
|
Name: Xxxxxx Xxxxxxx |
|
|
|
|
Title: President and Chief Executive Officer |
|
Signature Page to Pledge and Security Agreement
SCHEDULE I
LEGAL NAMES; ORGANIZATIONAL IDENTIFICATION NUMBERS; STATES OR JURISDICTIONS OF ORGANIZATION; TYPE OF ORGANIZATION; FEDERAL EMPLOYER IDENTIFICATION NUMBER
|
|
|
Organizational |
|
State/Jurisdiction |
|
Type of |
|
|
|
Company Name |
|
ID Number |
|
of Organization |
|
Organization |
|
FEIN |
|
Lantheus Medical Imaging, Inc. |
|
3098309 |
|
Delaware |
|
Corporation |
|
00-0000000 |
|
|
4465403 |
|
Delaware |
|
Corporation |
|
00-0000000 |
|
|
Lantheus MI Real Estate, LLC |
|
4469098 |
|
Delaware |
|
Limited Liability Company |
|
00-0000000 |
SCHEDULE II
INTELLECTUAL PROPERTY
A. COPYRIGHTS
None
B. PATENTS
See attached
C. TRADEMARKS
See attached
D. LEGAL NAMES USED BY ANY GRANTOR DURING THE PAST FIVE YEARS
|
Current Name |
|
Former Name |
|
Lantheus Medical Imaging, Inc.. |
|
Xxxxxxx-Xxxxx Squibb Imaging, Inc.. |
|
|
ACP Lantern Intermediate Holdings, Inc. |
|
|
Lantheus MI Real Estate, LLC |
|
ACP Lantern Real Estate, LLC |
Patents and Patent Applications
|
Country |
|
Title |
|
Application No. |
|
Filing Date |
|
Patent No. |
|
Issue Date |
|
Status |
|
USA |
|
ESTER-SUBSTITUTED DIAMINEDITHIOLS AND RADIOLABELED COMPLEXES THEREOF |
|
08/139894 |
|
20-Oct-93 |
|
5431900 |
|
11-Jul-95 |
|
Granted |
|
Argentina |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
P990100124 |
|
15-Jan-99 |
|
|
|
|
|
Pending |
|
Australia |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
21155/99 |
|
14-Jan-99 |
|
746067 |
|
25-Jul-02 |
|
Granted |
|
Australia |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
2006200015 |
|
14-Jan-99 |
|
2006200015 |
|
8-May-08 |
|
Granted |
|
Brazil |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
PI9907066-9 |
|
14-Jan-99 |
|
|
|
|
|
Pending |
|
Canada |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
2317921 |
|
14-Jan-99 |
|
|
|
|
|
Pending |
|
Chile |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
54-1999 |
|
14-Jan-99 |
|
|
|
|
|
Pending |
|
China |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
99802102.4 |
|
14-Jan-99 |
|
ZL 99802102.4 |
|
9-Mar-05 |
|
Granted |
|
Europe |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
04075388.1 |
|
14-Jan-99 |
|
|
|
|
|
Granted |
|
Hong Kong |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
04107194.5 |
|
14-Jan-99 |
|
|
|
|
|
Pending |
|
Hungary |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
P0100206 |
|
14-Jan-99 |
|
|
|
|
|
Pending |
|
Israel |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
137018 |
|
14-Jan-99 |
|
|
|
|
|
Pending |
|
Japan |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
2000-539875 |
|
14-Jan-99 |
|
|
|
|
|
Pending |
|
Korea |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
00-0000-0000000 |
|
14-Jan-99 |
|
00-0000000 |
|
19-Apr-07 |
|
Granted |
|
Mexico |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
006299 |
|
14-Jan-99 |
|
265347 |
|
23-Mar-09 |
|
Granted |
|
Norway |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
20003471 |
|
14-Jan-99 |
|
321866 |
|
16-Jul-06 |
|
Granted |
|
New Zealand |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
505082 |
|
14-Jan-99 |
|
505082 |
|
3-Mar-03 |
|
Granted |
|
Philippines |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
11999000083 |
|
14-Jan-99 |
|
|
|
|
|
Published |
|
Russia |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
200000765 |
|
14-Jan-99 |
|
/002978 |
|
26-Dec-02 |
|
Granted |
|
Poland |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
P342473 |
|
14-Jan-99 |
|
193672 |
|
5-Feb-08 |
|
Granted |
|
Singapore |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND |
|
200003772-1 |
|
14-Jan-99 |
|
74468 [WO 99/36104] |
|
31-Jul-02 |
|
Granted |
|
Slovakia |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
PV1031-2000S |
|
14-Jan-99 |
|
285333 |
|
6-Sep-06 |
|
Granted |
|
Taiwan |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
088100521 |
|
22-Feb-99 |
|
I242448 |
|
1-Nov-05 |
|
Granted |
|
USA |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
10/667931 |
|
22-Sep-03 |
|
|
|
|
|
Pending |
|
South Africa |
|
PREPARATION OF A LIPID BLEND AND A PHOSPHOLIPID SUSPENSION CONTAINING THE LIPID BLEND, AND CONTRAST AGENTS BASED ON THESE |
|
99/0247 |
|
14-Jan-99 |
|
99/0247 |
|
27-Sep-00 |
|
Granted |
|
Australia |
|
APPARATUS AND METHODS FOR ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL |
|
2002243807 |
|
1-Feb-02 |
|
2002243807 |
|
7-Jun-07 |
|
Granted |
|
Canada |
|
APPARATUS AND METHODS FOR ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL |
|
2437217 |
|
1-Feb-02 |
|
|
|
|
|
Pending |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Confidential |
|
|
|
|
|
|
|
|
|
|
|
5/7/2010 |
|
Europe |
|
APPARATUS AND METHODS FOR ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL |
|
02709316.0 |
|
1-Feb-02 |
|
|
|
|
|
Published |
|
Norway |
|
APPARATUS AND METHODS FOR ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL |
|
20033435 |
|
1-Feb-02 |
|
|
|
|
|
Pending |
|
USA |
|
APPARATUS AND METHODS FOR ON-LINE MONITORING OF FLUORINATED MATERIAL IN HEADSPACE OF VIAL |
|
10/062206 |
|
1-Feb-02 |
|
6943692 |
|
13-Sep-05 |
|
Granted |
|
Canada |
|
LIPOSOMES AS CONTRAST AGENTS FOR ULTRASONIC IMAGING |
|
2069759 |
|
19-Dec-90 |
|
2069759 |
|
16-Jan-07 |
|
Granted |
|
Japan |
|
LIPOSOMES AS CONTRAST AGENTS FOR ULTRASONIC IMAGING |
|
503276/91 |
|
19-Dec-90 |
|
3309356 |
|
24-May-02 |
|
Granted |
|
USA |
|
LIPOSOMES AS CONTRAST AGENTS FOR ULTRASONIC IMAGING AND METHODS FOR PREPARING THE SAME |
|
07/818069 |
|
8-Jan-92 |
|
5230882 |
|
27-Jul-93 |
|
Granted |
|
USA |
|
IONOPHORE CONTAINING LIPOSOMERS FOR ULTRASOUND IMAGING |
|
07/967974 |
|
27-Oct-92 |
|
5352435 |
|
4-Oct-94 |
|
Granted |
|
USA |
|
LIPOSOMES AS CONTRAST AGENTS FOR ULTRASONIC IMAGING |
|
08/395683 |
|
28-Feb-95 |
|
5456901 |
|
10-Oct-95 |
|
Granted |
|
USA |
|
NOVEL THERAPEUTIC DELIVERY SYSTEMS RELATED APPLICATIONS |
|
08/160232 |
|
30-Nov-93 |
|
5542935 |
|
6-Aug-96 |
|
Granted |
|
Austria |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
ATE203148 T2 |
|
18-Jul-01 |
|
Granted |
|
Australia |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
20020/92 |
|
31-Mar-92 |
|
667471 |
|
13-Aug-96 |
|
Granted |
|
Belgium |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Canada |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
2110491 |
|
31-Mar-92 |
|
2110491 |
|
24-Jul-07 |
|
Granted |
|
Switzerland |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Germany |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
69231950.6-08 |
|
18-Jul-01 |
|
Granted |
|
Denmark |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Europe |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Spain |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
France |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
United Kingdom |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Greece |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Italy |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
35846 BE/2004 |
|
18-Jul-01 |
|
Granted |
|
Japan |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
500847/93 |
|
31-Mar-92 |
|
3456584 |
|
1-Aug-03 |
|
Granted |
|
Liechtenstein |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Luxembourg |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Netherlands |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
Sweden |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
92912456.8 |
|
31-Mar-92 |
|
0616508 |
|
18-Jul-01 |
|
Granted |
|
USA |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
07/717084 |
|
18-Jun-91 |
|
5228446 |
|
20-Jul-93 |
|
Granted |
|
USA |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
08/017683 |
|
12-Feb-93 |
|
5305757 |
|
26-Apr-94 |
|
Granted |
|
USA |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
08/088268 |
|
7-Jul-93 |
|
5348016 |
|
20-Sep-94 |
|
Granted |
|
USA |
|
GAS FILLED LIPOSOMES AND THEIR USE AS ULTRASONIC CONTRAST AGENTS |
|
08/199462 |
|
22-Feb-94 |
|
5769080 |
|
23-Jun-98 |
|
Granted |
|
Austria |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
ATE233574 T1 |
|
5-Mar-03 |
|
Granted |
|
Australia |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
70431/94 |
|
20-May-94 |
|
683900 |
|
6-Aug-98 |
|
Granted |
|
Australia |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
56271/98 |
|
24-Feb-98 |
|
713127 |
|
9-Mar-00 |
|
Granted |
|
Belgium |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
Brazil |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
PI1100994-2 |
|
14-May-97 |
|
PI1100994-2 |
|
7-Dec-99 |
|
Granted |
|
Canada |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
2164845 |
|
20-May-94 |
|
2164845 |
|
29-Apr-08 |
|
Granted |
|
Switzerland |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted |
|
China |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94192402.5 |
|
20-May-94 |
|
ZL94192402.5 |
|
19-Oct-03 |
|
Granted |
|
Germany |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
69432219.9-08 |
|
5-Mar-03 |
|
Granted |
|
Denmark |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
Europe |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted |
|
Spain |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
France |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted |
|
United Kingdom |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted |
|
Greece |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
Hong Kong |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
99105053.5 |
|
20-Feb-04 |
|
HK1028943 |
|
14-May-04 |
|
Granted |
|
Ireland |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
Italy |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
24556 BE/2003 |
|
5-Mar-03 |
|
Granted - SPC |
|
Japan |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
501839/95 |
|
20-May-94 |
|
4274387 |
|
13-Mar-09 |
|
Granted |
|
Japan |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
2007-190697 |
|
23-Jul-07 |
|
|
|
|
|
Pending |
|
Liechtenstein |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted |
|
Luxembourg |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
Netherlands |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
Portugal |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
Sweden |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
94919208.2 |
|
20-May-94 |
|
0712293 |
|
5-Mar-03 |
|
Granted - SPC |
|
USA |
|
METHODS OF PREPARING GAS AND GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
08/159687 |
|
30-Nov-93 |
|
5585112 |
|
17-Dec-96 |
|
Granted |
|
USA |
|
METHODS OF PREPARING GASEOUS PRECURSOR-FILLED MICROSPHERES |
|
08/487230 |
|
6-Jun-95 |
|
5853752 |
|
29-Dec-98 |
|
Granted |
|
Argentina |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
P960101458 |
|
21-Feb-96 |
|
AR003110B1 |
|
28-Dec-05 |
|
Granted |
|
Australia |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
31465/95 |
|
26-Jul-95 |
|
708341 |
|
18-Nov-99 |
|
Granted |
|
Canada |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
2200061 |
|
26-Jul-95 |
|
2200061 |
|
10-Apr-07 |
|
Granted |
|
Switzerland |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
0788348 |
|
14-Jul-04 |
|
Granted |
|
Chile |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
217-1996 |
|
15-Feb-96 |
|
|
|
|
|
Pending |
|
China |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95195094.0 |
|
26-Jul-95 |
|
ZL95195094.0 |
|
8-Jan-03 |
|
Granted |
|
Germany |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
69533261.9-08 |
|
14-Jul-04 |
|
Granted |
|
Europe |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
0788348 |
|
14-Jul-04 |
|
Granted |
|
Europe |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
04076135.5 |
|
26-Jul-95 |
|
|
|
|
|
Granted |
|
Spain |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
0788348 |
|
14-Jul-04 |
|
Granted |
|
France |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
0788348 |
|
14-Jul-04 |
|
Granted |
|
United Kingdom |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
0788348 |
|
14-Jul-04 |
|
Granted |
|
Greece |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
0788348 |
|
14-Jul-04 |
|
Granted |
|
Ireland |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
0788348 |
|
14-Jul-04 |
|
Granted |
|
Italy |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
95927429.1 |
|
26-Jul-95 |
|
31278 BE/2004 |
|
14-Jul-04 |
|
Granted |
|
Japan |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
510174/96 |
|
26-Jul-95 |
|
4004063 |
|
31-Aug-07 |
|
Granted |
|
Mexico |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
PA/a/1997/001969 |
|
26-Jul-95 |
|
210448 |
|
25-Sep-02 |
|
Granted |
|
Mexico |
|
CONTAINER WITH MULTI-PHASE COMPOSITION FOR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
|
PA/a/2002/006115 |
|
19-Jun-02 |
|
|
|
|
|
Granted |
|
USA |
|
NOVEL COMPOSITIONS OF LIPIDS AND STABILIZING MATERIALS |
|
08/417238 |
|
5-Apr-95 |
|
5705187 |
|
6-Jan-98 |
|
Granted |
|
Australia |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
75947/96 |
|
6-Jun-96 |
|
703846 |
|
15-Jul-99 |
|
Granted |
|
Canada |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
2218860 |
|
6-Jun-96 |
|
2218860 |
|
5-Dec-06 |
|
Granted |
|
China |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
96194425.0 |
|
6-Jun-96 |
|
ZL96194425.0 |
|
5-Oct-05 |
|
Granted |
|
Germany |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
96938613.5 |
|
6-Jun-96 |
|
0840570 |
|
13-Aug-03 |
|
Granted |
|
Europe |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
96938613.5 |
|
6-Jun-96 |
|
0840570 |
|
13-Aug-03 |
|
Granted |
|
Spain |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
96938613.5 |
|
6-Jun-96 |
|
0840570 |
|
13-Aug-03 |
|
Granted |
|
France |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
96938613.5 |
|
6-Jun-96 |
|
0840570 |
|
13-Aug-03 |
|
Granted |
|
United Kingdom |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
96938613.5 |
|
6-Jun-96 |
|
0840570 |
|
13-Aug-03 |
|
Granted |
|
Hong Kong |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
98111007.1 |
|
28-Sep-98 |
|
1010127 |
|
4-May-06 |
|
Granted |
|
Ireland |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
96938613.5 |
|
6-Jun-96 |
|
0840570 |
|
13-Aug-03 |
|
Granted |
|
Japan |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
503846/97 |
|
6-Jun-96 |
|
3645909 |
|
10-Feb-05 |
|
Granted |
|
USA |
|
APPARATUS AND METHOD FOR MAKING GAS-FILLED VESICLES OF OPTIMAL SIZE |
|
08/482294 |
|
7-Jun-95 |
|
5656211 |
|
12-Aug-97 |
|
Granted |
|
Austria |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
ATE227960 |
|
20-Nov-02 |
|
Granted |
|
Belgium |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Switzerland |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Germany |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Denmark |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Europe |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Spain |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
00-Xxx-00 |
|
Xxxxxxx |
|
Xxxxxx |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
00-Xxx-00 |
|
Xxxxxxx |
|
Xxxxxx Xxxxxxx |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Greece |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Ireland |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Italy |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
20774 BE/2003 |
|
20-Nov-02 |
|
Granted |
|
Liechtenstein |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
00-Xxx-00 |
|
Xxxxxxx |
|
Xxxxxxxxxx |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Netherlands |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Portugal |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
Sweden |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
94919184.5 |
|
19-May-94 |
|
0711127 |
|
20-Nov-02 |
|
Granted |
|
USA |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
08/076239 |
|
11-Jun-93 |
|
5469854 |
|
28-Nov-95 |
|
Granted |
|
USA |
|
METHODS OF PREPARING GAS-FILLED LIPOSOMES |
|
08/471250 |
|
6-Jun-95 |
|
5715824 |
|
10-Feb-98 |
|
Granted |
|
Austria |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Australia |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
17442/92 |
|
18-Mar-92 |
|
660676 |
|
14-Nov-95 |
|
Granted |
|
Australia |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
33103/95 |
|
18-Mar-92 |
|
698209 |
|
2-May-02 |
|
Granted |
|
Australia |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
14280/99 |
|
18-Mar-92 |
|
740155 |
|
14-Feb-02 |
|
Granted |
|
Belgium |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Brazil |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
PI1100619-6 |
|
13-May-97 |
|
PI1100619-6 |
|
1-Aug-00 |
|
Granted |
|
Canada |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
2107466 |
|
18-Mar-92 |
|
2107466 |
|
3-Jul-01 |
|
Granted |
|
Switzerland |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Germany |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
69229342.6 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Denmark |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Europe |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Spain |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
France |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
United Kingdom |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Greece |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Italy |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
Japan |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
509585/92 |
|
18-Mar-92 |
|
3518548 |
|
6-Feb-04 |
|
Granted |
|
Japan |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
2002-339373 |
|
18-Mar-92 |
|
3888684 |
|
8-Dec-06 |
|
Granted |
|
Netherlands |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
92910021.2 |
|
18-Mar-92 |
|
0580726 |
|
2-Jun-99 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
07/680984 |
|
5-Apr-91 |
|
5205290 |
|
27-Apr-93 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
07/980594 |
|
19-Jan-93 |
|
5281408 |
|
25-Jan-94 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
08/116982 have C of C |
|
7-Sep-93 |
|
5456900 |
|
10-Oct-95 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
08/449090 |
|
24-May-95 |
|
5547656 |
|
20-Aug-96 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY, AND IN OTHER APPLICATIONS |
|
90/004720 |
|
8-Aug-97 |
|
5547656 |
|
3-Oct-00 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
08/456738 |
|
1-Jun-95 |
|
5527521 |
|
18-Jun-96 |
|
Granted (PTE) |
|
USA |
|
LOW DENSITY MICROSPHERES AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY AND IN OTHER APPLICATIONS |
|
08/878233 |
|
18-Jun-97 |
|
6528039 |
|
4-Mar-03 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
10/280844 |
|
25-Oct-02 |
|
6773696 |
|
10-Aug-04 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
10/864965 |
|
10-Jun-04 |
|
6998107 |
|
14-Feb-06 |
|
Granted |
|
USA |
|
LOW DENSITY MICROSPHERE AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY |
|
11/252659 |
|
18-Oct-05 |
|
7344705 |
|
18-Mar-08 |
|
Granted |
|
USA |
|
COMPOSITION COMPRISING LOW DENSITY MICROSPHERES |
|
12/014154 |
|
15-Jan-08 |
|
|
|
|
|
Published |
|
USA |
|
LOW DENSITY MICROSPHERES AND SUSPENSIONS AND THEIR USE AS CONTRAST AGENTS FOR COMPUTED TOMOGRAPHY AND IN OTHER APPLICATIONS |
|
90/004719 |
|
8-Aug-97 |
|
5527521 |
|
9-Nov-99 |
|
Granted |
|
Australia |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
3313197 |
|
16-Jun-97 |
|
733492 |
|
30-Aug-01 |
|
Granted |
|
Australia |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
6188501 |
|
16-Jun-97 |
|
774666 |
|
14-Oct-04 |
|
Granted |
|
Canada |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
2256592 |
|
16-Jun-97 |
|
|
|
|
|
Pending |
|
Germany |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
97928998.0 |
|
16-Jun-97 |
|
0930844 |
|
3-Sep-08 |
|
Granted |
|
Europe |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
97928998.0 |
|
16-Jun-97 |
|
0930844 |
|
3-Sep-08 |
|
Granted |
|
France |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
97928998.0 |
|
16-Jun-97 |
|
0930844 |
|
3-Sep-08 |
|
Granted |
|
United Kingdom |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
97928998.0 |
|
16-Jun-97 |
|
0930844 |
|
3-Sep-08 |
|
Granted |
|
Hong Kong |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
99104828.2 |
|
16-Jun-97 |
|
|
|
|
|
Granted |
|
Netherlands |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
97928998.0 |
|
16-Jun-97 |
|
0930844 |
|
3-Sep-08 |
|
Granted |
|
USA |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT |
|
08/666129 |
|
19-Jun-96 |
|
6033645 |
|
7-Mar-00 |
|
Granted |
|
USA |
|
IMPROVED METHODS FOR ULTRASOUND IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND MULTIPLE IMAGES AND PROCESSING OF SAME |
|
08/982829 |
|
2-Dec-97 |
|
6231834 |
|
15-May-01 |
|
Granted |
|
Australia |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR |
|
40898/97 |
|
26-Aug-97 |
|
732813 |
|
16-Aug-01 |
|
Granted |
|
Canada |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR |
|
2263924 |
|
26-Aug-97 |
|
2263924 |
|
18-Nov-08 |
|
Granted |
|
Germany |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR |
|
97938609.1 |
|
26-Aug-97 |
|
1017425 |
|
17-Oct-07 |
|
Granted |
|
Europe |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR |
|
97938609.1 |
|
26-Aug-97 |
|
1017425 |
|
17-Oct-07 |
|
Granted |
|
France |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR |
|
97938609.1 |
|
26-Aug-97 |
|
1017425 |
|
17-Oct-07 |
|
Granted |
|
United Kingdom |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR |
|
97938609.1 |
|
26-Aug-97 |
|
1017425 |
|
17-Oct-07 |
|
Granted |
|
Italy |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR |
|
97938609.1 |
|
26-Aug-97 |
|
19026 BE/2008 |
|
17-Oct-07 |
|
Granted |
|
USA |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING INVOLVING THE USE OF A CONTRAST AGENT AND A CORONARY VASODILATOR |
|
09/573265 |
|
18-May-00 |
|
6884407 |
|
26-Apr-05 |
|
Granted |
|
Austria |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Austria |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Australia |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
42356/97 |
|
26-Aug-97 |
|
736056 |
|
8-Nov-01 |
|
Granted |
|
Belgium |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Belgium |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Canada |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
2263568 |
|
26-Aug-97 |
|
2263568 |
|
2-Dec-08 |
|
Granted |
|
Switzerland |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Switzerland |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Germany |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
69718519.2-08 |
|
15-Jan-03 |
|
Granted |
|
Germany |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
69738223.0-08 |
|
11-Jul-07 |
|
Granted |
|
Denmark |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Denmark |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Europe |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Europe |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Spain |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Spain |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Finland |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Finland |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
France |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
France |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
United Kingdom |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
United Kingdom |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Hong Kong |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
00104933.2 |
|
26-Aug-97 |
|
HK1026139 |
|
23-May-03 |
|
Granted |
|
Hong Kong |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03106479.4 |
|
26-Aug-97 |
|
HK1062802 |
|
14-Mar-08 |
|
Granted |
|
Ireland |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Italy |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
23096 BE/2003 |
|
15-Jan-03 |
|
Granted |
|
Italy |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
31735 BE/2007 |
|
11-Jul-07 |
|
Granted |
|
Japan |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
513669/98 |
|
26-Aug-97 |
|
4139440 |
|
13-Jun-08 |
|
Granted |
|
Liechtenstein |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Liechtenstein |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Luxembourg |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Luxembourg |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Netherlands |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Netherlands |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
Sweden |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
97940615.4 |
|
26-Aug-97 |
|
0977597 |
|
15-Jan-03 |
|
Granted |
|
Sweden |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
03000267.9 |
|
26-Aug-97 |
|
1323434 |
|
11-Jul-07 |
|
Granted |
|
USA |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
08/790550 |
|
30-Jan-97 |
|
5846517 |
|
8-Dec-98 |
|
Granted |
|
USA |
|
IMPROVED METHODS FOR DIAGNOSTIC IMAGING USING A CONTRAST AGENT AND A VASODILATOR |
|
09/143304 |
|
28-Aug-98 |
|
6071494 |
|
6-Jun-00 |
|
Granted |
|
USA |
|
NOVEL CATIONIC LIPIDS AND THE USE THEREOF |
|
08/391938 |
|
21-Feb-95 |
|
5830430 |
|
3-Nov-98 |
|
Granted |
|
USA |
|
NOVEL CATIONIC LIPIDS AND THE USE THEREOF |
|
09/073181 |
|
5-May-98 |
|
6056938 |
|
2-May-00 |
|
Granted |
|
USA |
|
PREPARATION OF PARAMAGNETIC NANOPARTICLES CONJUGATED TO LEUKOTRIENE B4 (LTB 4) RECEPTOR ANTAGONISTS AND THEIR USE AS MRI CONTRAST AGENTS FOR THE DETECTION OF INFECTION AND INFLAMMATION |
|
11/959569 |
|
19-Dec-07 |
|
|
|
|
|
Pending |
|
Canada |
|
VITRONECTIN RECEPTOR ANTAGONIST COMPOUNDS AND THEIR USE IN THE PREPARATION OF PHARMACEUTICALS |
|
2525396 |
|
12-May-04 |
|
|
|
|
|
Pending |
|
USA |
|
|
|
12/713890 |
|
26-Feb-10 |
|
|
|
|
|
Pending |
|
USA |
|
NOVEL INTEGRIN RECEPTOR ANTAGONISTS |
|
08/980016 |
|
26-Nov-97 |
|
6130231 |
|
10-Oct-00 |
|
Granted |
|
USA |
|
INTEGRIN RECEPTOR ANTAGONISTS |
|
09/510379 |
|
22-Feb-00 |
|
6358976 |
|
19-Mar-02 |
|
Granted |
|
Canada |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
2324555 |
|
29-Mar-99 |
|
|
|
|
|
Pending |
|
Germany |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
99941944.3 |
|
29-Mar-99 |
|
69925262.8-08 |
|
11-May-05 |
|
Granted |
|
Europe |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
99941944.3 |
|
29-Mar-99 |
|
1068224 |
|
11-May-05 |
|
Granted |
|
Spain |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
99941944.3 |
|
29-Mar-99 |
|
1068224 |
|
11-May-05 |
|
Granted |
|
France |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
99941944.3 |
|
29-Mar-99 |
|
1068224 |
|
11-May-05 |
|
Granted |
|
United Kingdom |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
99941944.3 |
|
29-Mar-99 |
|
1068224 |
|
11-May-05 |
|
Granted |
|
Ireland |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
99941944.3 |
|
29-Mar-99 |
|
1068224 |
|
11-May-05 |
|
Granted |
|
Italy |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
99941944.3 |
|
29-Mar-99 |
|
28490 BE/2005 |
|
11-May-05 |
|
Granted |
|
Japan |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
2000-548013 |
|
29-Mar-99 |
|
|
|
|
|
Pending |
|
Luxembourg |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
99941944.3 |
|
29-Mar-99 |
|
1068224 |
|
11-May-05 |
|
Granted |
|
USA |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
09/599295 |
|
21-Jun-00 |
|
6537520 |
|
25-Mar-03 |
|
Granted |
|
USA |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
10/342081 |
|
14-Jan-03 |
|
6800273 |
|
5-Oct-04 |
|
Granted |
|
USA |
|
PHARMACEUTICALS FOR THE IMAGING OF ANGIOGENIC DISORDERS |
|
10/622246 |
|
18-Jul-03 |
|
7052673 |
|
30-May-06 |
|
Granted |
|
Canada |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
2412854 |
|
21-Jun-01 |
|
|
|
|
|
Pending |
|
Germany |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
01952180.6 |
|
21-Jun-01 |
|
1307226 |
|
19-Nov-08 |
|
Granted |
|
Europe |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
01952180.6 |
|
21-Jun-01 |
|
1307226 |
|
19-Nov-08 |
|
Granted |
|
France |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
01952180.6 |
|
21-Jun-01 |
|
1307226 |
|
19-Nov-08 |
|
Granted |
|
United Kingdom |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
01952180.6 |
|
21-Jun-01 |
|
1307226 |
|
19-Nov-08 |
|
Granted |
|
Canada |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
2349501 |
|
17-Dec-99 |
|
|
|
|
|
Pending |
|
USA |
|
QUINOLONE VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
09/281209 |
|
30-Mar-99 |
|
6524553 |
|
25-Feb-03 |
|
Granted |
|
USA |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
09/465300 |
|
17-Dec-99 |
|
6511648 |
|
28-Jan-03 |
|
Granted |
|
USA |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
09/948807 |
|
7-Sep-01 |
|
6683163 |
|
27-Jan-04 |
|
Granted |
|
USA |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
09/948390 |
|
7-Sep-01 |
|
6689337 |
|
10-Feb-04 |
|
Granted |
|
USA |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
09/947783 |
|
7-Sep-01 |
|
6743412 |
|
1-Jun-04 |
|
Granted |
|
USA |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
09/599364 |
|
21-Jun-00 |
|
6511649 |
|
28-Jan-03 |
|
Granted |
|
USA |
|
VITRONECTIN RECEPTOR ANTAGONIST PHARMACEUTICALS |
|
10/281015 |
|
26-Oct-02 |
|
7018611 |
|
28-Mar-06 |
|
Granted |
|
Australia |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
2005214898 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
Brazil |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
PI0507684-6 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
Canada |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
2556213 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
China |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
200580006479.9 |
|
11-Feb-05 |
|
|
|
|
|
Published |
|
Europe |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
05723066.6 |
|
11-Feb-05 |
|
|
|
|
|
Published |
|
Israel |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
177275 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
India |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
4441/DELNP/2006 |
|
11-Feb-05 |
|
|
|
|
|
Published |
|
Japan |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
2006-553329 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
Korea |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
00-0000-0000000 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
Mexico |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
PA/a/ 2006/008993 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
Norway |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
20064011 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
Russian Fed. |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
2006132814 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
Singapore |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
200900799-8 |
|
11-Feb-05 |
|
|
|
|
|
Pending |
|
Taiwan |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
94112302 |
|
18-Apr-05 |
|
|
|
|
|
Pending |
|
USA |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
11/055498 |
|
10-Feb-05 |
|
7344702 |
|
18-Mar-08 |
|
Granted |
|
USA |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
12/014161 |
|
15-Jan-08 |
|
|
|
|
|
Published |
|
South Africa |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
2006/06429 |
|
11-Feb-05 |
|
2006/06429 |
|
27-Feb-08 |
|
Granted |
|
Australia |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
2005238080 |
|
27-Apr-05 |
|
|
|
|
|
Pending |
|
Canada |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
2564737 |
|
27-Apr-05 |
|
|
|
|
|
Pending |
|
China |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
200580021474.3 |
|
27-Apr-05 |
|
|
|
|
|
Published |
|
Colombia |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
06109678 |
|
27-Apr-05 |
|
|
|
|
|
Pending |
|
Europe |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
05756378.5 |
|
27-Apr-05 |
|
|
|
|
|
Published |
|
Israel |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
178911 |
|
27-Apr-05 |
|
|
|
|
|
Pending |
|
Korea |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
00-0000-0000000 |
|
27-Apr-05 |
|
|
|
|
|
Pending |
|
Singapore |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
200606895-1 |
|
27-Apr-05 |
|
|
|
|
|
Granted |
|
Singapore |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
|
|
|
|
|
|
|
|
Pending |
|
USA |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
11/113486 |
|
25-Apr-05 |
|
7485283 |
|
3-Feb-09 |
|
Granted |
|
USA |
|
CONTRAST AGENTS FOR MYOCARDIAL PERFUSION IMAGING |
|
12/339694 |
|
19-Dec-08 |
|
|
|
|
|
Pending |
|
PCT |
|
|
|
TBD |
|
15-Apr-10 |
|
|
|
|
|
Pending |
|
PCT |
|
CONTRAST AGENTS FOR APPLICATIONS INCLUDING PERFUSION IMAGING |
|
PCT/US 2009/001247 |
|
27-Feb-09 |
|
|
|
|
|
Pending |
|
PCT |
|
CONTRAST AGENTS FOR APPLICATIONS INCLUDING PERFUSION IMAGING |
|
PCT/US 2009/001296 |
|
27-Feb-09 |
|
|
|
|
|
Pending |
|
USA |
|
MATRIX METALLOPROTEINASE INHIBITORS AS TARGETING COMPONENTS IN DIAGNOSTIC AGENTS |
|
09/783249 |
|
14-Feb-01 |
|
6656448 |
|
2-Dec-03 |
|
Granted |
|
USA |
|
MATRIX METALLOPROTEINASE INHIBITORS AS TARGETING COMPONENTS IN DIAGNOSTIC AGENTS |
|
10/645272 |
|
21-Aug-03 |
|
7060248 |
|
13-Jun-06 |
|
Granted |
|
Taiwan |
|
N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS |
|
98100454 |
|
8-Jan-09 |
|
|
|
|
|
Pending |
|
USA |
|
N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS |
|
12/350628 |
|
8-Jan-09 |
|
|
|
|
|
Pending |
|
PCT |
|
N-ALKOXYAMIDE CONJUGATES AS IMAGING AGENTS |
|
PCT/US 2009/000096 |
|
8-Jan-09 |
|
|
|
|
|
Pending |
|
Taiwan |
|
LIGANDS FOR IMAGING CONGESTIVE HEART FAILURE |
|
096149600 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Australia |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
2007339954 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Brazil |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
PCT/US 2007/088500 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Canada |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
PCT/US 2007/088500 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
China |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
PCT/US 2007/088500 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Colombia |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
09-076173 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Europe |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
7869717.4 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Israel |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
199563 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
India |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
PCT/US 2007/088500 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Japan |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
PCT/US2007/088500 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Korea |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
00-0000-0000000 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Mexico |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
MX/a/2009/007018 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Russia |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
2009128591 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
Singapore |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
200904382-9 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
South Africa |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
PCT/US2007/088500 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
USA |
|
LIGANDS FOR IMAGING CARDIAC INNERVATION |
|
12/448,575 |
|
21-Dec-07 |
|
|
|
|
|
Pending |
|
USA |
|
METHOD AND APPARATUS FOR SEPARATING IONS OF METALLIC ELEMENTS IN AQUEOUS SOLUTION |
|
10/762990 |
|
22-Jan-04 |
|
7138643 |
|
21-Nov-06 |
|
Granted |
|
USA |
|
APPARATUS AND METHOD FOR THE PREPARATION OF A RADIOPHARMACEUTICAL FORMULATION |
|
08/167685 |
|
15-Dec-93 |
|
5397902 |
|
14-Mar-95 |
|
Granted |
|
Austria |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Belgium |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Switzerland |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Germany |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
69126893.2-08 |
|
16-Jul-97 |
|
Granted |
|
Denmark |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Europe |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Spain |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
France |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
United Kingdom |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Greece |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Italy |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Liechtenstein |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Luxembourg |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Netherlands |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
Sweden |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
92902283.8 |
|
9-Oct-91 |
|
0646273 |
|
16-Jul-97 |
|
Granted |
|
USA |
|
STERILIZABLE RADIONUCLIDE GENERATOR AND METHOD FOR STERILIZING THE SAME |
|
07/596273 |
|
12-Oct-90 |
|
5109160 |
|
28-Apr-92 |
|
Granted |
|
Japan |
|
METHOD AND APPARATUS FOR SEPARATING IONS OF METALLIC ELEMENTS IN AQUEOUS SOLUTION |
|
2003-552418 |
|
12/18/2002 |
|
4162141 |
|
8/1/2008 |
|
Granted |
|
USA |
|
|
|
61/178,006 |
|
13-May-09 |
|
|
|
|
|
Pending |
|
PCT |
|
|
|
PCT/US2009/002998 |
|
13-May-09 |
|
|
|
|
|
Pending |
|
USA |
|
METHODS OF MAKING RADIOLABELED TRACERS AND PRECURSORS THEREOF |
|
11/492,729 |
|
27-Jul-06 |
|
|
|
|
|
Pending |
|
Canada |
|
METHODS OF MAKING RADIOLABELED TRACERS AND PRECURSORS THEREOF |
|
2618988 |
|
|
|
|
|
|
|
Pending |
|
USA |
|
|
|
61/302,477 |
|
8-Feb-10 |
|
|
|
|
|
Pending |
|
USA |
|
|
|
61/315,376 |
|
18-Mar-10 |
|
|
|
|
|
Pending |
|
USA |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
10/034,522 |
|
20-Dec-01 |
|
6676929 |
|
13-Jan-04 |
|
Granted |
|
USA |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
10/354,723 |
|
30-Jan-03 |
|
7011815 |
|
14-Mar-06 |
|
Granted |
|
USA |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
10/755,506 |
|
12-Jan-04 |
|
7060250 |
|
13-Jun-06 |
|
Granted |
|
USA |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
10/755,507 |
|
12-Jan-04 |
|
7229606 |
|
12-Jun-07 |
|
Granted |
|
USA |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
11/472,842 |
|
22-Jun-06 |
|
|
|
|
|
Published |
|
USA |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
11/526,302 |
|
25-Sep-06 |
|
|
|
|
|
Published |
|
USA |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
11/526,312 |
|
25-Sep-06 |
|
|
|
|
|
Published |
|
Australia |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
46543/96 |
|
16-Jan-96 |
|
689700 |
|
16-Jul-98 |
|
Granted |
|
Canada |
|
DIAGNOSTIC IMAGING CONTRAST AGENTS WITH EXTENDED BLOOD RETENTION |
|
2211100 |
|
16-Jan-96 |
|
2211100 |
|
20-Mar-07 |
|
Granted |
|
USA |
|
PROCESS FOR SYNTHESIZING PHOSPHODIESTERS |
|
08/833,745 |
|
11-Apr-97 |
|
5919967 |
|
06-Jul-99 |
|
Granted |
|
Australia |
|
PROCESS FOR SYNTHESIZING PHOSPHODIESTERS |
|
60425/98 |
|
27-Jan-98 |
|
728902 |
|
03-May-01 |
|
Granted |
|
Canada |
|
PROCESS FOR SYNTHESIZING PHOSPHODIESTERS |
|
2285417 |
|
27-Jan-98 |
|
2285417 |
|
24-Jan-06 |
|
Granted |
|
USA |
|
CONTRAST-ENHANCED DIAGNOSTIC IMAGING METHOD FOR MONITORING INTERVENTIONAL THERAPIES |
|
09/887,706 |
|
08-Sep-00 |
|
6861045 |
|
01-Mar-05 |
|
Granted |
|
USA |
|
CONTRAST-ENHANCED DIAGNOSTIC IMAGING METHOD FOR MONITORING INTERVENTIONAL THERAPIES |
|
10/961,872 |
|
08-Oct-04 |
|
7175829 |
|
13-Feb-07 |
|
Granted |
|
Australia |
|
CONTRAST-ENHANCED DIAGNOSTIC IMAGING METHOD FOR MONITORING INTERVENTIONAL THERAPIES |
|
96686/98 |
|
24-Sep-98 |
|
742438 |
|
18-Apr-02 |
|
Granted |
|
Canada |
|
CONTRAST-ENHANCED DIAGNOSTIC IMAGING METHOD FOR MONITORINGINTERVENTIONAL THERAPIES |
|
2303426 |
|
24-Sep-98 |
|
2303426 |
|
23-Sep-08 |
|
Granted |
|
Canada |
|
METHODS FOR LYMPH SYSTEM IMAGING |
|
2660717 |
|
16-Aug-07 |
|
|
|
|
|
Pending |
|
USA |
|
METHODS FOR LYMPH SYSTEM IMAGING |
|
11/840,070 |
|
16-Aug-07 |
|
|
|
|
|
Published |
|
USA |
|
IMAGING SEXUAL RESPONSE |
|
09/718,161 |
|
21-Nov-00 |
|
6548044 |
|
15-Apr-03 |
|
Granted |
|
USA |
|
IMAGING SEXUAL RESPONSE |
|
10/291,900 |
|
08-Nov-02 |
|
6969507 |
|
29-Nov-05 |
|
Granted |
|
USA |
|
IMAGING SEXUAL RESPONSE |
|
11/184,271 |
|
18-Jul-05 |
|
|
|
|
|
Published |
|
USA |
|
STEADY STATE PERFUSION METHODS |
|
11/346,884 |
|
03-Feb-06 |
|
|
|
|
|
Published |
|
Australia |
|
STEADY STATE PERFUSION METHODS |
|
2006210398 |
|
03-Feb-06 |
|
|
|
|
|
Pending |
|
Canada |
|
STEADY STATE PERFUSION METHODS |
|
2596863 |
|
03-Feb-06 |
|
|
|
|
|
Pending |
|
USA |
|
INTEGRIN TARGETED IMAGING AGENTS |
|
11/971818 |
|
09-Jan-08 |
|
7566442 |
|
28-Jul-09 |
|
Granted |
|
USA |
|
INTEGRIN TARGETED IMAGING AGENTS |
|
10/351463 |
|
24-Jan-03 |
|
7255875 |
|
14-Aug-07 |
|
Granted |
|
USA |
|
INTEGRIN TARGETED IMAGING AGENTS |
|
11/305416 |
|
16-Dec-05 |
|
7344698 |
|
18-Mar-08 |
|
Granted |
|
USA |
|
THERMAL PREACTIVATION OF GASEOUS PRECURSOR FILLED COMPOSITIONS |
|
08/929847 |
|
15-Sep-97 |
|
6548047 |
|
15-Apr-03 |
|
Granted |
Trademarks and Trademark Applications
|
Xxxx |
|
Country |
|
Application No. |
|
Filing Date |
|
Reg No. |
|
Reg Date |
|
Status |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
ABLAVAR (BLOCK) |
|
Argentina |
|
2642605 |
|
2-Jan-06 |
|
|
|
|
|
Pending |
|
ABLAVAR (BLOCK) |
|
Austria |
|
AM8773/2005 |
|
29-Dec-05 |
|
231337 |
|
24-Apr-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Australia |
|
1054235 |
|
6-May-05 |
|
1054235 |
|
19-Dec-05 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Brazil |
|
827589522 |
|
15-Jul-05 |
|
827589522 |
|
18-Dec-07 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Benelux |
|
1098847 |
|
23-Dec-05 |
|
788831 |
|
6-Apr-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Canada |
|
1256778 |
|
6-May-05 |
|
|
|
|
|
Published |
|
ABLAVAR (BLOCK) |
|
Switzerland |
|
55642/2005 |
|
8-Jul-05 |
|
536787 |
|
18-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXX (XXXXX) |
|
Xxxxx (People’s Republic) |
|
4775929 |
|
12-Jul-05 |
|
4775929 |
|
14-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXX (XXXXX) |
|
Xxxxxx, Xxxxxxxx xf |
|
71986 |
|
2-Jan-06 |
|
|
|
|
|
Pending |
|
ABLAVAR (BLOCK) |
|
Czech Republic |
|
432910 |
|
29-Dec-05 |
|
282088 |
|
26-Jul-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Germany |
|
305269844/05 |
|
9-May-05 |
|
30526984 |
|
4-Nov-05 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Denmark |
|
VA 2005 05903 |
|
29-Dec-05 |
|
VR 2006 01176 |
|
30-Mar-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Estonia |
|
M200501718 |
|
29-Dec-05 |
|
43492 |
|
22-Jan-07 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
European Community |
|
4390464 |
|
15-Apr-05 |
|
4390464 |
|
22-Feb-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Spain |
|
2650581(9) |
|
9-May-05 |
|
2650581 |
|
23-Mar-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Finland |
|
T200503494 |
|
29-Dec-05 |
|
236462 |
|
31-Jul-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
France |
|
053357818 |
|
9-May-05 |
|
053357818 |
|
14-Oct-05 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
United Kingdom |
|
2391178 |
|
6-May-05 |
|
2391178 |
|
21-Oct-05 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Greece |
|
151178 |
|
30-Dec-05 |
|
151178 |
|
17-Apr-07 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Hungary |
|
M0600105 |
|
11-Jan-06 |
|
188565 |
|
8-Feb-07 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Ireland |
|
2005/02681 |
|
29-Dec-05 |
|
233320 |
|
19-Jul-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Iceland |
|
4147/2005 |
|
29-Dec-05 |
|
186/2006 |
|
3-Feb-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Italy |
|
TO2005 C001418 |
|
9-May-05 |
|
1174404 |
|
5-Mar-09 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Japan |
|
2005-40339 |
|
9-May-05 |
|
4955744 |
|
26-May-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Lithuania |
|
2005 2270 |
|
29-Dec-05 |
|
54034 |
|
1-Sep-07 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Latvia |
|
M-05-1848 |
|
30-Dec-05 |
|
M57473 |
|
20-Apr-07 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Malta |
|
44677 |
|
29-Dec-05 |
|
44677 |
|
19-Jun-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Mexico |
|
727377 |
|
8-Jul-05 |
|
920285 |
|
22-Feb-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Norway |
|
200514758 |
|
30-Dec-05 |
|
234225 |
|
10-Aug-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Poland |
|
Z-304421 |
|
3-Jan-06 |
|
194640 |
|
11-Sep-07 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Portugal |
|
396869 |
|
6-Jan-06 |
|
396869 |
|
25-May-07 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Sweden |
|
2005/09882 |
|
30-Dec-05 |
|
380541 |
|
28-Apr-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Slovenia |
|
Z-200571839 |
|
29-Dec-05 |
|
200571839 |
|
22-Jun-06 |
|
Registered |
|
ABLAVAR (BLOCK) |
|
Slovakia |
|
2456-2005 |
|
29-Dec-05 |
|
216455 |
|
11-Jan-07 |
|
Registered |
Confidential
|
XXXXXXX (XXXXX) |
|
Xxxxxx Xxxxxx xf America |
|
78/929561 |
|
14-Jul-06 |
|
3769439 |
|
30-Mar-10 |
|
Registered |
|
AROLUME (BLOCK) |
|
Switzerland |
|
53834/2005 |
|
9-May-05 |
|
535032 |
|
27-Jun-05 |
|
Registered |
|
AROLUME (BLOCK) |
|
European Community |
|
4421591 |
|
4-May-05 |
|
4421591 |
|
9-Mar-06 |
|
Registered |
|
AROLUME (BLOCK) |
|
Iceland |
|
1236/2005 |
|
9-May-05 |
|
556/2005 |
|
6-Jun-05 |
|
Registered |
|
AROLUME (BLOCK) |
|
Norway |
|
200504403 |
|
11-May-05 |
|
231175 |
|
6-Mar-06 |
|
Registered |
|
ASPECTIV (BLOCK) |
|
Iceland |
|
1211/2005 |
|
9-May-05 |
|
531/2005 |
|
6-Jun-05 |
|
Registered |
|
ASPECTIV (BLOCK) |
|
Norway |
|
200504396 |
|
11-May-05 |
|
231161 |
|
3-Mar-06 |
|
Registered |
|
AU COEUR DE L’INNOVATION (BLOCK) |
|
Canada |
|
1174870 |
|
15-Apr-03 |
|
XXX000000 |
|
21-Apr-06 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
United Arab Emirates |
|
31093 |
|
28-Apr-99 |
|
|
|
|
|
Published |
|
CARDIOLITE (BLOCK) |
|
Argentina |
|
2308142 |
|
22-Sep-00 |
|
1889547 |
|
9-Oct-02 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Austria |
|
AM3202/88 |
|
15-Jul-88 |
|
122358 |
|
11-Nov-88 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Australia |
|
465624 |
|
21-May-87 |
|
465624 |
|
22-May-89 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Bosnia and Herzegovina |
|
BAZ058668A |
|
26-Apr-05 |
|
BAZ058668A |
|
4-Nov-09 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Bahrain |
|
49417 |
|
3-Aug-06 |
|
49417 |
|
3-Aug-06 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Brazil |
|
813573521 |
|
11-Jun-87 |
|
813573521 |
|
27-Nov-90 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Benelux |
|
0058861 |
|
26-May-87 |
|
430568 |
|
26-May-87 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Canada |
|
0592765 |
|
1-Oct-87 |
|
TMA355389 |
|
5-May-89 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Switzerland |
|
5106 |
|
15-Jul-88 |
|
364924 |
|
21-Dec-88 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Chile |
|
677859 |
|
1-Mar-05 |
|
727742 |
|
16-Jun-05 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
China (People’s Republic) |
|
9004153 |
|
16-Feb-90 |
|
595940 |
|
20-May-92 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Colombia |
|
374939 |
|
5-Feb-93 |
|
185322 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxx Xxxx |
|
00000 |
|
26-Aug-93 |
|
83836 |
|
30-Aug-93 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Germany |
|
D433985WZ |
|
26-May-87 |
|
1163253 |
|
30-Aug-90 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Denmark |
|
1988 04954 |
|
18-Jul-88 |
|
1990 00859 |
|
16-Feb-90 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Egypt |
|
89620 |
|
10-Jan-94 |
|
89620 |
|
31-May-97 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
European Community |
|
6800551 |
|
2-Apr-08 |
|
6800551 |
|
18-Dec-08 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Spain |
|
1,198,786 |
|
12-Jun-87 |
|
1,198,786 |
|
5-Oct-89 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Finland |
|
3111/88 |
|
19-Jul-88 |
|
109747 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx |
|
000000 |
|
27-May-87 |
|
1411084 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx Xxxxxxx |
|
1310679 |
|
21-May-87 |
|
1310679 |
|
8-Sep-89 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Greece |
|
89978 |
|
1-Aug-88 |
|
89978 |
|
17-Oct-91 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Hong Kong |
|
300683631 |
|
19-Jul-06 |
|
300683631 |
|
6-Feb-07 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Croatia |
|
Z20050481 |
|
19-Apr-05 |
|
Z20050481 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
M9301931 |
|
29-Jul-88 |
|
127666 |
|
23-Jan-89 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Indonesia |
|
D99-13523 |
|
4-Aug-99 |
|
511371 |
|
1-Jul-02 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Israel |
|
72262 |
|
17-Apr-89 |
|
72262 |
|
17-Mar-93 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
India |
|
497824 |
|
14-Sep-88 |
|
497824 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxx |
|
36032C/88 |
|
9-Aug-88 |
|
844131 |
|
14-Jun-91 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Jordan |
|
87575 |
|
23-Jul-06 |
|
|
|
|
|
Published |
|
CARDIOLITE (BLOCK) |
|
Japan |
|
57085/87 |
|
25-May-87 |
|
2212950 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxx, Xxxxxxxx of |
|
88-20575 |
|
10-Sep-88 |
|
40-192678 |
|
31-May-90 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Kuwait |
|
78557 |
|
19-Jul-06 |
|
|
|
|
|
Pending |
|
CARDIOLITE (BLOCK) |
|
Macedonia |
|
Z-2005/233 |
|
15-Apr-05 |
|
12756 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx |
|
000000 |
|
17-May-04 |
|
838248 |
|
17-Jun-04 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Norway |
|
872079 |
|
22-May-07 |
|
134431 |
|
1-Dec-88 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
New Zealand |
|
233259 |
|
6-Jan-94 |
|
233259 |
|
5-Jul-96 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Oman |
|
40911 |
|
25-Jul-06 |
|
40911 |
|
10-Jul-07 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Panama |
|
074219 |
|
27-Jan-95 |
|
074219 |
|
16-May-96 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Philippines |
|
0-0000-000000 |
|
31-Jul-98 |
|
0-0000-000000 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx |
|
X-00000 |
|
8-Aug-88 |
|
63998 |
|
8-Aug-88 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Portugal |
|
354442 |
|
13-Mar-01 |
|
354442 |
|
30-Jun-04 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Russian Federation |
|
I09652 |
|
9-Aug-88 |
|
85120 |
|
3-Apr-89 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Saudi Arabia |
|
7416 |
|
11-Sep-88 |
|
000/00 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx |
|
87-4401 |
|
14-Jun-87 |
|
215044 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxxxxx |
|
S/439/94 |
|
19-Jan-94 |
|
T94/00439E |
|
19-Jan-94 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Slovenia |
|
Z-200570518 |
|
14-Apr-05 |
|
Z-200570518 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxxxx |
|
259749 |
|
3-Feb-94 |
|
TM28685 |
|
12-May-95 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Turkey |
|
43591 |
|
24-Aug-88 |
|
107201 |
|
24-Aug-88 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Taiwan |
|
29883 |
|
3-Jun-87 |
|
388319 |
|
16-Jan-88 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
United States of America |
|
73/662052 |
|
21-May-87 |
|
1484982 |
|
19-Apr-88 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Uruguay |
|
266038 |
|
21-Oct-93 |
|
358.403 |
|
11-Jan-95 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Venezuela |
|
94-16939 |
|
20-Dec-94 |
|
188034-P |
|
9-Feb-96 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
Viet Nam |
|
0-0000-00000 |
|
27-Jul-93 |
|
12212 |
|
16-Jun-94 |
|
Registered |
|
CARDIOLITE (BLOCK) |
|
South Africa |
|
88/5957 |
|
18-Jul-88 |
|
88/5957 |
|
7-Nov-90 |
|
Registered |
|
CARDIOLITE IN XXXXXXXX |
|
Xxxxx |
|
00000/00 |
|
25-Aug-87 |
|
2266312 |
|
21-Sep-90 |
|
Registered |
|
CLEARAGE (BLOCK) |
|
Switzerland |
|
53869/2005 |
|
10-May-05 |
|
534934 |
|
23-Jun-05 |
|
Registered |
|
CLEARAGE (BLOCK) |
|
European Community |
|
4430229 |
|
10-May-05 |
|
4430229 |
|
25-Apr-06 |
|
Registered |
|
CLEARAGE (BLOCK) |
|
Iceland |
|
1225/2005 |
|
9-May-05 |
|
545/2005 |
|
6-Jun-05 |
|
Registered |
|
CLEARAGE (BLOCK) |
|
Norway |
|
200504405 |
|
11-May-05 |
|
231180 |
|
6-Mar-06 |
|
Registered |
|
CONSTALITE (BLOCK) |
|
Switzerland |
|
53925/2005 |
|
11-May-05 |
|
535348 |
|
5-Jul-05 |
|
Registered |
|
CONSTALITE (BLOCK) |
|
European Community |
|
4388518 |
|
15-Apr-05 |
|
4388518 |
|
22-Feb-06 |
|
Registered |
|
CONSTALITE (BLOCK) |
|
Iceland |
|
1212/2005 |
|
9-May-05 |
|
532/2005 |
|
6-Jun-05 |
|
Registered |
|
CONSTALITE (BLOCK) |
|
Norway |
|
200504368 |
|
11-May-05 |
|
231265 |
|
8-Mar-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Austria |
|
AM 6792/2005 |
|
11-Oct-05 |
|
229 298 |
|
10-Jan-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Australia |
|
1079053 |
|
4-Oct-05 |
|
1079053 |
|
22-May-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Benelux |
|
1086689 |
|
3-Oct-05 |
|
784455 |
|
7-Mar-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Switzerland |
|
53929/2005 |
|
11-May-05 |
|
535350 |
|
5-Jul-05 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
China (People’s Republic) |
|
4932556 |
|
8-Oct-05 |
|
4932556 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxx Xxxxxxxx |
|
X-000000 |
|
3-Oct-05 |
|
280408 |
|
19-Apr-06 |
|
Registered |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
000 00 724.2/05 |
|
4-Oct-05 |
|
30558724 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
VA200504171 |
|
3-Oct-05 |
|
VR200503905 |
|
11-Oct-05 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Estonia |
|
M200501257 |
|
3-Oct-05 |
|
43142 |
|
22-Sep-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
European Community |
|
4388641 |
|
15-Apr-05 |
|
4388641 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxx |
|
2672702 |
|
4-Oct-05 |
|
2672702 |
|
30-May-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Finland |
|
X000000000 |
|
3-Oct-05 |
|
236053 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx |
|
053383474 |
|
3-Oct-05 |
|
053383474 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx Xxxxxxx |
|
2402993 |
|
3-Oct-05 |
|
2402993 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx |
|
150994 |
|
10-Oct-05 |
|
150994 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
M0503233 |
|
6-Oct-05 |
|
187777 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
2005/02036 |
|
3-Oct-05 |
|
232693 |
|
10-Apr-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Iceland |
|
1214/2005 |
|
9-May-05 |
|
534/2005 |
|
6-Jun-05 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Italy |
|
TO2005C002840 |
|
5-Oct-05 |
|
1175186 |
|
6-Mar-09 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Japan |
|
2005-92510 |
|
4-Oct-05 |
|
4999886 |
|
2-Nov-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Lithuania |
|
2005 1732 |
|
3-Oct-05 |
|
53451 |
|
15-May-07 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Latvia |
|
M051426 |
|
30-Nov-05 |
|
M57210 |
|
20-Jan-07 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Malta |
|
44352 |
|
5-Oct-05 |
|
44352 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxx |
|
200504369 |
|
11-May-05 |
|
231267 |
|
8-Mar-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Poland |
|
Z-300785 |
|
4-Oct-05 |
|
191177 |
|
5-Dec-07 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Portugal |
|
394593 |
|
14-Oct-05 |
|
394593 |
|
11-Aug-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Sweden |
|
2005/07289 |
|
4-Oct-05 |
|
378117 |
|
13-Jan-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Singapore |
|
T05/19228Z |
|
4-Oct-05 |
|
T05/19228 |
|
13-Jul-06 |
|
Registered |
|
CONSTELITE (BLOCK) |
|
Slovenia |
|
Z-200571366 |
|
3-Oct-05 |
|
200571366 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxxxxx |
|
1819-2005 |
|
3-Oct-05 |
|
215213 |
|
11-Sep-06 |
|
Registered |
|
CONSTILITE (BLOCK) |
|
Switzerland |
|
53927/2005 |
|
11-May-05 |
|
535349 |
|
5-Jul-05 |
|
Registered |
|
CONSTILITE (BLOCK) |
|
European Community |
|
4388559 |
|
15-Apr-05 |
|
4388559 |
|
31-Mar-06 |
|
Registered |
|
CONSTILITE (BLOCK) |
|
Iceland |
|
1213/2005 |
|
9-May-05 |
|
533/2005 |
|
6-Jun-05 |
|
Registered |
|
CONSTILITE (BLOCK) |
|
Norway |
|
200504397 |
|
11-May-05 |
|
231268 |
|
8-Mar-06 |
|
Registered |
|
CORRELITE (BLOCK) |
|
Switzerland |
|
53864/2005 |
|
10-May-05 |
|
534929 |
|
23-Jun-05 |
|
Registered |
|
CORRELITE (BLOCK) |
|
European Community |
|
4430427 |
|
10-May-05 |
|
4430427 |
|
21-Mar-06 |
|
Registered |
|
CORRELITE (BLOCK) |
|
Iceland |
|
1220/2005 |
|
9-May-05 |
|
540/2005 |
|
6-Jun-05 |
|
Registered |
|
CORRELITE (BLOCK) |
|
Norway |
|
200504373 |
|
11-May-05 |
|
231303 |
|
9-Mar-06 |
|
Registered |
|
XXXXXXXXX (XXXXX) |
|
Xxxxxxxxxxx |
|
53868/2005 |
|
10-May-05 |
|
534933 |
|
23-Jun-05 |
|
Registered |
|
CRESONATE (BLOCK) |
|
European Community |
|
4430369 |
|
10-May-05 |
|
4430369 |
|
5-Apr-06 |
|
Registered |
|
CRESONATE (BLOCK) |
|
Iceland |
|
1224/2005 |
|
9-May-05 |
|
544/2005 |
|
6-Jun-05 |
|
Registered |
|
CRESONATE (BLOCK) |
|
Norway |
|
200504376 |
|
11-May-05 |
|
231312 |
|
9-Mar-06 |
|
Registered |
|
DEFINITY |
|
Austria |
|
AM6773/2003 |
|
14-Oct-03 |
|
214791 |
|
13-Jan-04 |
|
Registered |
|
DEFINITY |
|
Benelux |
|
1041399 |
|
7-Oct-03 |
|
744968 |
|
7-Oct-03 |
|
Registered |
|
DEFINITY |
|
Denmark |
|
VA200303637 |
|
8-Oct-03 |
|
VR200304229 |
|
23-Dec-03 |
|
Registered |
|
DEFINITY |
|
European Community |
|
4043428 |
|
24-Sep-04 |
|
4043428 |
|
16-Jun-06 |
|
Registered |
|
DEFINITY |
|
Italy |
|
T02004C002801 |
|
27-Sep-04 |
|
|
|
|
|
Pending |
|
DEFINITY |
|
Jordan |
|
|
|
9-Dec-03 |
|
72919 |
|
16-Jun-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
United Arab Emirates |
|
58056 |
|
30-Dec-03 |
|
49158 |
|
31-Oct-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Argentina |
|
2481681 |
|
4-Dec-03 |
|
2038737 |
|
19-Aug-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Bulgaria |
|
73798 |
|
24-Sep-04 |
|
55703 |
|
20-Sep-06 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Bahrain |
|
40543 |
|
19-Jan-04 |
|
40543 |
|
3-Aug-06 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Brazil |
|
821165925 |
|
23-Oct-98 |
|
821165925 |
|
2-May-07 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Benelux |
|
917629 |
|
11-Jun-98 |
|
647455 |
|
11-Jun-98 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Canada |
|
885825 |
|
29-Jul-98 |
|
TMA604670 |
|
10-Mar-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Switzerland |
|
04519 |
|
5-Jun-98 |
|
456755 |
|
4-Dec-98 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Switzerland |
|
56283/2004 |
|
17-Sep-04 |
|
528677 |
|
14-Dec-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Chile |
|
627594 |
|
11-Nov-03 |
|
695895 |
|
22-Jun-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
China (People’s Republic) |
|
2000175322 |
|
13-Nov-00 |
|
1684547 |
|
21-Dec-01 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Colombia |
|
T2003/095330 |
|
27-Oct-03 |
|
288124 |
|
9-Sep-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Xxxxx Xxxxxxxx |
|
000000 |
|
23-Sep-04 |
|
277224 |
|
22-Dec-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Germany |
|
398325103 |
|
10-Jun-98 |
|
39832510 |
|
6-Nov-98 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Germany |
|
303520582/82 |
|
9-Oct-03 |
|
30352058 |
|
6-Apr-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Denmark |
|
VA199802556 |
|
10-Jun-98 |
|
VR199803549 |
|
4-Nov-98 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Estonia |
|
M200401427 |
|
22-Sep-04 |
|
42075 |
|
11-Jan-06 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Egypt |
|
|
|
25-Oct-03 |
|
162754 |
|
16-Mar-06 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Spain |
|
2614823 (4) |
|
23-Sep-04 |
|
2614823 |
|
2-Feb-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Finland |
|
T200400588 |
|
10-Mar-04 |
|
231633 |
|
30-Nov-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
France |
|
03 3 250 257 |
|
9-Oct-03 |
|
03 3 250 257 |
|
19-Mar-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
United Kingdom |
|
2374021 |
|
24-Sep-04 |
|
2374021 |
|
18-Mar-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Greece |
|
137184 |
|
12-Jun-98 |
|
137184 |
|
19-Feb-01 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Greece |
|
150072 |
|
7-Oct-04 |
|
150072 |
|
18-Apr-06 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Hong Kong |
|
300118539 |
|
27-Nov-03 |
|
300118539 |
|
10-Aug-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Hungary |
|
M0403974 |
|
27-Sep-04 |
|
184834 |
|
12-Jun-06 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Indonesia |
|
DOO-28189 |
|
24-Nov-00 |
|
491755 |
|
1-Oct-01 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Ireland |
|
98/2416 |
|
8-Jun-98 |
|
209318 |
|
31-Mar-00 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Ireland |
|
2003/01875 |
|
7-Oct-03 |
|
228069 |
|
7-May-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Israel |
|
167544 |
|
24-Oct-03 |
|
167544 |
|
5-Sep-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
India |
|
970339 |
|
14-Nov-00 |
|
970339 |
|
31-Mar-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Iceland |
|
1091/1998 |
|
10-Jun-98 |
|
1181/1998 |
|
24-Nov-98 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Iceland |
|
2418/2004 |
|
17-Sep-04 |
|
841/2004 |
|
6-Oct-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Italy |
|
RM98C003094 |
|
17-Jun-98 |
|
839885 |
|
8-Mar-01 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Korea, Republic of |
|
00-0000-00000 |
|
11-Nov-00 |
|
00-0000000 |
|
29-Mar-02 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Kuwait |
|
61869 |
|
00-Xxx-00 |
|
00000 |
|
00-Xxx-00 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Lebanon |
|
96379 |
|
8-Jan-04 |
|
96379 |
|
8-Jan-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Lithuania |
|
20041886 |
|
22-Sep-04 |
|
51288 |
|
14-Mar-06 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Latvia |
|
M-04-1443 |
|
22-Sep-04 |
|
M55649 |
|
20-Nov-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Macao |
|
N/017396 |
|
1-Jun-05 |
|
N/017396 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Malta |
|
|
|
30-Sep-04 |
|
42705 |
|
21-Mar-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Mexico |
|
626695 |
|
28-Oct-03 |
|
821941 |
|
25-Feb-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Malaysia |
|
00015872 |
|
8-Nov-00 |
|
00015872 |
|
29-Nov-07 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Norway |
|
200309427 |
|
9-Oct-03 |
|
223995 |
|
9-Aug-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
New Zealand |
|
705127 |
|
27-Nov-03 |
|
705127 |
|
5-Jul-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Oman |
|
|
|
16-Dec-03 |
|
32096 |
|
10-Jul-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Philippines |
|
0-0000-000000 |
|
27-Oct-03 |
|
0-0000-000000 |
|
17-Aug-06 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Pakistan |
|
648 |
|
10-Nov-00 |
|
167487 |
|
10-Nov-00 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Poland |
|
Z-285820 |
|
24-Sep-04 |
|
188252 |
|
24-Sep-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Portugal |
|
375909 |
|
16-Oct-03 |
|
375909 |
|
3-Nov-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Romania |
|
M2004 08155 |
|
22-Sep-04 |
|
NR63773 |
|
22-Sep-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Saudi Arabia |
|
86886 |
|
27-Dec-03 |
|
747/49 |
|
20-Sep-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Sweden |
|
1998/04656 |
|
11-Jun-98 |
|
338235 |
|
9-Jun-00 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Sweden |
|
2004/07226 |
|
29-Oct-04 |
|
373766 |
|
22-Jul-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Singapore |
|
T02/16112Z |
|
16-Oct-02 |
|
T02/11612Z |
|
16-Oct-02 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Slovenia |
|
Z200471683 |
|
22-Sep-04 |
|
200471683 |
|
13-Jun-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Slovakia |
|
2898-2004 |
|
22-Sep-04 |
|
211567 |
|
10-Oct-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Thailand |
|
439865 |
|
28-Nov-00 |
|
146090 |
|
27-Oct-01 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Turkey |
|
2004030777 |
|
24-Sep-04 |
|
2004030777 |
|
24-Sep-04 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Taiwan |
|
89065181 |
|
10-Nov-00 |
|
983838 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx Xxxxxx of America |
|
75/479438 |
|
5-May-98 |
|
2478324 |
|
14-Aug-01 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Venezuela |
|
15475/2003 |
|
27-Oct-03 |
|
P261256 |
|
25-May-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Viet Nam |
|
0-0000-00000 |
|
26-Dec-03 |
|
62986 |
|
24-May-05 |
|
Registered |
|
DEFINITY (BLOCK) |
|
Serbia (Old Code) |
|
Z-522/05 |
|
5-May-05 |
|
50885 |
|
7-Jun-06 |
|
Registered |
|
DEFINITY (DI FEN LI TI) (SIMPLIFIED CHINESE CHARACTERS) (BLOCK) |
|
China (People's Republic) |
|
4636959 |
|
30-Apr-05 |
|
4636959 |
|
14-Sep-08 |
|
Registered |
|
DEFINITY (DI FEN LI) (SIMPLIFIED CHINESE CHARACTERS) (VERSION 1) (BLOCK) |
|
China (People's Republic) |
|
4636957 |
|
30-Apr-05 |
|
4636957 |
|
28-Aug-08 |
|
Registered |
|
DEFINITY (DI FEN LI) (SIMPLIFIED CHINESE CHARACTERS) (VERSION 2) (BLOCK) |
|
China (People's Republic) |
|
4636953 |
|
30-Apr-05 |
|
4636953 |
|
28-Aug-08 |
|
Registered |
|
DEFINITY (DI FEN NI TI) (SIMPLIFIED CHINESE CHARACTERS) (BLOCK) |
|
China (People's Republic) |
|
4636951 |
|
30-Apr-05 |
|
4636951 |
|
14-Sep-08 |
|
Registered |
|
DEFINITY (DI FEN NI) (SIMPLIFIED CHINESE CHARACTERS) (BLOCK) |
|
China (People's Republic) |
|
4636952 |
|
30-Apr-05 |
|
4636952 |
|
28-Aug-08 |
|
Registered |
|
DEFINITY (DI FEN NI) (SIMPLIFIED CHINESE CHARACTERS) VERSION 1 (BLOCK) |
|
China (People's Republic) |
|
4636958 |
|
30-Apr-05 |
|
4636958 |
|
28-Aug-08 |
|
Registered |
|
DEFINITY (DI FEN NI) (SIMPLIFIED CHINESE CHARACTERS) VERSION 2 (BLOCK) |
|
China (People's Republic) |
|
4636954 |
|
30-Apr-05 |
|
4636954 |
|
28-Aug-08 |
|
Registered |
|
DEFINITY (DI FEN) (SIMPLIFIED CHINESE CHARACTERS) VERSION 2 (BLOCK) |
|
China (People's Republic) |
|
4636955 |
|
30-Apr-05 |
|
4636955 |
|
28-Aug-08 |
|
Registered |
|
DEFINITY IN CHINESE (DE FEN LI) (BLOCK) |
|
Hong Kong |
|
300415692 |
|
5-May-05 |
|
300415692 |
|
18-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DE FEN LI) (BLOCK) |
|
Macao |
|
N/017399 |
|
1-Jun-05 |
|
N/017399 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN LI TI) (BLOCK) |
|
Hong Kong |
|
300415746 |
|
5-May-05 |
|
300415746 |
|
18-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN LI TI) (BLOCK) |
|
Macao |
|
N/017404 |
|
1-Jun-05 |
|
N/017404 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN LI) - VERSION 2 (BLOCK) |
|
Macao |
|
N/017400 |
|
1-Jun-05 |
|
N/017400 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN LI) (BLOCK) |
|
Hong Kong |
|
300415728 |
|
5-May-05 |
|
300415728 |
|
18-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN LI) (BLOCK) |
|
Hong Kong |
|
300415737 |
|
5-May-05 |
|
300415737 |
|
18-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN LI) (BLOCK) |
|
Macao |
|
N/017402 |
|
1-Jun-05 |
|
N/017402 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN NI TI) (BLOCK) |
|
Hong Kong |
|
300415773 |
|
5-May-05 |
|
300415773 |
|
18-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN NI TI) (BLOCK) |
|
Macao |
|
N/017405 |
|
1-Jun-05 |
|
N/017405 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN NI) - VERSION 2 (BLOCK) |
|
Hong Kong |
|
300415755 |
|
5-May-05 |
|
300415755 |
|
18-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN NI) - VERSION 2 (BLOCK) |
|
Macao |
|
N/017403 |
|
1-Jun-05 |
|
N/017403 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN NI) (BLOCK) |
|
Hong Kong |
|
300415764 |
|
5-May-05 |
|
300415764 |
|
18-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN NI) (BLOCK) |
|
Macao |
|
N/017401 |
|
1-Jun-05 |
|
N/017401 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN) - VERSION 2 (BLOCK) |
|
Macao |
|
N/017398 |
|
1-Jun-05 |
|
N/017398 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI FEN) (BLOCK) |
|
Macao |
|
N/017397 |
|
1-Jun-05 |
|
N/017397 |
|
6-Oct-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI-FEN) - VERSION 2 (BLOCK) |
|
Taiwan |
|
094020928 |
|
3-May-05 |
|
01197686 |
|
1-Mar-06 |
|
Registered |
|
DEFINITY IN CHINESE (DI-FEN) (BLOCK) |
|
Taiwan |
|
094020927 |
|
3-May-05 |
|
01197685 |
|
1-Mar-06 |
|
Registered |
|
DEFINITY IN CHINESE (DI-FEN-LI) - VERSION 2 (BLOCK) |
|
Taiwan |
|
094020930 |
|
3-May-05 |
|
01197688 |
|
1-Mar-06 |
|
Registered |
|
DEFINITY IN CHINESE (DI-FEN-LI) (BLOCK) |
|
Taiwan |
|
094020926 |
|
3-May-05 |
|
01197684 |
|
1-Mar-06 |
|
Registered |
|
DEFINITY IN CHINESE (DI-FEN-LI-TI) (BLOCK) |
|
Taiwan |
|
094020922 |
|
3-May-05 |
|
01185604 |
|
16-Dec-05 |
|
Registered |
|
DEFINITY IN CHINESE (DI-FEN-NI) - VERSION 2 (BLOCK) |
|
Taiwan |
|
094020929 |
|
3-May-05 |
|
01197687 |
|
1-Mar-06 |
|
Registered |
|
DEFINITY IN CHINESE (DI-FEN-NI) (BLOCK) |
|
Taiwan |
|
094020943 |
|
3-May-05 |
|
01197690 |
|
1-Mar-06 |
|
Registered |
|
DEFINITY IN CHINESE (DI-FEN-NI-TI) (BLOCK) |
|
Taiwan |
|
094020920 |
|
3-May-05 |
|
01183223 |
|
1-Dec-05 |
|
Registered |
|
DEFINITY IN CHINESE (TE-FEN-LI) (BLOCK) |
|
Taiwan |
|
094020932 |
|
3-May-05 |
|
01197689 |
|
1-Mar-06 |
|
Registered |
|
DEFINITY WITH KATAKANA (BLOCK) |
|
Japan |
|
914981999 |
|
12-Oct-99 |
|
4412056 |
|
25-Aug-00 |
|
Registered |
|
DEFINTY (BLOCK) |
|
Australia |
|
980075 |
|
27-Nov-03 |
|
980075 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
AM6794/2005 |
|
11-Oct-05 |
|
229 300 |
|
|
|
Pending |
|
DEPICTRA (BLOCK) |
|
Australia |
|
1079051 |
|
4-Oct-05 |
|
1079051 |
|
22-May-06 |
|
Registered |
|
DEPICTRA (BLOCK) |
|
Benelux |
|
1086688 |
|
3-Oct-05 |
|
0784453 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxxxxxx |
|
53833/2005 |
|
9-May-05 |
|
535031 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxx (People’s Republic) |
|
4932557 |
|
8-Oct-05 |
|
4932557 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx, Xxxxxxxx of |
|
71783 |
|
5-Oct-05 |
|
|
|
|
|
Pending |
|
DEPICTRA (BLOCK) |
|
Czech Republic |
|
O-430238 |
|
3-Oct-05 |
|
280406 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
30558722.6/05 |
|
4-Oct-05 |
|
30558722 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
VA200504170 |
|
3-Oct-05 |
|
VR200503903 |
|
11-Oct-05 |
|
Registered |
|
DEPICTRA (BLOCK) |
|
Estonia |
|
M200501255 |
|
3-Oct-05 |
|
43140 |
|
22-Sep-06 |
|
Registered |
|
DEPICTRA (BLOCK) |
|
European Community |
|
004421632 |
|
4-May-05 |
|
004421632 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxx |
|
2672704 |
|
4-Oct-05 |
|
2672704 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
T200502573 |
|
3-Oct-05 |
|
236051 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
053383469 |
|
3-Oct-05 |
|
053383469 |
|
3-Oct-05 |
|
Registered |
|
DEPICTRA (BLOCK) |
|
United Kingdom |
|
2402991 |
|
3-Oct-05 |
|
2402991 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
150992 |
|
10-Oct-05 |
|
150992 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
M0503231 |
|
6-Oct-05 |
|
187775 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
2005/02034 |
|
3-Oct-05 |
|
232689 |
|
10-Apr-06 |
|
Registered |
|
DEPICTRA (BLOCK) |
|
Iceland |
|
1235/2005 |
|
9-May-05 |
|
000/0000 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxx |
|
TO2005C002838 |
|
5-Oct-05 |
|
1175184 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxx |
|
0000-00000 |
|
4-Oct-05 |
|
4959290 |
|
9-Jun-06 |
|
Registered |
|
DEPICTRA (BLOCK) |
|
Lithuania |
|
2005 1730 |
|
3-Oct-05 |
|
53449 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
M-05-1424 |
|
30-Nov-05 |
|
M57208 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxx |
|
44351 |
|
5-Oct-05 |
|
44351 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
200504372 |
|
11-May-05 |
|
231295 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
X-000000 |
|
4-Oct-05 |
|
191179 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxxx |
|
000000 |
|
14-Oct-05 |
|
394584 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
2005/07290 |
|
4-Oct-05 |
|
378118 |
|
13-Jan-06 |
|
Registered |
|
DEPICTRA (BLOCK) |
|
Singapore |
|
T05/19226C |
|
4-Oct-05 |
|
T05/19226C |
|
6-Jun-06 |
|
Registered |
|
DEPICTRA (BLOCK) |
|
Slovenia |
|
Z-200571368 |
|
3-Oct-05 |
|
200571368 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxxx |
|
1820-2005 |
|
3-Oct-05 |
|
215214 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxxxxxx |
|
53870/2005 |
|
10-May-05 |
|
534935 |
|
23-Jun-05 |
|
Registered |
|
FORELUME (BLOCK) |
|
European Community |
|
4430146 |
|
10-May-05 |
|
4430146 |
|
31-Mar-06 |
|
Registered |
|
FORELUME (BLOCK) |
|
Iceland |
|
1226/2005 |
|
9-May-05 |
|
546/2005 |
|
6-Jun-05 |
|
Registered |
|
FORELUME (BLOCK) |
|
Norway |
|
200504378 |
|
11-May-05 |
|
231314 |
|
9-Mar-06 |
|
Registered |
|
GLUDEF (BLOCK) |
|
Canada |
|
1466957 |
|
25-Jan-10 |
|
|
|
|
|
Pending |
|
GLUDEF (BLOCK) |
|
United States of America |
|
77/917593 |
|
22-Jan-10 |
|
|
|
|
|
Pending |
|
ILLUSTREL (BLOCK) |
|
Switzerland |
|
53871/2005 |
|
10-May-05 |
|
534936 |
|
23-Jun-05 |
|
Registered |
|
ILLUSTREL (BLOCK) |
|
European Community |
|
4429742 |
|
10-May-05 |
|
4429742 |
|
21-Mar-06 |
|
Registered |
|
ILLUSTREL (BLOCK) |
|
Iceland |
|
1227/2005 |
|
9-May-05 |
|
547/2005 |
|
6-Jun-05 |
|
Registered |
|
ILLUSTREL (BLOCK) |
|
Norway |
|
200504406 |
|
11-May-05 |
|
231201 |
|
6-Mar-06 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Argentina |
|
2426151 |
|
24-Apr-03 |
|
1988805 |
|
24-Aug-04 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Australia |
|
947429 |
|
18-Mar-03 |
|
947429 |
|
9-Oct-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Bahrain |
|
33216 |
|
11-May-03 |
|
33216 |
|
26-Dec-05 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Brazil |
|
825542944 |
|
27-May-03 |
|
|
|
|
|
Published |
|
INNOVATORS AT HEART (BLOCK) |
|
Canada |
|
1171363 |
|
17-Mar-03 |
|
TMA669731 |
|
14-Aug-06 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Chile |
|
604884 |
|
17-Apr-03 |
|
675787 |
|
15-Oct-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
China (People’s Republic) |
|
3550190 |
|
8-May-03 |
|
3550190 |
|
28-Jan-09 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Colombia |
|
T2003/032097 |
|
15-Apr-03 |
|
284624 |
|
30-Apr-04 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Costa Rica |
|
2003-0002801 |
|
13-May-03 |
|
145862 |
|
17-Mar-04 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Egypt |
|
159020 |
|
29-Apr-03 |
|
159020 |
|
25-Jul-06 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
European Community |
|
003168176 |
|
6-May-03 |
|
003168176 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX XX XXXXX (XXXXX) |
|
Xxxxxx Xxxxxxx |
|
2327461 |
|
25-Mar-03 |
|
2327461 |
|
26-Sep-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Ireland |
|
2003/00533 |
|
25-Mar-03 |
|
227896 |
|
25-Mar-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Israel |
|
163951 |
|
24-Apr-03 |
|
163951 |
|
4-Jan-05 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Jordan |
|
71333 |
|
4-Aug-03 |
|
71333 |
|
26-Feb-04 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Japan |
|
2003-29892 |
|
14-Apr-03 |
|
4714745 |
|
3-Oct-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Korea, Republic of |
|
00-0000-00000 |
|
7-May-03 |
|
40-586813 |
|
6-Jul-04 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Kuwait |
|
59150 |
|
23-Apr-03 |
|
|
|
|
|
Pending |
|
INNOVATORS AT HEART (BLOCK) |
|
Mexico |
|
597827 |
|
22-Apr-03 |
|
798463 |
|
30-Jun-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Malaysia |
|
2003/05663 |
|
19-May-03 |
|
2003/05663 |
|
3-Feb-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Oman |
|
30510 |
|
6-May-03 |
|
30510 |
|
2-Jul-05 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Panama |
|
127224 |
|
20-May-03 |
|
127224 |
|
20-May-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Philippines |
|
42003002819 |
|
26-Mar-03 |
|
42003002819 |
|
14-Apr-08 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Saudi Arabia |
|
82529 |
|
23-Apr-03 |
|
735/13 |
|
|
|
Published |
|
INNOVATORS AT HEART (BLOCK) |
|
Singapore |
|
T03/06048C |
|
25-Apr-03 |
|
T03/06048 C |
|
25-Apr-03 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Taiwan |
|
092018264 |
|
16-Apr-03 |
|
1089258 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX XX XXXXX (XXXXX) |
|
Xxxxxx Xxxxxx of America |
|
78/210142 |
|
3-Feb-03 |
|
3276023 |
|
7-Aug-07 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
Venezuela |
|
04611/2003 |
|
22-Apr-03 |
|
P254452 |
|
14-Sep-04 |
|
Registered |
|
INNOVATORS AT HEART (BLOCK) |
|
South Africa |
|
2003/04645 |
|
19-Mar-03 |
|
2003/04645 |
|
20-Feb-08 |
|
Registered |
|
INTELLIPIN (BLOCK) |
|
Australia |
|
1046747 |
|
17-Mar-05 |
|
1046747 |
|
24-Oct-05 |
|
Registered |
|
INTELLIPIN (BLOCK) |
|
Brazil |
|
827273975 |
|
18-Mar-05 |
|
|
|
|
|
Published |
|
INTELLIPIN (BLOCK) |
|
Canada |
|
1250924 |
|
16-Mar-05 |
|
|
|
|
|
Published |
|
INTELLIPIN (BLOCK) |
|
Switzerland |
|
58050/2005 |
|
3-Oct-05 |
|
540105 |
|
6-Dec-05 |
|
Registered |
|
INTELLIPIN (BLOCK) |
|
European Community |
|
4346102 |
|
18-Mar-05 |
|
4346102 |
|
8-Mar-06 |
|
Registered |
|
INTELLIPIN (BLOCK) |
|
Iceland |
|
2774/2005 |
|
3-Oct-05 |
|
000/0000 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXXX (XXXXX) |
|
Xxxxx |
|
2005-024285 |
|
18-Mar-05 |
|
4959316 |
|
9-Jun-06 |
|
Registered |
|
INTELLIPIN (BLOCK) |
|
Mexico |
|
711147 |
|
8-Apr-05 |
|
891151 |
|
25-Jul-05 |
|
Registered |
|
INTELLIPIN (BLOCK) |
|
Norway |
|
200510192 |
|
4-Oct-05 |
|
232962 |
|
31-May-06 |
|
Registered |
|
INTELLIPIN (BLOCK) |
|
United States of America |
|
78/436013 |
|
16-Jun-04 |
|
3127726 |
|
8-Aug-06 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING |
|
Brazil |
|
829916156 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING |
|
Peru |
|
362643 |
|
7-Aug-08 |
|
150330 |
|
26-Mar-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
United Arab Emirates |
|
117813 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
United Arab Emirates |
|
117812 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Argentina |
|
2846697 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Argentina |
|
2846698 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Argentina |
|
2846696 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Australia |
|
1254050 |
|
25-Jul-08 |
|
1254050 |
|
9-Dec-08 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Bahrain |
|
71833 |
|
19-Aug-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Bahrain |
|
71834 |
|
19-Aug-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Bolivia |
|
3745-2008 |
|
8-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Bolivia |
|
3744-2008 |
|
8-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Brazil |
|
829916172 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Brazil |
|
829916199 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Canada |
|
1404829 |
|
25-Jul-08 |
|
|
|
|
|
Allowed |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Switzerland |
|
59431/2008 |
|
29-Jul-08 |
|
582123 |
|
27-Jan-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Chile |
|
831148 |
|
30-Jul-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Chile |
|
831147 |
|
30-Jul-08 |
|
845.152 |
|
26-Mar-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
China (People’s Republic) |
|
6891457 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
China (People’s Republic) |
|
6891456 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
China (People’s Republic) |
|
6891458 |
|
11-Aug-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Colombia |
|
00000000 |
|
11-Aug-08 |
|
385894 |
|
31-Jul-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Colombia |
|
00000000 |
|
11-Aug-08 |
|
385895 |
|
31-Jul-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Costa Rica |
|
2008-9852 |
|
3-Oct-08 |
|
187183 |
|
27-Feb-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Costa Rica |
|
2008-0009851 |
|
3-Oct-08 |
|
190722 |
|
29-May-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Ecuador |
|
202742 |
|
30-Jul-08 |
|
1529-09 |
|
21-Jan-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Ecuador |
|
202741 |
|
30-Jul-08 |
|
1528-09 |
|
21-Jan-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Egypt |
|
219988 |
|
27-Jul-08 |
|
219988 |
|
17-Jan-10 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Egypt |
|
219989 |
|
27-Jul-08 |
|
219989 |
|
17-Jan-10 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
European Community |
|
7119712 |
|
1-Aug-08 |
|
7119712 |
|
11-May-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Hong Kong |
|
301168975 |
|
25-Jul-08 |
|
301168975 |
|
5-Feb-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Croatia |
|
X00000000 |
|
25-Jul-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Indonesia |
|
X000000000000 |
|
11-Aug-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Indonesia |
|
X000000000000 |
|
11-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Israel |
|
214010 |
|
10-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Israel |
|
214011 |
|
10-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Israel |
|
214009 |
|
10-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
India |
|
1719854 |
|
11-Aug-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Iceland |
|
2532/2008 |
|
25-Jul-08 |
|
945/2008 |
|
1-Sep-08 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Japan |
|
2008-065825 |
|
8-Aug-08 |
|
5266851 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX XXXXXXX XXXXXXX (XXXXX) |
|
Xxxxx, Xxxxxxxx of |
|
00-0000-0000 |
|
8-Aug-08 |
|
45-29150 |
|
1-Oct-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Kuwait |
|
99301 |
|
16-Nov-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Kuwait |
|
99302 |
|
16-Nov-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Liechtenstein |
|
15053 |
|
6-Aug-08 |
|
15053 |
|
6-Aug-08 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Mexico |
|
953911 |
|
11-Aug-08 |
|
1085795 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX XXXXXXX XXXXXXX (XXXXX) |
|
Xxxxxx |
|
000000 |
|
11-Aug-08 |
|
1078471 |
|
13-Jan-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Malaysia |
|
08015849 |
|
11-Aug-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Malaysia |
|
08015848 |
|
11-Aug-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Norway |
|
200810102 |
|
19-Aug-08 |
|
248235 |
|
21-Oct-08 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
New Zealand |
|
793323 |
|
25-Jul-08 |
|
793323 |
|
29-Jan-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Peru |
|
362644 |
|
7-Aug-08 |
|
150331 |
|
26-Mar-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Philippines |
|
0-0000-000000 |
|
11-Aug-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Pakistan |
|
253882 |
|
31-Jul-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Pakistan |
|
253883 |
|
31-Jul-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Russian Federation |
|
2008725562 |
|
8-Aug-08 |
|
390038 |
|
28-Sep-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Saudi Arabia |
|
135890 |
|
11-Oct-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Saudi Arabia |
|
135891 |
|
11-Oct-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Singapore |
|
T08/10387C |
|
5-Aug-08 |
|
T0810387C |
|
11-Jun-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Thailand |
|
703875 |
|
1-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Thailand |
|
703874 |
|
1-Aug-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Turkey |
|
2008/44719 |
|
30-Jul-08 |
|
2008 44719 |
|
7-Sep-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Taiwan |
|
097037777 |
|
11-Aug-08 |
|
1369375 |
|
1-Jul-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
United States of America |
|
77/394021 |
|
11-Feb-08 |
|
3699730 |
|
20-Oct-09 |
|
Registered |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Venezuela |
|
14944-2008 |
|
31-Jul-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
Venezuela |
|
14945-2008 |
|
31-Jul-08 |
|
|
|
|
|
Published |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
South Africa |
|
2008/17501 |
|
29-Jul-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
South Africa |
|
2008/17502 |
|
29-Jul-08 |
|
|
|
|
|
Pending |
|
LANTHEUS MEDICAL IMAGING (BLOCK) |
|
South Africa |
|
2008/17503 |
|
29-Jul-08 |
|
|
|
|
|
Pending |
|
LUMIFY (BLOCK) |
|
Switzerland |
|
53831/2005 |
|
9-May-05 |
|
535029 |
|
27-Jun-05 |
|
Registered |
|
LUMIFY (BLOCK) |
|
European Community |
|
4421558 |
|
4-May-05 |
|
4421558 |
|
25-Apr-06 |
|
Registered |
|
LUMIFY (BLOCK) |
|
Iceland |
|
1233/2005 |
|
9-May-05 |
|
553/2005 |
|
6-Jun-05 |
|
Registered |
|
LUMIFY (BLOCK) |
|
Norway |
|
200504371 |
|
11-May-05 |
|
231170 |
|
6-Mar-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Austria |
|
AM 6795/2005 |
|
11-Oct-05 |
|
229 301 |
|
10-Jan-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Australia |
|
1079052 |
|
4-Oct-05 |
|
1079052 |
|
22-May-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Benelux |
|
1086686 |
|
3-Oct-05 |
|
784452 |
|
7-Mar-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Switzerland |
|
53872/2005 |
|
10-May-05 |
|
534937 |
|
23-Jun-05 |
|
Registered |
|
LUMINITY (BLOCK) |
|
China (People’s Republic) |
|
4932558 |
|
28-Dec-05 |
|
4932558 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxx Xxxxxxxx |
|
X-000000 |
|
3-Oct-05 |
|
280405 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
305587218/05 |
|
4-Oct-05 |
|
30558721 |
|
12-Dec-05 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Denmark |
|
V A 2005 04169 |
|
3-Oct-05 |
|
VR 2005 03906 |
|
11-Oct-05 |
|
Registered |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
M200501254 |
|
3-Oct-05 |
|
43139 |
|
22-Sep-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
European Community |
|
4429676 |
|
10-May-05 |
|
4429676 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxx |
|
2672701(3) |
|
4-Oct-05 |
|
2672701 |
|
30-May-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Finland |
|
T200502572 |
|
3-Oct-05 |
|
236050 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
053383470 |
|
3-Oct-05 |
|
053383470 |
|
3-Oct-05 |
|
Registered |
|
LUMINITY (BLOCK) |
|
United Kingdom |
|
2402990 |
|
3-Oct-05 |
|
2402990 |
|
24-Mar-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Greece |
|
150991 |
|
10-Oct-05 |
|
150991 |
|
19-Mar-07 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Hungary |
|
M0503230 |
|
6-Oct-05 |
|
188266 |
|
11-Jan-07 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Ireland |
|
2005/02035 |
|
3-Oct-05 |
|
232691 |
|
10-Apr-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Iceland |
|
1229/2005 |
|
9-May-05 |
|
549/2005 |
|
6-Jun-05 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Italy |
|
TO2005C002841 |
|
5-Oct-05 |
|
1175187 |
|
6-Mar-09 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Japan |
|
2005-92513 |
|
4-Oct-05 |
|
4959291 |
|
9-Jun-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Lithuania |
|
20051729 |
|
3-Oct-05 |
|
53448 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
M-05-1423 |
|
30-Nov-05 |
|
M57207 |
|
20-Jan-07 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Malta |
|
44350 |
|
5-Oct-05 |
|
44350 |
|
1-Feb-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Norway |
|
200504389 |
|
11-May-05 |
|
231348 |
|
13-Mar-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Poland |
|
Z-300788 |
|
4-Oct-05 |
|
191180 |
|
5-Dec-07 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Portugal |
|
394592 |
|
14-Oct-05 |
|
394592 |
|
11-Aug-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Sweden |
|
2005/073333 |
|
5-Oct-05 |
|
378428 |
|
3-Feb-06 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Singapore |
|
T05/19224G |
|
4-Oct-05 |
|
T05/19924G |
|
4-Oct-05 |
|
Registered |
|
LUMINITY (BLOCK) |
|
Slovenia |
|
Z-200571369 |
|
3-Oct-05 |
|
200571369 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxxx |
|
XXX-0000-0000 |
|
3-Oct-05 |
|
215216 |
|
11-Sep-06 |
|
Registered |
|
MIBI (BLOCK) |
|
Finland |
|
T200000804 |
|
9-Mar-00 |
|
219718 |
|
15-Dec-00 |
|
Registered |
|
MIBI (BLOCK) |
|
Norway |
|
200002833 |
|
9-Mar-00 |
|
204759 |
|
14-Sep-00 |
|
Registered |
|
MIBI (BLOCK) |
|
Sweden |
|
00-01987 |
|
10-Mar-00 |
|
346010 |
|
4-May-01 |
|
Registered |
|
MIRALUMA |
|
Switzerland |
|
5243/1997 |
|
1-Jul-97 |
|
P447024 |
|
24-Nov-97 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Austria |
|
AM 3516/97 |
|
30-Jun-97 |
|
171 776 |
|
30-Sep-97 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Benelux |
|
896692 |
|
1-Jul-97 |
|
616726 |
|
5-Jun-98 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Canada |
|
850538 |
|
11-Jul-97 |
|
TMA497274 |
|
16-Jul-98 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Colombia |
|
00000000 |
|
2-Jul-97 |
|
205111 |
|
28-Jan-98 |
|
Registered |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
000 00 205.3 |
|
30-Jun-97 |
|
397 30 205 |
|
5-Sep-97 |
|
Registered |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
XX 0000/00000 |
|
2-Jul-97 |
|
VA 1998 01749 |
|
10-Apr-98 |
|
Registered |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
00000 |
|
30-Jun-97 |
|
5711-98 |
|
6-Oct-98 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
European Community |
|
006800461 |
|
2-Apr-08 |
|
006800461 |
|
9-Jun-09 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Spain |
|
2102469 |
|
3-Jul-97 |
|
2102469 |
|
5-Jan-98 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Finland |
|
T199702696 |
|
8-Jul-97 |
|
210212 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
97/685106 |
|
1-Jul-97 |
|
97685106 |
|
1-Jul-97 |
|
Registered |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx Xxxxxxx |
|
2137649 |
|
2-Jul-97 |
|
2137649 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
133802 |
|
10-Jul-97 |
|
133802 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxxx |
|
97/2447 |
|
1-Jul-97 |
|
205192 |
|
1-Jul-97 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Iceland |
|
875/1997 |
|
4-Jul-97 |
|
1162/1997 |
|
29-Aug-97 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Italy |
|
M197C007563 |
|
7-Aug-97 |
|
810717 |
|
13-Apr-00 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Nicaragua |
|
97-02359 |
|
17-Jul-97 |
|
38314 |
|
14-Aug-98 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Norway |
|
975329 |
|
2-Jul-97 |
|
190858 |
|
18-Jun-98 |
|
Registered |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx |
|
000000 |
|
12-Sep-97 |
|
089875 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxx |
|
056152 |
|
30-Jan-98 |
|
045442 |
|
30-Apr-98 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Portugal |
|
324794 |
|
3-Jul-97 |
|
324794 |
|
2-Feb-98 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Turkey |
|
11991 |
|
15-Aug-97 |
|
187438 |
|
15-Aug-97 |
|
Registered |
|
MIRALUMA (BLOCK) |
|
Trinidad and Tobago |
|
27459 |
|
9-Sep-97 |
|
27459 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXX (XXXXX) |
|
Xxxxxx Xxxxxx of America |
|
75/237528 |
|
6-Feb-97 |
|
2276361 |
|
7-Sep-99 |
|
Registered |
|
MISCELLANEOUS DESIGN (MEDICAL IMAGING LOGO) (Miscellaneous Design) |
|
Argentina |
|
2582023 |
|
7-Apr-05 |
|
2107504 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXX (XXXXX) |
|
Xxxxxx Xxxx Xxxxxxxx |
|
84456 |
|
20-Aug-06 |
|
93914 |
|
23-Mar-09 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Argentina |
|
2510828 |
|
|
|
1997972 |
|
9-Nov-04 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Austria |
|
AM1415/88 |
|
30-Mar-88 |
|
121071 |
|
31-Aug-88 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Australia |
|
484320 |
|
28-Mar-88 |
|
A484320 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXX (XXXXX) |
|
Xxxxxx xxx Xxxxxxxxxxx |
|
BAZ058667A |
|
26-Apr-05 |
|
BAZ058667A |
|
4-Nov-09 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Brazil |
|
818278820 |
|
29-Dec-94 |
|
818278820 |
|
12-Feb-97 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Benelux |
|
62760 |
|
5-Apr-88 |
|
444513 |
|
5-Apr-88 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Canada |
|
621320 |
|
13-Dec-88 |
|
441704 |
|
14-Apr-95 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Switzerland |
|
2145 |
|
28-Mar-88 |
|
362123 |
|
10-Aug-88 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Chile |
|
677.858 |
|
7-Jan-94 |
|
727.741 |
|
16-Jun-05 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
China (People’s Republic) |
|
95009559 |
|
24-Jan-95 |
|
904635 |
|
00-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXX (XXXXX) |
|
Xxxxxxxx |
|
000000 |
|
7-Mar-94 |
|
165863 |
|
30-Jun-94 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Costa Rica |
|
85662 |
|
20-Sep-93 |
|
85662 |
|
21-Jan-94 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Czech Republic |
|
56088 |
|
27-Jan-89 |
|
167547 |
|
26-Jan-90 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Germany |
|
W57127 |
|
00-Xxx-00 |
|
XX000000 |
|
1-Feb-89 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Germany |
|
D44039/5WZ |
|
28-Nov-87 |
|
1186914 |
|
5-Feb-93 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Denmark |
|
VA 1988/02332 |
|
30-Mar-88 |
|
VR 1990/01372 |
|
2-Mar-90 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Spain |
|
1245600 |
|
12-Apr-88 |
|
1245600 |
|
5-Jul-93 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Finland |
|
T198801399 |
|
29-Mar-88 |
|
107627 |
|
21-May-90 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
France |
|
918206 |
|
5-Apr-88 |
|
1604283 |
|
0-Xxx-00 |
|
Xxxxxxxxxx |
|
XXXXXXXXX (XXXXX) |
|
Xxxxxx Xxxxxxx |
|
1340170 |
|
31-Mar-88 |
|
1340170 |
|
31-Mar-88 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Greece |
|
88987 |
|
5-May-88 |
|
88987 |
|
19-May-92 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Hong Kong |
|
300683622 |
|
19-Jul-06 |
|
300683622 |
|
6-Feb-07 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Croatia |
|
Z20050482A |
|
19-Apr-05 |
|
Z20050482 |
|
28-Feb-06 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Hungary |
|
M9300814 |
|
10-Nov-88 |
|
128006 |
|
22-Jun-89 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Israel |
|
87657 |
|
7-Jun-93 |
|
87657 |
|
6-Apr-95 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
India |
|
679529 |
|
8-Sep-95 |
|
679529 |
|
2-Jul-05 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Italy |
|
RM98C002191 |
|
9-May-88 |
|
521940 |
|
6-Feb-90 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Korea, Republic of |
|
40-2006-37106 |
|
19-Apr-06 |
|
40-0714201 |
|
20-Jun-07 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Macedonia |
|
Z-2005/234 |
|
15-Apr-05 |
|
12757 |
|
13-Mar-07 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Norway |
|
88.1416 |
|
29-Mar-88 |
|
137161 |
|
22-Jun-89 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
New Zealand |
|
751574 |
|
19-Jul-06 |
|
751574 |
|
25-Jan-07 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Panama |
|
074220 |
|
27-Jan-95 |
|
074220 |
|
16-May-96 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Poland |
|
Z-86738 |
|
10-Nov-88 |
|
64438 |
|
29-Jun-90 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Portugal |
|
354443 |
|
19-Mar-01 |
|
354443 |
|
28-May-03 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Russian Federation |
|
110459 |
|
11-Nov-88 |
|
87404 |
|
25-Dec-89 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Sweden |
|
88-2869 |
|
30-Mar-88 |
|
242651 |
|
27-Nov-92 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Singapore |
|
T06/14391F |
|
20-Jul-06 |
|
T06/14391F |
|
20-Jul-06 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Slovenia |
|
Z-200570517 |
|
15-Apr-05 |
|
Z-200570517 |
|
6-Feb-06 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Slovakia |
|
56088-89 |
|
27-Jan-89 |
|
167547 |
|
26-Jan-90 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Thailand |
|
259750 |
|
3-Feb-94 |
|
TM22866 |
|
30-Dec-94 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
Turkey |
|
5115 |
|
25-Jan-89 |
|
109937 |
|
25-Jan-89 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
United States of America |
|
73/700614 |
|
14-Dec-87 |
|
1496535 |
|
19-Jul-88 |
|
Registered |
|
NEUROLITE (BLOCK) |
|
South Africa |
|
88/9680 |
|
1-Nov-88 |
|
88/9680 |
|
3-Jul-91 |
|
Registered |
|
NEUROLITE IN KATAKANA (BLOCK) |
|
Japan |
|
36541/88 |
|
1-Apr-88 |
|
2286501 |
|
30-Nov-90 |
|
Registered |
|
ONSISTA (BLOCK) |
|
Switzerland |
|
53867/2005 |
|
10-May-05 |
|
534932 |
|
23-Jun-05 |
|
Registered |
|
ONSISTA (BLOCK) |
|
European Community |
|
004430377 |
|
10-May-05 |
|
004430377 |
|
21-Mar-06 |
|
Registered |
|
ONSISTA (BLOCK) |
|
Iceland |
|
1223/2005 |
|
9-May-05 |
|
543/2005 |
|
6-Jun-05 |
|
Registered |
|
ONSISTA (BLOCK) |
|
Norway |
|
200504404 |
|
11-May-05 |
|
231177 |
|
6-Mar-06 |
|
Registered |
|
OSPECTIV (BLOCK) |
|
Switzerland |
|
53930/2005 |
|
11-May-05 |
|
535351 |
|
5-Jul-05 |
|
Registered |
|
OSPECTIV (BLOCK) |
|
European Community |
|
004390225 |
|
15-Apr-05 |
|
004390225 |
|
22-Feb-06 |
|
Registered |
|
OSPECTIV (BLOCK) |
|
Iceland |
|
1215/2005 |
|
9-May-05 |
|
535/2005 |
|
6-Jun-05 |
|
Registered |
|
OSPECTIV (BLOCK) |
|
Norway |
|
200504398 |
|
11-May-05 |
|
231162 |
|
3-Mar-06 |
|
Registered |
|
PRODICTRA (BLOCK) |
|
European Community |
|
003736824 |
|
30-Mar-04 |
|
003736824 |
|
16-Jun-05 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Austria |
|
AM 5796/93 |
|
7-Dec-93 |
|
151676 |
|
17-Mar-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Australia |
|
617745 |
|
6-Dec-93 |
|
A617745 |
|
1-May-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Brazil |
|
817795405 |
|
2-May-94 |
|
817795405 |
|
2-Jan-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Benelux |
|
76438 |
|
10-Dec-93 |
|
546472 |
|
3-Nov-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Switzerland |
|
12392/1993 |
|
6-Dec-93 |
|
417515 |
|
3-Jul-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Chile |
|
261269 |
|
10-Dec-93 |
|
709206 |
|
26-Oct-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
China (People’s Republic) |
|
94012786 |
|
16-Feb-94 |
|
812541 |
|
7-Feb-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Colombia |
|
421571 |
|
7-Dec-93 |
|
159022 |
|
17-May-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Costa Rica |
|
|
|
7-Jun-95 |
|
94673 |
|
8-Feb-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Czech Republic |
|
85838-94 |
|
14-Jan-94 |
|
194151 |
|
23-Oct-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Germany |
|
D53859/10Wz |
|
7-Dec-93 |
|
2087751 |
|
19-Dec-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Denmark |
|
VA199307913 |
|
8-Dec-93 |
|
VR199407061 |
|
21-Oct-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Egypt |
|
89236 |
|
6-Dec-93 |
|
89236 |
|
1-Jun-98 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Spain |
|
1795669 |
|
22-Dec-93 |
|
1795669 |
|
3-May-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Finland |
|
5578/93 |
|
9-Dec-93 |
|
140423 |
|
20-Oct-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
France |
|
94/501595 |
|
14-Jan-94 |
|
94/501595 |
|
14-Jan-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
United Kingdom |
|
1558518 |
|
6-Jan-94 |
|
1558518 |
|
9-Apr-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Greece |
|
117051 |
|
9-Dec-93 |
|
117051 |
|
19-Feb-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Hong Kong |
|
9400158 |
|
5-Jan-94 |
|
199507472 |
|
5-Sep-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Croatia |
|
Z940368A |
|
15-Feb-94 |
|
Z940368 |
|
30-Jun-97 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Hungary |
|
M9306231 |
|
22-Dec-93 |
|
141414 |
|
4-Dec-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Ireland |
|
158517 |
|
6-Dec-93 |
|
158517 |
|
17-Jul-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Israel |
|
90194 |
|
6-Dec-93 |
|
90194 |
|
1-Apr-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
India |
|
613708 |
|
10-Dec-93 |
|
613708 |
|
20-Dec-03 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Italy |
|
31012003TO |
|
20-Nov-03 |
|
1058013 |
|
27-Aug-07 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Japan |
|
123226 |
|
8-Dec-93 |
|
3270506 |
|
12-Mar-97 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Korea, Republic of |
|
93-44079 |
|
8-Dec-93 |
|
40-311673 |
|
17-Apr-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Mexico |
|
186323 |
|
15-Dec-93 |
|
462289 |
|
1-Jun-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Malaysia |
|
94/01373 |
|
22-Feb-94 |
|
94001373 |
|
22-Feb-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Norway |
|
936041 |
|
8-Dec-93 |
|
170445 |
|
21-Dec-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
New Zealand |
|
232626 |
|
6-Dec-93 |
|
232626 |
|
10-Jun-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Portugal |
|
297942 |
|
7-Feb-94 |
|
297942 |
|
15-May-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Russian Federation |
|
93054300 |
|
9-Dec-93 |
|
131021 |
|
28-Aug-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Saudi Arabia |
|
23232 |
|
8-Dec-93 |
|
325/19 |
|
12-Nov-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Sweden |
|
93-11699 |
|
10-Dec-93 |
|
260110 |
|
5-Aug-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Singapore |
|
S/100/94 |
|
5-Jan-94 |
|
T94/00100J |
|
5-Jan-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Slovakia |
|
93-1994 |
|
19-Jan-94 |
|
178156 |
|
21-Oct-97 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Thailand |
|
257945 |
|
27-Dec-93 |
|
TM26034 |
|
27-Dec-93 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Turkey |
|
959023 |
|
23-Aug-95 |
|
164624 |
|
23-Aug-95 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Uruguay |
|
267760 |
|
19-Jan-94 |
|
367182 |
|
14-Feb-96 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
Viet Nam |
|
N0064/94 |
|
8-Jan-94 |
|
14178 |
|
11-Nov-94 |
|
Registered |
|
RECON-O-STAT (BLOCK) |
|
South Africa |
|
93/11537 |
|
6-Dec-93 |
|
93/11537 |
|
8-Mar-96 |
|
Registered |
|
REFINIAN (BLOCK) |
|
Australia |
|
1058266 |
|
1-Jun-05 |
|
1058266 |
|
5-Dec-05 |
|
Registered |
|
REFINIAN (BLOCK) |
|
Puerto Rico |
|
65597 |
|
29-Jun-05 |
|
65597 |
|
30-Mar-06 |
|
Registered |
|
RELIALITE (BLOCK) |
|
Switzerland |
|
53873/2005 |
|
10-May-05 |
|
534938 |
|
23-Jun-05 |
|
Registered |
|
RELIALITE (BLOCK) |
|
European Community |
|
4430161 |
|
10-May-05 |
|
4430161 |
|
21-Mar-06 |
|
Registered |
|
RELIALITE (BLOCK) |
|
Iceland |
|
1228/2005 |
|
9-May-05 |
|
548/2005 |
|
6-Jun-05 |
|
Registered |
|
RELIALITE (BLOCK) |
|
Norway |
|
200504407 |
|
11-May-05 |
|
231202 |
|
6-Mar-06 |
|
Registered |
|
REVALUME (BLOCK) |
|
Switzerland |
|
53875/2005 |
|
10-May-05 |
|
534940 |
|
23-Jun-05 |
|
Registered |
|
REVALUME (BLOCK) |
|
European Community |
|
4429701 |
|
10-May-05 |
|
4429701 |
|
21-Mar-06 |
|
Registered |
|
REVALUME (BLOCK) |
|
Iceland |
|
1231/2005 |
|
9-May-05 |
|
551/2005 |
|
6-Jun-05 |
|
Registered |
|
REVALUME (BLOCK) |
|
Norway |
|
200504388 |
|
11-May-05 |
|
234138 |
|
8-Aug-06 |
|
Registered |
|
REVELUME (BLOCK) |
|
Switzerland |
|
53874/2005 |
|
10-May-05 |
|
534939 |
|
23-Jun-05 |
|
Registered |
|
REVELUME (BLOCK) |
|
European Community |
|
4430088 |
|
10-May-05 |
|
4430088 |
|
25-Apr-06 |
|
Registered |
|
REVELUME (BLOCK) |
|
Iceland |
|
1230/2005 |
|
9-May-05 |
|
550/2005 |
|
6-Jun-05 |
|
Registered |
|
REVELUME (BLOCK) |
|
Norway |
|
200504379 |
|
11-May-05 |
|
234137 |
|
8-Aug-06 |
|
Registered |
|
SIGNALITE (BLOCK) |
|
Switzerland |
|
53931/2005 |
|
11-May-05 |
|
535316 |
|
4-Jul-05 |
|
Registered |
|
SIGNALITE (BLOCK) |
|
European Community |
|
4388708 |
|
15-Apr-05 |
|
4388708 |
|
31-Mar-06 |
|
Registered |
|
SIGNALITE (BLOCK) |
|
Iceland |
|
1216/2005 |
|
9-May-05 |
|
536/2005 |
|
6-Jun-05 |
|
Registered |
|
SIGNALITE (BLOCK) |
|
Norway |
|
200504399 |
|
11-May-05 |
|
231163 |
|
3-Mar-06 |
|
Registered |
|
SIGNILITE (BLOCK) |
|
Switzerland |
|
53932/2005 |
|
11-May-05 |
|
535352 |
|
5-Jul-05 |
|
Registered |
|
SIGNILITE (BLOCK) |
|
European Community |
|
4388691 |
|
15-Apr-05 |
|
4388691 |
|
22-Feb-06 |
|
Registered |
|
SIGNILITE (BLOCK) |
|
Iceland |
|
1217/2005 |
|
|
|
537/2005 |
|
6-Jun-05 |
|
Registered |
|
SIGNILITE (BLOCK) |
|
Norway |
|
200504400 |
|
11-May-05 |
|
231164 |
|
3-Mar-06 |
|
Registered |
|
SIGNYLITE (BLOCK) |
|
Switzerland |
|
53933/2005 |
|
11-May-05 |
|
535353 |
|
5-Jul-05 |
|
Registered |
|
SIGNYLITE (BLOCK) |
|
European Community |
|
4388658 |
|
15-Apr-05 |
|
4388658 |
|
22-Feb-06 |
|
Registered |
|
SIGNYLITE (BLOCK) |
|
Iceland |
|
1218/2005 |
|
9-May-05 |
|
538/2005 |
|
6-Jun-05 |
|
Registered |
|
SIGNYLITE (BLOCK) |
|
Norway |
|
200504370 |
|
11-May-05 |
|
231168 |
|
6-Mar-06 |
|
Registered |
|
SPANSIFY (BLOCK) |
|
Switzerland |
|
53934/2005 |
|
11-May-05 |
|
535308 |
|
4-Jul-05 |
|
Registered |
|
SPANSIFY (BLOCK) |
|
European Community |
|
4390531 |
|
15-Apr-05 |
|
4390531 |
|
22-Feb-06 |
|
Registered |
|
SPANSIFY (BLOCK) |
|
Iceland |
|
1219/2005 |
|
9-May-05 |
|
539/2005 |
|
6-Jun-05 |
|
Registered |
|
SPANSIFY (BLOCK) |
|
Norway |
|
200504401 |
|
11-May-05 |
|
231171 |
|
6-Mar-06 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
Australia |
|
1054234 |
|
6-May-05 |
|
1054234 |
|
19-Dec-05 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
Canada |
|
1256779 |
|
6-May-05 |
|
|
|
|
|
Allowed |
|
SPANTRIA (BLOCK) |
|
Germany |
|
30526985.2/05 |
|
9-May-05 |
|
30526985 |
|
4-Nov-05 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
European Community |
|
004390399 |
|
15-Apr-05 |
|
4390399 |
|
22-May-06 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
Spain |
|
2650582 |
|
9-May-05 |
|
2650582 |
|
27-Mar-06 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
France |
|
053357816 |
|
9-May-05 |
|
053357816 |
|
9-May-05 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
United Kingdom |
|
2391179 |
|
6-May-05 |
|
2391179 |
|
21-Oct-05 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
Italy |
|
TO2005C001417 |
|
9-May-05 |
|
1174403 |
|
5-Mar-09 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
Japan |
|
2005-40340 |
|
9-May-05 |
|
4955745 |
|
26-May-06 |
|
Registered |
|
SPANTRIA (BLOCK) |
|
United States of America |
|
77/519175 |
|
10-Jul-08 |
|
|
|
|
|
Allowed |
|
SPOTLIGHT ON CONTRAST (BLOCK) |
|
United States of America |
|
78/698194 |
|
23-Aug-05 |
|
3129463 |
|
15-Aug-06 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Argentina |
|
1900473 |
|
24-Nov-93 |
|
1528255 |
|
4-Feb-05 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Australia |
|
587230 |
|
28-Sep-92 |
|
587230 |
|
14-Mar-94 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Brazil |
|
817795391 |
|
2-May-94 |
|
817795391 |
|
17-Sep-96 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Benelux |
|
74332 |
|
25-Sep-92 |
|
523256 |
|
1-Jun-93 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Canada |
|
714072 |
|
2-Oct-92 |
|
TMA424737 |
|
4-Mar-94 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Switzerland |
|
6945 |
|
24-Sep-92 |
|
400733 |
|
2-Jun-93 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Chile |
|
259642 |
|
23-Nov-93 |
|
777320 |
|
13-Dec-96 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
China (People’s Republic) |
|
95009562 |
|
4-Feb-95 |
|
902256 |
|
21-Nov-96 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Colombia |
|
361660 |
|
10-Jun-92 |
|
153287 |
|
23-Feb-94 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Colombia |
|
T2009/003630 |
|
|
|
|
|
|
|
Published |
|
TECHNELITE (BLOCK) |
|
Costa Rica |
|
81821 |
|
4-Aug-92 |
|
81821 |
|
7-Jan-93 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Germany |
|
D 51 613/1OWz |
|
24-Sep-92 |
|
2045158 |
|
17-Sep-93 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
European Community |
|
6800353 |
|
2-Apr-08 |
|
|
|
|
|
Published |
|
TECHNELITE (BLOCK) |
|
Spain |
|
1722388 |
|
29-Sep-92 |
|
1722388 |
|
5-Jun-95 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
France |
|
92/438877 |
|
26-Oct-92 |
|
92438877 |
|
26-Oct-92 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
United Kingdom |
|
1514608 |
|
6-Oct-92 |
|
1514608 |
|
10-Jun-94 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
United Kingdom |
|
1562156 |
|
11-Feb-94 |
|
1562156 |
|
29-Sep-95 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Hong Kong |
|
9312365 |
|
19-Nov-93 |
|
199510394 |
|
12-Dec-95 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Italy |
|
MI92C006662 |
|
29-Sep-92 |
|
997788 |
|
7-Jun-95 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Korea, Republic of |
|
92-18467 |
|
6-Jul-92 |
|
40-271979 |
|
18-Aug-93 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Mexico |
|
144915 |
|
15-Jul-92 |
|
467513 |
|
25-Jul-94 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
New Zealand |
|
235960 |
|
14-Apr-94 |
|
235690 |
|
17-Jul-97 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Panama |
|
68625 |
|
24-Nov-93 |
|
68625 |
|
12-Apr-96 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Peru |
|
240816 |
|
22-Apr-94 |
|
008856 |
|
2-Aug-94 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Philippines |
|
4-2003-003319 |
|
10-Apr-03 |
|
4-2003-003319 |
|
12-Mar-07 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Puerto Rico |
|
31489 |
|
13-Jul-92 |
|
31489 |
|
13-Jul-92 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Paraguay |
|
6642 |
|
18-Apr-94 |
|
276090 |
|
30-Dec-94 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Saudi Arabia |
|
23047 |
|
21-Nov-93 |
|
320/25 |
|
19-Sep-94 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Sweden |
|
92/08489 |
|
25-Sep-92 |
|
250937 |
|
20-Aug-93 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Taiwan |
|
81-28809 |
|
12-Jun-92 |
|
592398 |
|
1-Apr-93 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
United States of America |
|
74/254668 |
|
12-Mar-92 |
|
1812837 |
|
21-Dec-93 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
Venezuela |
|
98/15198 |
|
14-Aug-98 |
|
18128P-213637 |
|
6-Aug-99 |
|
Registered |
|
TECHNELITE (BLOCK) |
|
South Africa |
|
93/10973 |
|
19-Nov-93 |
|
93/10973 |
|
10-Nov-95 |
|
Registered |
|
TECHNELITE (STYLIZED) (BLOCK) |
|
United States of America |
|
74/254537 |
|
12-Mar-92 |
|
1812836 |
|
21-Dec-93 |
|
Registered |
|
TRULIGHT |
|
Iceland |
|
1221/2005 |
|
9-May-05 |
|
541/2005 |
|
6-Jun-05 |
|
Registered |
|
TRULIGHT (BLOCK) |
|
Switzerland |
|
53865/2005 |
|
10-May-05 |
|
534930 |
|
23-Jun-05 |
|
Registered |
|
TRULIGHT (BLOCK) |
|
European Community |
|
4430401 |
|
10-May-05 |
|
4430401 |
|
3-Apr-06 |
|
Registered |
|
TRULIGHT (BLOCK) |
|
Norway |
|
200504374 |
|
11-May-05 |
|
231308 |
|
9-Mar-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Austria |
|
6793/2005 |
|
11-Oct-05 |
|
229299 |
|
10-Jan-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Australia |
|
1079050 |
|
4-Oct-05 |
|
1079050 |
|
4-Oct-05 |
|
Registered |
|
TRULITE (BLOCK) |
|
Benelux |
|
1086687 |
|
3-Oct-05 |
|
784454 |
|
3-Oct-05 |
|
Registered |
|
TRULITE (BLOCK) |
|
Switzerland |
|
53866/2005 |
|
10-May-05 |
|
534931 |
|
23-Jun-05 |
|
Registered |
|
TRULITE (BLOCK) |
|
China (People’s Republic) |
|
4932559 |
|
8-Oct-05 |
|
4932559 |
|
21-Feb-09 |
|
Registered |
|
TRULITE (BLOCK) |
|
Cyprus, Republic of |
|
71785 |
|
5-Oct-05 |
|
|
|
|
|
Pending |
|
TRULITE (BLOCK) |
|
Czech Republic |
|
430239 |
|
3-Oct-05 |
|
|
|
|
|
Published |
|
TRULITE (BLOCK) |
|
Germany |
|
305587234 |
|
4-Oct-05 |
|
30558723 |
|
12-Dec-05 |
|
Registered |
|
TRULITE (BLOCK) |
|
Denmark |
|
VA0041682005 |
|
3-Oct-05 |
|
VR0048892005 |
|
5-Dec-05 |
|
Registered |
|
TRULITE (BLOCK) |
|
Estonia |
|
M200501256 |
|
3-Oct-05 |
|
43141 |
|
22-Sep-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
European Community |
|
4430435 |
|
10-May-05 |
|
4430435 |
|
12-Apr-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Spain |
|
2672705M6 |
|
4-Oct-05 |
|
2672705M6 |
|
30-May-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Finland |
|
200502574 |
|
3-Oct-05 |
|
236052 |
|
31-May-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
France |
|
053383472 |
|
3-Oct-05 |
|
053383472 |
|
10-Mar-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
United Kingdom |
|
2402992 |
|
3-Oct-05 |
|
2402992 |
|
13-Oct-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Greece |
|
150993 |
|
10-Oct-05 |
|
150993 |
|
19-Mar-07 |
|
Registered |
|
TRULITE (BLOCK) |
|
Hungary |
|
M0503232 |
|
6-Oct-05 |
|
187776 |
|
11-Dec-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Ireland |
|
232688 |
|
3-Oct-05 |
|
232688 |
|
3-May-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Iceland |
|
1222/2005 |
|
9-May-05 |
|
542/2005 |
|
6-Jun-05 |
|
Registered |
|
TRULITE (BLOCK) |
|
Italy |
|
TO/2005/2839 |
|
5-Oct-05 |
|
1175185 |
|
6-Mar-09 |
|
Registered |
|
TRULITE (BLOCK) |
|
Lithuania |
|
20051731 |
|
3-Oct-05 |
|
53450 |
|
15-Dec-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Latvia |
|
M-05-1425 |
|
30-Nov-05 |
|
M57209 |
|
20-Jan-07 |
|
Registered |
|
TRULITE (BLOCK) |
|
Malta |
|
44353 |
|
5-Oct-05 |
|
44353 |
|
1-Feb-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Norway |
|
200504375 |
|
11-May-05 |
|
231310 |
|
9-Mar-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Poland |
|
Z-300786 |
|
4-Oct-05 |
|
191178 |
|
25-Jun-07 |
|
Registered |
|
TRULITE (BLOCK) |
|
Portugal |
|
394583 |
|
14-Oct-05 |
|
394583 |
|
11-Aug-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Sweden |
|
2005/07334 |
|
5-Oct-05 |
|
378429 |
|
3-Feb-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Singapore |
|
T05/19227A |
|
4-Oct-05 |
|
T05/19227A |
|
5-Oct-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Slovenia |
|
Z-200571367 |
|
3-Oct-05 |
|
200571367 |
|
24-Apr-06 |
|
Registered |
|
TRULITE (BLOCK) |
|
Slovakia |
|
POZ-1821-2005 |
|
3-Oct-05 |
|
215215 |
|
11-Sep-06 |
|
Registered |
|
UDS RADIOPHARMACY (Design plus character (s)) |
|
Australia |
|
1171037 |
|
10-Apr-07 |
|
1171037 |
|
19-Nov-07 |
|
Registered |
|
VERILUME (BLOCK) |
|
Switzerland |
|
53923/2005 |
|
11-May-05 |
|
535346 |
|
5-Jul-05 |
|
Registered |
|
VERILUME (BLOCK) |
|
European Community |
|
4429643 |
|
10-May-05 |
|
4429643 |
|
21-Mar-06 |
|
Registered |
|
VERILUME (BLOCK) |
|
Iceland |
|
1232/2005 |
|
9-May-05 |
|
552/2005 |
|
6-Jun-05 |
|
Registered |
|
VERILUME (BLOCK) |
|
Norway |
|
200504380 |
|
11-May-05 |
|
231319 |
|
9-Mar-06 |
|
Registered |
|
VERLUMIFY (BLOCK) |
|
Switzerland |
|
53832/2005 |
|
9-May-05 |
|
535030 |
|
27-Jun-05 |
|
Registered |
|
VERLUMIFY (BLOCK) |
|
European Community |
|
4421566 |
|
4-May-05 |
|
4421566 |
|
25-Apr-06 |
|
Registered |
|
VERLUMIFY (BLOCK) |
|
Iceland |
|
1234/2005 |
|
9-May-05 |
|
554/2005 |
|
6-Jun-05 |
|
Registered |
|
VERLUMIFY (BLOCK) |
|
Norway |
|
200504402 |
|
11-May-05 |
|
231174 |
|
6-Mar-06 |
|
Registered |
|
VIALMIX (BLOCK) |
|
United Arab Emirates |
|
58057 |
|
30-Dec-03 |
|
49157 |
|
31-Oct-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Argentina |
|
2593926 |
|
31-May-05 |
|
2115120 |
|
20-Sep-06 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Bahrain |
|
40542 |
|
19-Jan-04 |
|
40542 |
|
3-Aug-06 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Brazil |
|
826255191 |
|
13-Feb-04 |
|
826255191 |
|
24-Jul-07 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Canada |
|
1020047 |
|
22-Jun-99 |
|
TMA564418 |
|
8-Jul-02 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Switzerland |
|
5519/1999 |
|
23-Jun-99 |
|
467778 |
|
16-Dec-99 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Chile |
|
625992 |
|
28-Oct-03 |
|
694542 |
|
3-Jun-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
China (People’s Republic) |
|
3785698 |
|
5-Nov-03 |
|
3785698 |
|
21-Mar-05 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Colombia |
|
T2003/095329 |
|
27-Oct-03 |
|
287837 |
|
9-Sep-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Denmark |
|
VA199902669 |
|
24-Jun-99 |
|
VR200005203 |
|
13-Nov-00 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Egypt |
|
163012 |
|
5-Nov-03 |
|
163012 |
|
16-Mar-06 |
|
Registered |
|
VIALMIX (BLOCK) |
|
European Community |
|
001219989 |
|
25-Jun-99 |
|
001219989 |
|
6-Nov-00 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Hong Kong |
|
300101087 |
|
27-Oct-03 |
|
300101087 |
|
24-Mar-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Israel |
|
167545 |
|
24-Oct-03 |
|
167545 |
|
4-Jan-05 |
|
Registered |
|
VIALMIX (BLOCK) |
|
India |
|
1252700 |
|
2-Dec-03 |
|
1252700 |
|
3-Jan-06 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Jordan |
|
72918 |
|
9-Dec-03 |
|
72918 |
|
16-Jun-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Japan |
|
2003-106340 |
|
1-Dec-03 |
|
4862136 |
|
13-May-05 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Korea, Republic of |
|
40-2003-47515 |
|
29-Oct-03 |
|
40-607324 |
|
28-Jan-05 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Kuwait |
|
61870 |
|
30-Nov-03 |
|
51228 |
|
30-Nov-03 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Lebanon |
|
96380 |
|
8-Jan-04 |
|
96380 |
|
8-Jan-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Mexico |
|
627456 |
|
31-Oct-03 |
|
833792 |
|
28-May-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Malaysia |
|
2003-16495 |
|
5-Dec-03 |
|
03016495 |
|
12-May-03 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Norway |
|
199906219 |
|
25-Jun-99 |
|
199801 |
|
7-Oct-99 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Oman |
|
32097 |
|
16-Dec-03 |
|
32097 |
|
10-Oct-05 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Philippines |
|
4-2003-010942 |
|
28-Nov-03 |
|
4-2003-010942 |
|
18-Sep-06 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Pakistan |
|
190236 |
|
4-Dec-03 |
|
|
|
|
|
Published |
|
VIALMIX (BLOCK) |
|
Saudi Arabia |
|
86887 |
|
27-Dec-03 |
|
747/50 |
|
20-Sep-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Sweden |
|
1999/04943 |
|
1-Jul-99 |
|
348244 |
|
31-Aug-01 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Singapore |
|
T03/17389Z |
|
29-Oct-03 |
|
T03/17389Z |
|
29-Oct-03 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Thailand |
|
538010 |
|
1-Dec-03 |
|
KOR202756 |
|
10-Sep-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Taiwan |
|
092062698 |
|
27-Oct-03 |
|
1111085 |
|
16-Jul-04 |
|
Registered |
|
VIALMIX (BLOCK) |
|
United States of America |
|
78/100860 |
|
4-Jan-02 |
|
2628446 |
|
1-Oct-02 |
|
Registered |
|
VIALMIX (BLOCK) |
|
Venezuela |
|
15476/2003 |
|
27-Oct-03 |
|
|
|
|
|
Published |
|
VIALMIX (BLOCK) |
|
Viet Nam |
|
4-2003-11884 |
|
26-Dec-03 |
|
62987 |
|
24-May-05 |
|
Registered |
SCHEDULE III
LOCATIONS OF GRANTORS
|
LOCATION |
|
|
|
|
|
|
|
|
Chief Executive Office of Lantheus MI |
|
|
331 Treble Cove Road, North |
|
Intermediate, Inc. |
|
Billerica, MA 01862 |
|
|
|
|
|
|
|
Lantheus Medical Imaging, Inc. |
|
Chief Executive Office of Lantheus Medical |
|
331 Treble Cove Road, North |
|
Imaging, Inc. |
|
Billerica, MA 01862 |
|
|
|
|
|
|
|
Lantheus MI Real Estate, LLC |
|
Chief Executive Office of Lantheus MI Real Estate, |
|
331 Treble Cove Road, North |
|
Inc. |
|
Billerica, MA 01862 |
|
|
|
|
|
|
|
Ben Venue Laboratories, Inc. |
|
Location contains Equipment, Fixtures, Inventory or |
|
300 Northfield Road |
|
Other Goods |
|
Bedford, OH 44146 |
|
|
|
|
|
|
|
Mallinckrodt Inc. (Covidien) |
|
Location contains Equipment, Fixtures, Inventory or |
|
675 McDonnell Blvd. |
|
Other Goods |
|
Hazelwood, MO 63042 |
|
|
|
|
|
|
|
8800 Durant Road |
|
|
|
Raleigh, NC 27616 |
|
|
|
|
|
|
|
McKesson Specialty Care |
|
Location contains Equipment, Fixtures, Inventory or |
|
Distribution |
|
Other Goods |
|
401 Mason Road |
|
|
|
LaVergne, TN 37086 |
|
|
|
|
|
|
|
4001 Quest Way, Suite 114 |
|
|
|
Memphis, TN 38115 |
|
|
SCHEDULE IV
UCC FINANCING STATEMENTS
UCC Financing Statements have been filed in the jurisdictions below against the Grantors:
|
Name of Grantor |
|
Secretary of State |
|
UCC Type |
|
Secured Party |
|
Lantheus Medical Imaging Inc. |
|
Delaware SOS |
|
UCC-1 |
|
Harris N.A., as Collateral Agent |
|
Lantheus MI Intermediate Inc. |
|
Delaware SOS |
|
UCC-1 |
|
Harris N.A., as Collateral Agent |
|
Lantheus MI Real Estate, LLC |
|
Delaware SOS |
|
UCC-1 |
|
Harris N.A., as Collateral Agent |
SCHEDULE VII
PLEDGED SHARES
|
|
|
|
|
|
|
Percentage of |
|
|
|
|
|
|
|
Name of Pledged |
|
Number of |
|
Outstanding |
|
|
|
Certificate |
|
Grantor |
|
Issuer |
|
Shares |
|
Shares |
|
Class |
|
Number |
|
Lantheus Medical Imaging, Inc. |
|
Lantheus MI Australia Pty Ltd |
|
65 |
|
65% |
|
Common |
|
5 |
|
Lantheus Medical Imaging, Inc. |
|
Lantheus MI Canada Inc. |
|
65 |
|
65% |
|
Common |
|
C-5 |
|
Lantheus Medical Imaging, Inc. |
|
Lantheus MI Real Estate LLC |
|
n/a |
|
100% |
|
n/a |
|
n/a |
|
Lantheus Medical Imaging, Inc. |
|
Lantheus MI Radiopharmaceuticals, Inc. |
|
650,000 |
|
65% |
|
Common |
|
3 |
|
Lantheus Medical Imaging, Inc. |
|
Lantheus MI UK Limited |
|
65 |
|
65% |
|
Common |
|
3 |
|
|
Lantheus Medical Imaging, Inc. |
|
1000 |
|
100% |
|
Common |
|
C-3 |
EXHIBIT A
PLEDGE AMENDMENT
This Pledge Amendment, dated , , is delivered pursuant to Section 4 of the Pledge and Security Agreement referred to below. The undersigned hereby agrees that this Pledge Amendment may be attached to the Pledge and Security Agreement, dated May 10, 2010, as it may heretofore have been or hereafter may be amended, restated, supplemented, modified or otherwise changed from time to time (the “Security Agreement”) and that the promissory notes or shares listed on this Pledge Amendment shall be hereby pledged and assigned to the Collateral Agent and become part of the Pledged Interests referred to in such Pledge Agreement and shall secure all of the Secured Obligations referred to in such Security Agreement.
Pledged Debt
|
|
|
|
|
|
|
Principal Amount |
|
|
Grantor |
|
Name of Maker |
|
Description |
|
Outstanding as of |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Pledged Shares
|
|
|
|
|
|
|
Percentage |
|
|
|
|
|
|
|
|
|
|
Number |
|
of |
|
|
|
|
|
|
|
|
Name of |
|
of |
|
Outstanding |
|
|
|
Certificate |
|
|
|
Pledged Issuer |
|
Shares |
|
Shares |
|
Class |
|
Number |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
[GRANTOR] |
|||
|
|
|
|||
|
|
By: |
|
||
|
|
Name: |
|
||
|
|
Title: |
|
||
|
|
|
|||
|
HARRIS N.A., |
|
|||
|
as the Collateral Agent |
|
|||
|
|
|
|||
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
EXHIBIT B
GRANT OF A
SECURITY INTEREST —[TRADEMARKS]
[PATENTS] [COPYRIGHTS]
WHEREAS, (the “Grantor”) [own the trademarks and service marks listed on the attached Schedule A, which trademarks and service marks are registered or applied for in the United States Patent and Trademark Office (the “Trademarks”)] [own the letter patents, design patents and utility patents listed on the attached Schedule A, which patents are issued or applied for in the United States Patent and Trademark Office (the “Patents”)] [owns the copyrights listed on the attached Schedule A, which copyrights are registered in the United States Copyright Office (the “Copyrights”)];
WHEREAS, the Grantor has entered into a Pledge and Security Agreement, dated May 10, 2010 (as amended, restated, supplemented, modified or otherwise changed from time to time, the “Security Agreement”), in favor of Harris N.A., as the Collateral Agent for itself and certain lenders (in such capacity, together with its successors and assigns, if any, the “Grantee”); and
WHEREAS, pursuant to the Security Agreement, the Grantor has granted to the Grantee, and granted to the Grantee for the benefit of the Secured Parties and the L/C Issuer (each such term as defined in the Security Agreement), a continuing security interest in all right, title and interest of the Grantor in, to and under the [Trademarks, together with, among other things, the goodwill of the business symbolized by the Trademarks] [Patents] [Copyrights] and the applications and registrations thereof, and all proceeds thereof, including, without limitation, any and all causes of action which may exist by reason of infringement thereof and any and all damages arising from past, present and future violations thereof (the “Collateral”), to secure the payment, performance and observance of the Secured Obligations (as defined in the Security Agreement).
NOW, THEREFORE, for good and valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the Grantor does hereby grant to the Grantee and grant to the Grantee for the benefit of the Secured Parties and the L/C Issuer, a continuing security interest in the Collateral to secure the prompt payment, performance and observance of the Secured Obligations.
The Grantor does hereby further acknowledge and affirm that the rights and remedies of the Grantee with respect to the Collateral are more fully set forth in the Security Agreement, the terms and provisions of which are hereby incorporated herein by reference as if fully set forth herein.
IN WITNESS WHEREOF, the Grantor has caused this Assignment to be duly executed by its officer thereunto duly authorized as of , 20 .
|
|
[GRANTOR] |
|
|
|
|
|
|
|
By: |
|
|
|
Name: |
|
|
|
Title: |
|
SCHEDULE A TO GRANT OF A SECURITY INTEREST
[Trademark Registrations and Applications]
[Patents and Patent Applications]
[Copyright Registrations and Applications]
EXHIBIT C
FORM OF SECURITY AGREEMENT SUPPLEMENT
[Date of Security Agreement Supplement]
Harris N.A., as Collateral Agent
Ladies and Gentlemen:
Reference hereby is made to (i) the Credit Agreement, dated as of May 10, 2010 (such agreement, as amended, restated, supplemented, modified or otherwise changed from time to time, including any replacement agreement therefor, being hereinafter referred to as the “Credit Agreement”) by and among Lantheus MI Intermediate, Inc., a Delaware corporation (the “Parent”), Lantheus Medical Imaging, Inc., a Delaware corporation (the “Borrower”), the “Guarantors” from time to time party thereto, the lenders from time to time party thereto (each a “Lender” and collectively, the “Lenders”), Harris N.A., as collateral agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, the “Collateral Agent”), Bank of Montreal, as administrative agent for the Lenders (in such capacity, together with its successors and assigns in such capacity, if any, the “Administrative Agent” and together with the Collateral Agent, each an “Agent” and collectively, the “Agents”), Bank of Montreal and NATIXIS, as joint bookrunners, Bank of Montreal and NATIXIS, as joint lead arrangers, NATIXIS, as syndication agent, and Jefferies Finance, LLC, as documentation agent, and (ii) the Pledge and Security Agreement, dated as of May 10, 2010 (as amended, restated, supplemented or otherwise modified from time to time, the “Security Agreement”), made by the Grantors from time to time party thereto in favor of the Collateral Agent. Capitalized terms defined in the Credit Agreement or the Security Agreement and not otherwise defined herein are used herein as defined in the Credit Agreement or the Security Agreement.
SECTION 1. Grant of Security. The undersigned hereby grants to the Collateral Agent, for the ratable benefit of the Secured Parties and the L/C Issuer, a security interest in, all of its right, title and interest in and to all of the Collateral (as defined in the Security Agreement) of the undersigned, whether now owned or hereafter acquired by the undersigned, wherever located and whether now or hereafter existing or arising, including, without limitation, the property and assets of the undersigned set forth on the attached supplemental schedules to the Schedules to the Security Agreement.
SECTION 2. Security for Obligations. The grant of a security interest in the Collateral by the undersigned under this Security Agreement Supplement and the Security Agreement secures the payment of all Secured Obligations of the undersigned now or hereafter existing under or in respect of the Loan Documents, whether direct or indirect,
absolute or contingent, and whether for principal, reimbursement obligations, interest, premiums, penalties, fees, indemnifications, contract causes of action, costs, expenses or otherwise. Without limiting the generality of the foregoing, each of this Security Agreement Supplement and the Security Agreement secures the payment of all amounts that constitute part of the Secured Obligations and that would be owed by the undersigned to the Collateral Agent or any Secured Party or the L/C Issuer under the Loan Documents but for the fact that such Secured Obligations are unenforceable or not allowable due to the existence of a bankruptcy, reorganization or similar proceeding involving a Grantor.
SECTION 3. Supplements to Security Agreement Schedules. The undersigned has attached hereto supplemental Schedules I through VIII to Schedules I through VIII, respectively, to the Security Agreement, and the undersigned hereby certifies, as of the date first above written, that such supplemental Schedules have been prepared by the undersigned in substantially the form of the equivalent Schedules to the Security Agreement, and such supplemental Schedules include all of the information required to be scheduled to the Security Agreement and do not omit to state any information material thereto.
SECTION 4. Representations and Warranties. The undersigned hereby makes each representation and warranty set forth in Section 5 of the Security Agreement (as supplemented by the attached supplemental Schedules) to the same extent as each other Grantor.
SECTION 5. Obligations Under the Security Agreement. The undersigned hereby agrees, as of the date first above written, to be bound as a Grantor by all of the terms and provisions of the Security Agreement to the same extent as each of the other Grantors. The undersigned further agrees, as of the date first above written, that each reference in the Security Agreement to an “Additional Grantor” or a “Grantor” shall also mean and be a reference to the undersigned.
SECTION 6. Governing Law. This Security Agreement Supplement shall be governed by, and construed in accordance with, the laws of the State of New York.
SECTION 7. Loan Document. In addition to and without limitation of any of the foregoing, this Security Agreement Supplement shall be deemed to be a Loan Document and shall otherwise be subject to all of terms and conditions contained in Sections 12.10 and 12.11 of the Credit Agreement, mutatis mutandi.
|
|
|
Very truly yours, |
||
|
|
|
|
||
|
|
|
[NAME OF ADDITIONAL CREDIT PARTY] |
||
|
|
|
|
||
|
|
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
|
|
||
|
HARRIS N.A., |
|
|
||
|
as the Collateral Agent |
|
|
||
|
|
|
|
||
|
By: |
|
|
|
|
|
Name: |
|
|
|
|
|
Title: |
|
|
|
|
